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Concordia University, 2017 
 
Lysosomes are dynamic organelles most notably known as the terminal compartments of the 
endocytic and autophagy pathways in eukaryotic cells. However, lysosome function is not simply 
for the elimination and catabolism of biomaterials. Rather lysosomes have emerged as critical 
and dynamic signaling hubs via their ability to sense and provide nutrients, and communicate this 
information to biosynthetic or metabolic processes. Lysosome physiology relies on membrane 
transporter activity, best signified by loss-of-function mutations linked to lysosomal storage 
disorders. These include nutrient transporter proteins that export products of catabolism to the 
cytoplasm for cellular reuse, as well as Ca2+ pumps and transporters important for signaling, and 
transporters for metal storage and homeostasis. Eukaryotic cells, and their lysosomes, undergo 
continuous renovation to clear damaged or unused proteins or to alter their proteome 
accommodating functional changes in response to the environment, physiological cues, or aging. 
Despite the importance of lysosomal transporters to cell physiology, little is known about their 
lifetimes and it remains unclear how they are degraded.  
Here, I used Saccharomyces cerevisiae and its vacuolar lysosome as models to study 
lysosomal transporter lifetimes and discovered a new cellular protein degradation pathway, the 
IntraLumenal Fragment (ILF) pathway: During membrane fusion events between lysosomes, 
transporters are selectively labeled for recognition and sorting by the fusion protein machinery 
into an area of membrane spanning the apposed organelles. Upon fusion, this membrane and 
proteins embedded within it are internalized into the lumen as a byproduct for degradation by 
hydrolases. I find the ILF pathway selectively degrades lysosomal transporters when misfolded, 
in response to TOR signaling or changes in substrate levels. I also find that protein clients are not 
limited to lysosomal transporters, as this pathway degrades internalized surface membrane 
proteins that bypass entry into the canonical MultiVesicular Body pathway, which was 
previously thought to be the exclusive mechanism for selective surface protein degradation. 
Finally, I find the ILF pathway cooperates with a second, independent protein degradation 
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pathway, the vReD pathway, to change the lysosomal membrane proteome. The underlying 
machinery and transporters studied are evolutionarily conserved, suggesting the ILF pathway 
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Chapter 1. Introduction 
1.1 Lysosome physiology 
All eukaryotic cells contain organelles that perform specific functions. Lysosomes are 
dynamic organelles implicated in a variety of cellular processes including, nutrient sensing 
through mTOR signaling (Perera and Zoncu, 2016), the storage or metals, ions and amino acids 
(Li and Kane, 2009), plasma membrane repair (Andrews, 2002), and transcriptional regulation 
(Settembre et al., 2013). First discovered in 1955 by Belgian biochemist Christian de Duve, the 
lysosome is perhaps most notably known as the degradative organelle, responsible for the 
catabolism and recycling of both intracellular and extracellular biomaterials. Important for its 
degradative function is the acidic lumenal pH – ranging between pH 4.5 and 5.5 – which provides 
an optimal environment for hydrolase activity. Lumenal acid hydrolases catabolize a wide variety 
of cellular compartments leading to the production of nutrients such as amino acids, nucleotides, 
monosaccharides, and fatty free acids, which are exported for cellular reuse by dedicated 
transporters. Since these transporters support lysosomal function, their lifetimes must be tightly 
regulated to ensure organelle homeostasis. As with other cellular proteins, lysosomal polytopic 
proteins are at constant risk of misfolding or aggregating to potentially cause toxicity and disease.  
Lysosomes are the terminal hub of multiple trafficking pathways that carry biomaterials 
destined for degradation. These pathways, including the secretory, endocytic, phagocytic and 
autophagic membrane-trafficking pathways, are dependent on lysosome function for the 
degradation of cellular components. Essential for proper lysosome function, there are three 
specific events that must occur: membrane fusion between the lysosome and various transport 
vesicles, the catabolism of biomaterials, and the export of nutrients for cellular reuse. First, in 
order for lysosomes to receive incoming biomaterials, the lysosome must undergo a membrane 
fusion event with transport vesicles encapsulating biomaterials from within the cell, through 
autophagy or from outside the cell, via endocytosis and the MultiVesicular Body pathway. Once 
within the lysosomal lumen, biomaterials are exposed to lumenal acid hydrolases, such as 
proteases and lipases, for catabolism into their constituents, including amino acids, lipids, and 
nucleotides. Once degraded, these nutrients are exported back out into the cytoplasm for reuse by 
the cell through resident lysosomal membrane transporters. These lysosomal transporter proteins 
are thus essential for lysosomal function as they also regulate the lumenal environment and 
contribute to cellular signaling. 
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For example, the V-type H+-ATPase drives lumenal acidification required for the proper 
maturation and function of acid hydrolases that degrade proteins, lipids and DNA into their 
constituents (Tarsio, et al., 2011). In turn, these constituents are returned to the cytoplasm for 
reuse through the activities of other transporters that mobilize nucleotides (ENT3) (Song et al., 
2014), amino acids (SLC38A9, PQLC2) (Jung et al., 2015; Jezegou et al., 2013), lipids (NPC1, 
CLN3) (Ko, et al., 2001), and other metabolites and macromolecules (e.g. ABCB6) (Kiss et al., 
2015). Lysosomes are also critical for cellular Ca2+ signaling (TRPML1) (Wang et al., 2015) and 
storage of divalent metals – including Zn2+ by ZnT2 (Hennigar and Kelleher, 2015), Cu2+ by 
SLC31A2 (Schweigel-Rontgen, 2014) and iron by NRAMP2/DMT1 (Ehrnstorfer et al., 2011) – 
essential cofactors for many cellular enzymes. Due to their importance to lysosome physiology, 
mutations that target many of these transporters underlie human diseases related to lysosome 
dysfunction, classified as lysosomal storage disorders. These include mucolipidosis type IV 
linked to TRPML1 (Waller-Evans and Lloyd-Evans, 2015), juvenile neuronal ceroid 
lipofuscinosis (or Batten disease) linked to CLN3 (Arlt et al., 2011), or Niemann-Pick disease 
type C linked to NPC1 (Berger et al., 2005). Despite the fact that lysosomal transporters are 
critical for cellular homeostasis and their lifetimes must be tightly regulated, these proteins are 
understudied leading to the pivotal question: How are resident lysosomal polytopic proteins 
turned over by degradation? 
 
1.2 ESCRT-dependent degradation of polytopic proteins 
One possibility is that lysosomal polytopic proteins use the canonical cellular protein 
degradation pathway known to control lifetimes of polytopic proteins that relies on lysosome 
function, the MultiVesicular Body (MVB) pathway (Figure 1A). Surface polytopic proteins, 
such as receptors or transporters, are responsible for diverse physiology, including cellular 
growth and differentiation, the immune response, and neurotransmission (Raiteri and Raiteri, 
2015). As such, their lifetimes are tightly regulated through the biosynthesis of new proteins as 
well as the removal and degradation of existing proteins via endocytosis and the MVB pathway. 
Since their discovery, how ESCRTs (Endosomal Sorting Complexes Required for Transport) 
function in regulating protein turnover has been extensively studied. With a few exceptions, 
ESCRT-dependent protein sorting into the MVB pathway relies on cargo protein ubiquitylation, a 
universal signal for protein degradation (MacDonald et al, 2012). These proteins are 
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ubiquitinated primarily through the coordinated action of an E3-ubiquitin ligase and an E4-
adaptor protein, either constitutively (i.e. Ste3-GFP; Davis et al., 1993), in response to protein 
misfolding (Keener and Babst, 2013), TOR activation (MacGurn et al., 2011), or due to changes 
in cognate substrate levels (i.e. Mup1-GFP; MacDonald et al., 2012). Once ubiquitinated, 
proteins are internalized by endocytosis and sent to endosomal membranes, where they are 
recognized and interact with ESCRT machinery that function sequentially to sort and package 
protein cargoes into intralumenal vesicles (ILVs) (Raiborg and Stenmark, 2009; Henne et al., 
2011). After multiple rounds of this process, a mature MVB forms that upon fusing with the 
lysosome, deposits protein-laden vesicles within the lumen for degradation by lumenal acid 
hydrolases. 
The ESCRT protein machinery are evolutionarily conserved and function sequentially to 
drive surface protein recognition and sorting. This sorting machinery is comprised of five protein 
complexes (ESCRT-0, ESCRT-I, ESCRT-II, ESCRT-III and the Vps4 complex) that initially 
reside in the cytoplasm, but are successively recruited to the endosomal membrane for assembly 
and to facilitate protein sorting and MVB genesis. 
The ESCRT-0 complex initiates the MVB pathway and is a heterodimer consisting of Vps27 
(Vacuole Protein Sorting) and Hse1 (Henne et al., 2011). ESCRT-0 localizes to endosomal 
membranes where both subunits can recognize and engage ubiquitylated plasma membrane 
polytopic proteins, or ‘cargoes’. ESCRT-0 also recruits the ESCRT-1 complex, comprised of 
Vps23, Vps28, Vps37, and Mvb12, through its interaction with Vps23. ESCRT-I, through the 
UEV (Ubiquitin E2 Variant) domain of Vps23, binds ubiquitylated protein cargoes and recruits 
ESCRT-II via the interaction between Vps28 and Vps36. ESCRT-II, comprised of Vps36, Vps22, 
and Vps25, propagates ubiquitylated protein sorting through Vps36 and recruits ESCRT-III with 
the interaction between Vps25 and Vps20. The ESCRT-III complex, consisting of Vps20, Snf7, 
Vps24 and Vps2, is required for the final steps of the MVB sorting, cargo protein sequestration, 
and MVB vesicle formation. Snf7 sequesters cargo proteins into membrane patches to initiate 
MVB formation and Vps2 recruits the Vps4 complex consists of three subunits, Vps4, Vps60 and 
Vta1, for final scission of the invaginated membrane, via the ATPase activity of Vps4, and 
creation of the intralumenal vesicle and ESCRT disassembly. Unlike the other ESCRT  
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Figure 1. Summary of the canonical ESCRT-dependent pathway and the ESCRT-
independent, IntraLumenal Fragment pathway for polytopic protein degradation 
(A) Cartoon models of key stages in ESCRT-dependent (MVB and vReD) and ESCRT-
independent (ILF) protein degradation pathways. Surface polytopic proteins (dark blue) and 
lysosomal polytopic proteins (light blue) are sent to the endosome for sorting into ILVs by 
ESCRT machinery before deposition within the lysosomal lumen for degradation. Surface or 
lysosomal polytopic proteins (red) are present within the boundary membrane and internalized as 
an ILF for degradation within the lysosomal lumen.  (B) Stages of homotypic membrane fusion 
demonstrating how the ILF pathway accommodates lysosomal polytopic protein sorting and 
internalization. (C) Working model describing how lysosomal nutrient transporters are labeled 
with ubiquitin for selective sorting into the boundary membrane in the ILF pathway. Upon 
stimulation, nutrient transporters are labeled with ubiquitin through coordination of an E3 
Ubiquitin-ligase and an E4-adaptor protein. Once ubiquitinated, the membrane fusion machinery 
– including SNARE proteins, the Rab GTPase Ypt7, and the HOPS tethering complex – 
recognize and bind the protein for active sorting into the boundary membrane for subsequent 
internalization into the lysosomal lumen and exposure to lumenal acid hydrolases for degradation 
upon lipid bilayer fusion. The membrane fusion machinery concentrates at the vertex domain of 
docked organelles to facilitate fusion, thus they are in an ideal location to regulate polytopic 
protein sorting as the vertex surrounds the boundary membrane in a ring. Additionally, three of 
the six HOPS subunits contain RING (Really Interesting New Gene)-like motifs that when in 
complex form a predicted ubiquitin-binding domain. (D) Cartoon comparing polytopic protein 
sorting at the endosome and lysosome. At the endosome, proteins undergo ESCRT-dependent 
sorting into a ring surrounding the nascent ILV prior to a membrane scission event mediated by 
the ESCRT-III complex for ILV genesis. At the lysosomal membrane, the membrane fusion 
machinery including Ypt7 and HOPS assemble in a vertex ring surround the boundary membrane 
for protein sorting prior to SNARE-mediated membrane fusion and internalization of the 
boundary as an ILF. Black dots represent polytopic proteins. PM: Plasma membrane MVB: 
MultiVesicular Body. ILVs: Inralumenal vesicles. ILF: Intralumenal fragment. MTC: 
multisubunit tethering complex. HOPS: homotypic fusion and vacuole protein sorting. SNAREs: 
soluble NSF attachment protein receptor. Ub: ubiquitin. Ypt7: Rab GTPase. PY: PY-motif. E3: 
E3-ubiquitin ligase. l = lumen. c = cytoplasm.  
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complexes, none of the ESCRT-III subunits contain ubiquitin-binding domains, rather they are 
thought to function as the membrane scission (or fission) machinery. These subunits can 
oligomerize into spiral-shaped polymers capable of deforming endosomal membranes into 
inward budding tubular structures (Mageswaran et al., 2014), allowing for the final scission of 
the invaginated membrane and creation of the intralumenal vesicle. Together, the ESCRT 
complexes form a concentric ring or circle to concentrate cargo proteins for their internalization 
into nascent ILVs (Figure 1D; Piper et al., 1995; Urbanowski and Piper, 2001; Babst et al., 2002; 
Katzmann et al., 2003; Nickerson et al., 2007; Teis et al., 2009; Shields and Piper, 2012; Vild et 
al., 2015). 
Recently Scott Emr and colleagues proposed an ESCRT-dependent mechanism, termed the 
vReD (Vacuole membrane REcycling and Degradation) pathway, capable of degrading 
lysosomal transporter proteins in response to changes in cognate substrate levels. Here, instead of 
entering the MVB pathway from the surface, lysosomal transporter proteins are sent directly from 
the lysosome (vacuole) to the endosome for ESCRT-dependent sorting and ILV packaging 
(Figure 1A). In their founding publication, the authors demonstrated that Ypq1, a vacuolar amino 
acid transporter protein, is ubiquitinated and sent through a retrograde trafficking pathway to the 
MVB when cells are starved of lysine. Briefly, Ypq1 is ubiquitinated by the E3-ligase Rsp5 and 
E4 adaptor protein Ssh4, where it is sorted into patches on the vacuolar membrane. These patches 
then bud off of the membrane as post-vacuolar compartments where the ESCRT-machinery can 
further package Ypq1 into ILVs creating a mature MVB. Upon fusion between the MVB and the 
vacuole, Ypq1-containing ILVs are deposited within the lumen for degradation (Li et al., 2015a). 
Shortly after characterizing the selective degradation of Ypq1, the authors published a similar 
story for the turnover of Cot1 – a zinc transporter – in response to changes in zinc levels. Here, 
Cot1 is ubiquitinated by the E3-ligase Tul1 and the DSC (Defective in SREBP Cleavage) 
complex when cells are grown in the absence of zinc (Li et al., 2015b). 
While the vReD pathway represents the first descriptions of how vacuolar lysosome 
polytopic proteins can be degraded, Ypq1 and Cot1 are the only known cargoes and authors 
admit that other transporters (e.g. Fth1, Vph1, Fet5, Ncr1, Ycf1 and Vba4; Li et al., 2015a,b) do 
not use this pathway for degradation upon substrate manipulation. Additionally, the authors only 
observe protein degradation by the vReD pathway in response to substrate chelation or addition 
and have yet to identify any lysosomal proteins constitutively degraded by this pathway and the 
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ESCRT machinery. It is known that cells survive when components of the ESCRT machinery are 
impaired, suggesting another pathway for vacuolar lysosome transporter degradation exists 
within the cell. One cellular process that may accommodate the topological challenge of 
internalizing lysosomal polytopic proteins for degradation is through homotypic lysosome 
(lysosome-lysosome) membrane fusion. 
 
1.3 Vacuolar lysosome membrane fusion 
When degradative processes were first discovered, membrane fragments present within the 
lysosomal lumen were also identified, which facilitate lipid and protein catabolism. These 
fragments are known to result from two main cellular protein degradation pathways, autophagy 
and endocytosis, that terminate with a heterotypic membrane fusion event between their 
respective transport vesicle and the lysosome. However, when components of these pathways are 
impaired, lumenal membrane fragments persist, suggesting another process exists that results in 
lipid fragment formation. Based on current knowledge, there is one cellular event that may result 
in lumenal fragment formation and intrinsically could accommodate the turnover of lysosomal 
polytopic proteins: the process of homotypic lysosome membrane fusion. 
Around the same time that the molecular machinery responsible for selective down-
regulation of surface transporters was first discovered, Wickner, Merz and colleagues 
demonstrated that upon fusion of two vacuolar lysosomes, a portion of the membrane is 
internalized into the lumen as a byproduct of the reaction (Wang et al., 2002) using 
Saccharomyces cerevisiae and its vacuolar lysosome as models. This process of homotypic 
membrane fusion has been very well characterized and occurs in four distinct subreactions: 
priming, tethering, docking, and fusion (Figure 1B).  
Priming prepares vacuoles for the fusion reaction by disassembling cis-SNARE (Soluble N-
ethylmaleimide-sensitive factor (NSF) Attachment REceptor) complexes, to ensure that 
individual SNARE proteins will interact and form new complexes in trans, a prerequisite for 
fusion. This stage is initiated by the ATPase activity of Sec18 (NSF homologue) to release Sec17 
(a cis-SNARE chaperone and α-SNAP homologue) and disassemble the cis-SNARE complex 
(Eitzen et al., 2000; Wickner and Haas, 2000; Wang et al., 2003b). This disassembly frees 
individual SNARE proteins (Vam3, Vit1, Vam7, and Nyv1) and the HOPS (HOmotypic vacuole 
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fusion and Protein Sorting) tethering holocomplex from their complexed state to allow for the 
formation of new SNARE complexes on apposed organelle membranes.  
Tethering, a prerequisite for membrane fusion, occurs when apposing membranes make 
initial contact and establish a site for formation of the vertex domain. This step requires the Rab 
GTPase Ypt7 (Rab 7 homolog) to associate with HOPS, its effector. HOPS is comprised of a 
class C core complex (Vps11, 16, 18, and 33) with two accessory proteins (Vps39 and 41; 
Nickerson et al., 2009), and this Rab-mediated step tethers membranes reversibly. 
Docking occurs as the vertex domain expands radially, forming the boundary membrane – 
the area of membrane within the vertex of apposed vacuoles (Wang et al., 2002). During this 
stage, the membrane fusion machinery – including Ypt7, HOPS, and SNARE proteins – 
accumulate and assemble into an expanding ring that stabilizes contact at the vertex between 
apposed membranes (Wickner and Haas, 2000; Wickner, 2010). Ypt7 localizes to the vertex 
domain and functions to recruit additional fusion machinery to stabilize this site in support of 
fusion. In order to recruit additional machinery, Ypt7 must first be activated, or converted from a 
GDP-bound state to a GTP-bound state by its guanine nucleotide exchange factor (GEF), the 
Mon1-Ccz1 complex (Wang et al., 2003a; Nordmann et al., 2010; Kiontke et al., 2017). GEFs are 
thus critical activators of fusion reactions, by coupling Rab activation with recruitment to cognate 
membranes. In its active state, Ypt7 binds and recruits HOPS to the vertex, which in cooperation 
with other machinery components, ensures fidelity of the membrane fusion event by creating a 
physical link between the two apposed membranes. Other effectors of docking include Gyp3 and 
Gyp7, both Rab GTPase-activating proteins (GAPs) that inactivate Ypt7 through GTP hydrolysis, 
and a GDP dissociation inhibitor (GDI) chaperone, which extracts inactive Rab (Ypt7:GDP) and 
retains it in the cytoplasm (Eitzen et al., 2000; Cabrera and Ungermann, 2013). 
As docking proceeds, trans-SNARE complexes within this assembly progressively twist into 
stable helical bundles (or SNARE pins) that drives lipid bilayers together leading to complete 
membrane fusion. This trans-SNARE pairing involves the binding of three Q-SNAREs (Vam3, 
Vti1 and Vam7) with one R-SNARE (Nyv1), and renders the fusion reaction irreversible 
(Wickner, 2010). SNAREs are categorized based on the residue they contribute to the ‘zero-
layer’, or the center of the helical bundle (glutamine (Q) or arginine (R)), which generates polar 
interactions to ensure proper SNARE assembly (Baker et al., 2015). SNARE assembly also 
requires Sec1/Munc18 (SM) proteins that interact with individual SNAREs, as well as with 
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partial or complete complexes. Recent evidence suggests that Vps33, a SM protein and subunit of 
HOPS, orchestrates SNARE pairing by binding to two SNARE proteins (Nyv1 and Vam3 via 
their SNARE motifs), one from each apposed membrane, to act as a template for generating 
partially zippered SNARE complex intermediates (Baker et al. 2015). Once SNARE complexes 
are fully zippered, they bring apposed membranes in close proximity to promote lipid bilayer 
merger for full membrane fusion and lumenal content mixing. 
Importantly, the boundary membrane is internalized as an intralumenal fragment and 
degraded as a byproduct of this fusion event (Wang et al., 2002). Topologically, formation of this 
intralumenal fragment is analogous to genesis of intralumenal vesicles within the MultiVesicular 
Body pathway (Figure 1D), which accommodates exposure of internalized surface transporters 
to acid hydrolases for degradation. Although fusion proteins are spared from internalization upon 
fusion, it was previously unclear whether polytopic proteins can be selectively sorted into the 
boundary membrane, where they would be degraded as a byproduct of organelle fusion.  
Thus, we hypothesized that the process of homotypic organelle membrane fusion could 
accommodate the selective turnover of lysosomal polytopic proteins upon internalization of the 
boundary membrane fragment after fusion. Using S. cerevisiae, we examined polytopic protein 
membrane localization or sorting, internalization, and degradation upon organelle fusion within 
cells as well as using purified organelles. In summary, we discovered a new cellular degradation 
pathway, which we named the IntraLumenal Fragment pathway (Figure 1A and B), that 
selectively degrades lysosomal membrane proteins as well as surface proteins in response to 
protein misfolding, TOR signaling, and changes in cognate substrate levels.  
 
1.4 ESCRT-dependent and –independent pathways coordinate function for cellular protein 
turnover  
Until now, the ESCRT machinery and the MultiVesicular Body pathway represented the 
only known mechanism for the regulated turnover of polytopic proteins, post-endoplasmic 
reticulum exit. However, when key components of the ESCRT machinery are impaired, cells still 
survive and known MVB cargo proteins are still degraded, although less efficiently. Since both 
the quality and the quantity of polytopic proteins is essential for proper cellular function, it seems 
likely that eukaryotic cells would not exclusively rely on one core mechanism for the degradation 
of these proteins. The IntraLumenal Fragment (ILF) pathway represents a completely new and 
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different mechanism than the canonical ESCRT-dependent pathway for polytopic protein 
degradation. While there are clear differences between these processes, they perform analogous 
roles in protein catabolism, relying on distinct molecular machinery for protein sorting and 
internalization at their respective cellular locations. Both contribute to the degradation of a 
variety of cellular cargoes in response to protein misfolding, changes in substrate levels and TOR 
(target of rapamycin) signaling. Ultimately, ESCRT-dependent and ESCRT-independent 
pathways complement each other by remodeling membrane protein landscapes to preserve 
organelle identity and maintain cellular proteostasis. These findings are summarized in Table 1 
and Figure 1. 
Both ESCRT-dependent and –independent pathways accommodate the degradation of a 
variety of protein cargoes. While the primary function of the MVB pathway is to down-regulate 
surface polytopic proteins, evidence exists that ESCRTs can sort and package lysosomal 
polytopic proteins (via the vReD pathway), soluble proteins and biosynthetic proteins (i.e. 
carboxypeptidase S (CPS) Tran et al., 2009; Mageswaran et al., 2014; Feyder et al., 2015). It has 
yet to be elucidated if the ILF pathway can selectively degrade non-polytopic proteins. However, 
if soluble or membrane-associated proteins localize to lysosomal membranes, the ILF pathway 
likely can accommodate their internalization and degradation.  
The majority of ESCRT client proteins undergo ubiquitylation either at the plasma 
membrane (i.e. surface polytopic proteins) or at endosomal membranes (i.e. biosynthetic 
proteins) prior to sorting by the ESCRT complexes. Several ubiquitin-binding domains or motifs 
have been identified in ESCRT-0 (Vps27 and Hse1), ESCRT-I (Vps23 and Mvb12), and ESCRT-
II (Vps36) complexes, highlighting that the earlier stages of ESCRT trafficking are important for 
cargo protein binding and sorting. Similarly in the vReD pathway, lysosomal membrane proteins 
are first labeled with ubiquitin prior to packaging into the post-vacuolar compartments for 
ESCRT-mediated sorting and degradation. Since the ILF pathway selectively sorts and degrades 
polytopic proteins, a labeling mechanism likely exists. Based on these studies as well as the 
extensive literature detailing other eukaryotic protein degradation pathways, we speculate that 
ubiquitin is the label to identify proteins for degradation in the ILF pathway (Figure 1B and C). 
In this work we have shown that the ILF pathway recognizes and degrades misfolded proteins, 
which are typically labeled with ubiquitin (Claessen et al., 2011; Keener and Babst, 2013; Zhao 
et al., 2013; Fang et al., 2014). Nutrient transporters degraded by this pathway can be 
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Cargoes   
Lysosome polytopic   
Surface polytopic   
Membrane-associated   
Soluble cytoplasmic   
Biosynthetic          ? 
Lipids (selective)              ? (DAG) 
   
Labeling and sorting   
Ubiquitin label  ? 
E3-ligase   
E4-adaptor   
Sorting ESCRT-0-II HOPS (Ypt7) 
   





Change in membrane 
morphology 
Scission (Fission) Fusion 
Number of compartments 
required 
1 2 
Size of product ~ 100 nm > 100 nm 
Catalytic machinery ESCRT-III SNAREs 
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ubiquitylated and interact with the ubiquitylation machinery based on results from genome-wide 
studies (Urbanowski and Piper, 2001; Peng et al., 2003). Additionally, E3-ubiquitin ligases and 
E4-adaptor proteins are capable of ubiquitylating lysosomal proteins in the vReD pathway (Li et 
al., 2015a,b) and through our own observations are important for protein degradation by the ILF 
pathway (unpublished data). Lastly, the ILF pathway can accommodate the sorting and 
degradation of surface proteins, and vReD client proteins, if they avoid packaging into 
intralumenal vesicles (but are still labeled with ubiquitin), thus it is likely that protein labeling 
and sorting in the ILF pathway is ubiquitin-dependent as well. 
Based on these observations and what we know about the ILF pathway, we propose a model 
for the ubiquitin-dependent sorting and internalization of lysosomal polytopic proteins in the ILF 
pathway (Figure 1C). First, a stimulus, such as heat stress, triggers the ubiquitination of a 
lysosomal membrane protein through coordination of an E3-ubiquitin ligase and E4-adaptor 
protein. Once ubiquitinated, the protein must be actively sorted into the boundary membrane for 
subsequent internalization into the lysosomal lumen upon fusion. We speculate that the 
membrane fusion machinery – including the Rab GTPase Ypt7 and the HOPS tethering complex 
– facilitate protein recognition and sorting as they localize to the vertex domain of docked 
vacuoles (Wang et al., 2002; Wickner, 2010) and are thus in a location capable of regulating 
boundary membrane protein composition. Additionally, we have shown that impairing Ypt7 
function inhibits protein sorting, internalization, and degradation (Figures 7, 10, 11, 12, 18, S6, 
S9 and S11), and that these proteins are actively sorted in a molecular sieving mechanism during 
vertex ring expansion (Figures 8). Furthermore, three of the six subunits of the HOPS tethering 
complex (Vps39, Vps18, and Vps11) contain partial RING (Really Interesting New Gene)-like 
motifs that when in complex form a predicted ubiquitin-binding domain (Nickerson et al., 2009). 
Similar to the how the numerous ubiquitin-binding domains of the ESCRT machinery sort 
surface proteins in the MVB pathway (Nickerson et al., 2007; Henne et al., 2011; Shields and 
Piper, 2012) these HOPS subunits could recognize and sort ubiquitinated lysosomal proteins into 
the boundary for subsequent internalization as the intralumenal fragment and degradation by 
lumenal acid hydrolases. 
Once cargo proteins are efficiently sorted into ILVs or into the boundary membrane, the 
limiting membrane must undergo a change in morphology to allow for subsequent protein 
degradation. In the MVB pathway, the ESCRT-III complex facilitates the final scission between 
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the nascent ILV and the endosomal membrane for cargo internalization and MVB maturation. 
Additionally, homologs of ESCRT-III subunits and Vps4 are implicated in other membrane 
scission or fission events, such as cell division in Archaea (Samson et al., 2008) and cytokinesis 
in mammals (Carlton and Martin-Serrano, 2007). Similarly, in the ILF pathway SNARE proteins 
are the catalytic machinery responsible for membrane fusion and the internalization of the 
boundary as an intralumenal membrane fragment. SNAREs are found in all eukaryotic organisms 
and are recognized as the key components of protein complexes that mediate and drive 
membrane fusion events at distinct subcellular locations. SNARE-mediated membrane fusion 
events are implicated in both endocytic and exocytic trafficking pathways, thus they are essential 
for a variety of cellular processes including cell growth, membrane repair, cytokinesis, hormone 
secretion and synaptic transmission (Fasshauer et al., 1998; Hong, 2005; Wickner and Schekman, 
2008). While both processes generate a similar product to topologically accommodate protein 
internalization, ILVs are much smaller than ILFs, typically being around 100 nm in diameter. 
 
Despite clear mechanistic differences between ESCRT-dependent and –independent 
pathways, they both are capable of accommodating the topological challenge of internalizing 
polytopic proteins for degradation. Thus, both pathways are equally important for cellular 
homeostasis by remodeling protein landscapes to allow for organelle adaptation in response to 
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Chapter 2. Selective Lysosomal Transporter Degradation  
by Organelle Membrane Fusion 
2.1 Abstract 
Lysosomes rely on their resident transporter proteins to return products of catabolism to the 
cell for reuse, and for cellular signaling, metal storage and maintaining the lumenal environment. 
Despite their importance, little is known about the lifetime of these transporters or how they are 
regulated. Using Saccharomyces cerevisiae as a model, we discovered a new pathway intrinsic to 
homotypic lysosome membrane fusion that is responsible for their degradation. Transporter 
proteins are selectively sorted by the docking machinery into an area between apposing lysosome 
membranes, which is internalized and degraded by lumenal hydrolases upon organelle fusion. 
These proteins have diverse lifetimes that are regulated in response to protein misfolding, 
changing substrate levels or TOR activation. Analogous to endocytosis for controlling surface 
protein levels, the “intralumenal fragment pathway” is critical for lysosome membrane 
remodeling required for organelle function in context to cellular protein quality control, ion 
homeostasis and metabolism. 
 
2.2 Introduction 
All eukaryotic organisms use organelles called lysosomes to recycle biomaterials. To receive 
incoming biomaterial, lysosomes must fuse with encapsulated compartments containing proteins, 
DNA, damaged organelles, or cellular debris packaged within through autophagy or collected 
from outside the cell by endocytosis. Fusion events expose the biomaterials to lumenal 
hydrolases for catabolism and once degraded, resident lysosomal transporters translocate the 
constituents from the lumen to the cytoplasm for reuse by the cell. These transporters include 
nucleotide transporters ENT3 (Song et al., 2014), amino acid transporters SLC38A9 (Jung et al., 
2015), lipid transporters NPC1 (Berger et al., 2005) and transporters for metabolites and 
macromolecules, e.g. ABCB6 (Kiss et al., 2015). Lysosomes are also critical for storage of 
divalent metals – including zinc by ZnT2 (Hennigar and Kelleher, 2015), copper by SLC31A2 
(Schweigel-Rontgen, 2014) and iron by NRAMP2/DMT1 (Ehrnstorfer et al., 2011) – essential 
cofactors for many cellular enzymes. Because of their importance to lysosome physiology, 
mutations that target many of these transporters, channels and pumps underlie human lysosomal 
storage disorders, such as mucolipidosis type IV (TRPML1; Waller-Evans and Lloyd-Evans, 
 15  
2015) or Niemann-Pick disease type C (NPC1; Berger et al., 2005). Despite being critical for 
lysosome function and their relationship with human disease, we know little about how these 
transporters are regulated or degraded. 
Most polytopic proteins, after passing endoplasmic reticulum quality control, are degraded 
by the MultiVesicular Body (MVB) pathway. This pathway mediates the ubiquitin-dependent 
downregulation of surface transporters and receptors (Katzmann et al., 2001; Babst, 2011) either 
constitutively (e.g. Ste3; Davis et al., 1993) or in response to cellular cues, such as changes in 
substrate levels (e.g. Mup1; MacDonald et al., 2012) or upon protein misfolding (e.g. Fur4; 
Keener and Babst, 2013). A critical step in the MVB pathway is the inward budding of the 
membrane, which results in formation of intralumenal vesicles (ILVs) within the MVB. 
Importantly, surface proteins targeted for downregulation are sorted into the ILVs where upon 
heterotypic fusion between the MVB and the lysosome, the protein laden ILVs are delivered to 
the lysosomal lumen for exposure to acid hydrolases and degradation (Katzmann et al., 2001; 
Shields and Piper, 2012).  
MVB formation and protein sorting are achieved through the sequential function of a 
multisubunit machinery comprised of the endosomal sorting complex required for transport 
(ESCRT) complexes. Recently, Emr and colleagues demonstrated that some resident lysosomal 
membrane proteins utilize components of the MVB pathway machinery for degradation using 
Saccharomyces cerevisiae as a model (Li et al., 2015a,b). While this is the first description of a 
mechanism for lysosomal polytopic proteins degradation, the authors disclose that this process, 
termed vReD (vacuolar membrane REcycling and Degradation), does not regulate the lifetimes of 
other yeast transporters and pumps, e.g. Vph1 (subunit of the V-ATPase), Fth1 (iron transporter) 
and Vba4 (cationic amino acid transporter). Additionally, cells survive and divide when key 
components of the ESCRT machinery are eliminated or dysfunctional (Mageswaran et al., 2015). 
Thus it is possible that eukaryotic cells have an additional ESCRT-independent pathway to 
degrade polytopic proteins. If so, this new degradation pathway must possess ESCRT-
independent mechanisms that recognize and sort labeled polytopic proteins into an area of 
membrane that is internalized within the lysosomal lumen for exposure to acid hydrolases for 
degradation. Based on current knowledge, there is a cellular event that may fulfill all criteria: the 
process of homotypic lysosome membrane fusion.   
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Lysosomes are dynamic organelles constantly undergoing cycles of fission and homotypic 
fusion to retain copy number and accommodate organelle inheritance (de Duve and Wattiaux, 
1966; Wickner and Haas, 2000). Homotypic vacuolar lysosome fusion requires a sequential 
series of four distinct subreactions: priming, tethering, docking and fusion: Priming involves the 
disassembly of cis-SNARE complexes, which ensures that individual SNARE proteins will 
interact to form new complexes in trans, a prerequisite for fusion. Tethering occurs when 
apposing membranes make first contact, which requires active Ypt7, a Rab-GTPase, and the 
HOPS (HOmotypic vacuole fusion and Protein Sorting) tethering holocomplex. Docking is 
operationally defined as the period between tethering and lipid bilayer fusion. During this stage, 
fusogenic lipids and proteins assemble into an expanding ring that stabilizes contact at the vertex 
between apposing membranes (Wickner and Haas, 2000; Wang et al., 2002; Fratti et al., 2004). 
Here, trans-SNARE complexes within this assembly progressively twist into stable helical 
bundles that drive lipid bilayers together leading to complete membrane fusion. Importantly, the 
area of membrane and embedded proteins within the vertex ring, called the boundary, is 
internalized as a byproduct of this fusion event (Wang et al., 2002). Topologically, formation of 
this intralumenal fragment is analogous to genesis of intralumenal vesicles in the MVB pathway, 
which accommodates exposure of membrane proteins to hydrolases for degradation. Although 
fusion proteins are spared upon fusion, it was previously unclear whether vacuolar polytopic 
proteins can be selectively sorted into the boundary. If so, then this process could accommodate 
their internalization into the lumen for subsequent degradation. Thus we hypothesize that resident 
lysosomal membrane proteins may be selectively sorted into the boundary, internalized and 
degraded upon homotypic vacuole fusion. 
 
2.3 Materials and Methods 
2.3.1 Yeast strains and materials 
Yeast strains used in this study are listed in Table 2. Biochemical and yeast growth reagents 
were purchased from either Sigma-Aldrich, Invitrogen or BioShop Canada Inc. Proteins used 
include recombinant Gdi1 purified as previously described (Brett and Merz, 2008), recombinant 
Gyp1-46 purified as previously described (Eitzen et al. 2000), and recombinant soluble Qc-
SNARE Vam7 purified as previously described (Schwartz and Merz, 2009). Reagents used in 
fusion reactions were prepared in 20 mM Pipes-KOH, pH 6.8, and 200 mM sorbitol. 
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2.3.2 Microscopy 
Images were acquired with a Nikon Eclipse TiE inverted microscope equipped with either a 
motorized laser TIRF illumination unit, Photometrics Evolve 512 EM-CCD camera, CFI 
ApoTIRF 1.49 NA 100x objective lens, and 488 nm or 561 nm (50 mW) solid-state lasers or 
Agilent MLC400 Monolithic Laser Combiner unit, Andor Ixon3 512 EM-CCD camera, CFI Plan 
Apo Lambda 1.49 NA 100x objective lens, and Diode 488 nm or 561 nm (100mW) lasers. Both 
systems are operated with Nikon Elements software. Cross sectional images were recorded 1 μm 
into the sample and resulting micrographs were deconvolved using AutoQuant X3 (Media 
Cybernetics) and processed using ImageJ software (National Institutes of Health) and Adobe 
Photoshop CC. GFP fluorescence intensity profiles were generated using ImageJ software. 
Live yeast cells were stained with FM4-64 using a pulse-chase method as previously 
described (Brett et al., 2008). Where indicated, cells were incubated at 37 °C for 30 minutes for 
heat stress and with 100 μM cycloheximide or puromycin for 90 minutes after FM4-64 staining. 
Time-lapse videos were acquired at 30°C using a Chamlide TC-N incubator (Live Cell 
Instruments) with cells plated on coverslips coated with concanavalin-A (1 mg/ml in 50 mM 
HEPES, pH 7.5, 20 mM CaAcetate, 1 mM MnSO4). Approximately 150 vacuole fusion events 
were observed. 
 
2.3.3 Vacuole isolation and homotypic vacuole fusion 
Vacuoles were isolated from yeast cells as previously described (Haas, 1995). Fusion 
reactions were prepared using 6 μg of vacuoles isolated from GFP derivative strains in standard 
fusion reaction buffer with 0.125 M KCl, 5 mM MgCl2, 1 mM ATP and 10 μM CoA. Vacuolar 
membranes stained with FM4-64 by treating vacuoles with 3 μM FM4-64 for 10 minutes at 27 
°C. Reactions were incubated at 27 °C for 60 minutes, unless otherwise noted, and placed on ice 
prior to visualization by microscopy. For examining the contribution of the fusion machinery, 
vacuoles were incubated in the absence (CTL) or presence of 3.2 μM Gyp1-46, 4 μM rGdi, or 
100 nM rVam7 (in the absence of ATP). For heat stress treatment, vacuoles were pretreated for 5 
minutes at 37 °C before addition to the fusion reaction and incubation for 30 minutes at 27 °C. 
Where indicated, vacuoles were pretreated with 7 μM Rapamycin or DMSO, 100 μM 
cycloheximide or 100 μM puromycin for 15 minutes at 27 °C and incubated for an additional 15 
minutes with the fusion reaction. 
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Vacuole content mixing was assessed using a complementary, split β-lactamase based assay 
(Jun and Wickner, 2007). Data shown was normalized to values obtained at 120 minutes under 
standard fusion conditions (n = 3). 
To assess protein exclusion during vertex expansion, isolated vacuoles were stained with 
FM4-64 and reactions were prepared by mixing vacuole populations, 3 μg of either Vps33-GFP 
or Fet5-GFP with 3 μg of DKY6281, and were incubated for 0-60 minutes. 
 
2.3.4 Fluorescence Recovery After Photobleaching (FRAP) 
FRAP experiments were conducted using vacuoles isolated from yeast strains expressing 
Fth1-GFP, Vph1-GFP and Vps33-GFP or lacking a GFP tag (DKY6281 stained with FM4-64). 
Fusion reactions were incubated at 27 °C for 10 minutes or 60 minutes prior to imaging using a 
Nikon Eclipse TiE inverted microscope equipped with Laser Scanning C2 Confocal system and 
an CFI ApoTIRF 1.49 NA 100x objective lens. ROIs were first scanned using a 488 nm laser (3-
5% power) for five cycles to establish the prebleached fluorescence intensity. ROIs were then 
photobleached for three cycles using 100% 488 nm laser power. ROI fluorescence intensity was 
then recorded every 20 seconds for 10 minutes at 3-5% laser power of the 488 nm laser using a 
dichroic 525/50 561LP nm emission filter. FM4-64 FRAP experiments were conducted as 
described except with a dichroic 447/60 nm emission filter. Unprocessed data obtained as mean 
fluorescence values measured were corrected with respect to background fluorescence intensity 
and spontaneous photobleaching and then were normalized with respect to fluorescence intensity 
of prebleached images. Mobile fraction (Mf) values were calculated by fitting experimental 
values with the equation: Mf = (Fend – Fpost)/(Fpre – Fpost). Where Fpre corresponds to prebleach 
fluorescence, Fpost to fluorescence intensity after photobleaching and Fend to recovered 
fluorescence intensity. Fluorescence intensity curves and Mf values are means ± SEM. 
 
2.3.5 pHluorin-based assay 
Ecleptic pHluorin was cytoplasmically tagged to lysosomal membrane proteins (see Prosser 
et al., 2010). Fusion reactions (15 μl) were prepared using 6 μg of isolated vacuoles and standard 
reaction buffer. Reactions were transferred to black 96-well conical-bottom microtiter plates with 
15 μl of reaction buffer titrated to different pH values. pHluorin fluorescence (λex = 480 nm; λem 
= 515 nm) was recorded every two minutes for 90 minutes using a BioTek Synergy H1 plate 
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reading flourometer. Data shown are representative traces with values normalized to time zero, 
n≥6. 
 
2.3.6 Western blot analysis 
Fusion reactions were prepared from isolated vacuoles as previously described, expect where 
noted for altered buffer pH. Where indicated, samples were pretreated with rapamycin, 
cycloheximide, puromycin, or at 37 °C as previously described. Reactions were incubated at 27 
°C followed by addition of protease inhibitors (6.7 μM leupeptin, 33 μM pepstatin, 1 mM PMSF 
and 10.7 mM AEBSF), 1% DDM and 5X laemmli sample buffer. To solubilize membrane 
proteins but avoid aggregation due to boiling, reactions were incubated at 27 °C for 10 minutes 
prior to running on an SDS-Page gel. Samples were probed for α-GFP or α-Vph1 (Abcam, 
Cambridge, UK). All samples were repeated at least three times. Gels were imaged using GE 
Amersham Imager 600 by chemiluminescence and prepared using Adobe Photoshop and 
Illustrator CC software. 
  
 20  
Table 2. Yeast strains used in Chapter 2 
Strain Genotype Source 
BY4741 MATα his3-Δ1 leu2-Δ0 met15-Δ0 ura3-Δ0 Huh et al., 2003 
Fet5-GFP BY4741, Fet5-GFP::HIS3MX Huh et al., 2003 
Fth1-GFP BY4741, Fth1-GFP::HIS3MX Huh et al., 2003 
Vph1-GFP BY4741, Vph1-GFP::HIS3MX Huh et al., 2003 
Cot1-GFP BY4741, Cot1-GFP::HIS3MX Huh et al., 2003 
Sna4-GFP BY4741, Sna4-GFP::HIS3MX Huh et al., 2003 
Ncr1-GFP BY4741, Ncr1-GFP::HIS3MX Huh et al., 2003 
Ybt1-GFP BY4741, Ybt1-GFP::HIS3MX Huh et al., 2003 
Ycf1-GFP BY4741, Ycf1-GFP::HIS3MX Huh et al., 2003 
Vps33-GFP BY4741, Vps33-GFP::HIS3MX Huh et al., 2003 
Fth1-pHluorin BY4741, Fth1-pHluorin::KanMX This study 
Fet5-pHluorin BY4741, Fet5-pHluorin::KanMX This study 
Fth1-GFP:vps27Δ Fth1-GFP::HIS3MX, vps27Δ::KanMX This study 
Fth1-GFP:vps23Δ Fth1-GFP::HIS3MX, vps23Δ::KanMX This study 
Fth1-GFP:vps36Δ Fth1-GFP:: HIS3MX, vps36Δ::KanMX This study 
Fet5-GFP:vps27Δ Fet5-GFP::HIS3MX, vps27Δ::KanMX This study 
Fet5-GFP:vps23Δ Fet5-GFP::HIS3MX, vps23Δ::KanMX This study 
Fet5-GFP:vps36Δ Fet5-GFP::HIS3MX, vps36Δ::KanMX This study 
Fth1-GFP:atg1Δ Fth1-GFP::HIS3MX, atg1Δ::KanMX This study 
Fth1-GFP:atg7Δ Fth1-GFP::HIS3MX, atg7Δ::KanMX This study 
Fet5-GFP:atg1Δ Fet5-GFP::HIS3MX, atg1Δ::KanMX This study 
Fet5-GFP:atg7Δ Fet5-GFP::HIS3MX, atg7Δ::KanMX This study 
BJ3505 MATa Δpep4::HIS3 prb1-Δ1.6R HIS3 lys2–
208 trp1-Δ101 ura3–52 gal2 can1 
Haas et al., 1994 
DKY6210 MATα leu2-3 leu2-112 ura3-52 his3- Δ200 
trpl-Δ901 lys2-801 suc2-Δ9 pho8::TRP1 
Haas et al., 1994 
Fth1-GFP BJ3505, Fth1-GFP::KanMX This study 
Fet5-GFP BJ3505, Fet5-GFP::KanMX This study 
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2.4 Results 
2.4.1 Polytopic proteins are selectively sorted for degradation during homotypic lysosome 
fusion 
To test our hypothesized model of lysosomal polytopic protein degradation (Figure 2A) we 
examined the sorting (membrane distribution), internalization and degradation of eight GFP-
tagged lysosomal polytopic proteins during homotypic fusion events using Saccharomyces 
cerevisiae and its vacuolar lysosome as models, as the underlying machinery and transporters are 
largely evolutionarily conserved. To begin, we monitored the distribution of GFP-tagged 
transporter proteins on the vacuole membrane over time during homotypic vacuole fusion within 
live S. cerevisiae cells (Figure 2B, movies S1-S3). We first confirmed that Vph1, the stalk 
domain of the V-ATPase complex, was uniformly distributed on the lysosomal membrane during 
fusion and, as a consequence, internalized (Wang et al., 2002). Then we made two striking 
observations: (1) The lysosomal multi-copper oxidase Fet5 (Urbanowski and Piper, 1999) was 
excluded from the boundary membrane of docked organelles and spared from being internalized 
upon fusion, despite formation of a lumenal lipid membrane fragment. (2) The lysosomal iron 
transporter Fth1 accumulated within the boundary and was internalized upon lysosome fusion. 
We conducted similar studies with five other GFP-tagged resident polytopic proteins (Figure 2C) 
and classified their sorting phenotypes as either uniformly distributed (Vph1), excluded from 
(Fet5; Ybt1 and Ycf1, ABC-C transporters; the sterol transporter Ncr1) or enriched within (Fth1; 
the zinc transporter Cot1; and Sna4, an E3-Ub ligase adaptor protein) the boundary membrane 
during lysosome fusion. These data demonstrate that protein sorting is selective and highlights 
the dependence of this process on intralumenal membrane fragment formation during organelle 
fusion. As such, we named this new cellular protein degradation pathway the IntraLumenal 
Fragment (ILF) pathway. 
To further study the molecular basis of the ILF pathway, we isolated vacuolar lysosomes 
from yeast cells and conducted in vitro fusion reactions (Wickner, 2010). We first confirmed our 
initial findings, whereby the same sorting phenotypes were observed in vitro as in vivo for all 
GFP-tagged polytopic proteins studied (Figure 3A). This important result indicates that all 
molecular machinery necessary for protein sorting and internalization during fusion co-purifies 
with the organelles. Next, to examine the sorting process in more detail, we quantified GFP 
fluorescence within the boundary on organelles undergoing fusion in vitro (Figures 3B and 3C).  
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Figure 2. Polytopic proteins are selectively sorted for degradation during homotypic 
lysosome fusion within live cells 
(A) Working model describing how lysosomal membrane proteins are selectively sorted into the 
boundary for internalization into the vacuolar lumen and subsequent degradation by the 
IntraLumenal Fragment (ILF) pathway. (B) Images from time-lapse videos of live yeast cells 
undergoing vacuole fusion in vivo, expressing Vph1-GFP, Fet5-GFP or Fth1-GFP stained with 
FM4-64 to label the vacuolar membrane. See also movies S1-S3. (C) Line-scan analysis of Fet5-
GFP, Fth1-GFP or Vph1-GFP along dotted line illustrating GFP (blue) or FM4-64 (red) 
fluorescence distribution (same images as shown in D). (D) Micrographs of yeast cells expressing 
eight different GFP-labeled lysosomal polytopic proteins illustrating the three sorting phenotypes 
by the ILF pathway; excluded, enriched or uniformly distributed. Dotted lines outline each cell as 
observed by DIC. GFP fluorescence intensity profile plots (left panel). Scale bars, 1 μm (in vivo).  
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As compared to Vph1-GFP fluorescence, which is uniformly distributed on the boundary and 
outer membranes, Fet5-GFP is clearly expelled from the boundary, whereas Fth1-GFP 
concentrates within apposed boundary membranes as the fusion reaction progresses. Results from 
these experiments also offer evidence that support the internalization of boundary-localized 
polytopic proteins (Figures 3D and 3E): As compared to Vph1-GFP, there is no lumenal 
accumulation of Fet5-GFP (even at 120 minutes when most vacuoles have fused; Merz and 
Wickner, 2004) but more accumulation of lumenal Fth1-GFP as the fusion reaction progresses, 
consistent with their sorting phenotypes. When internalized within the lumen, the membrane 
fragment and polytopic proteins embedded within it are exposed to lysosomal acid hydrolases for 
degradation. Thus, we conducted western blot analysis to detect cleavage of GFP from the 
polytopic proteins by lumenal proteases (Figure 3F; Li et al., 2015a). Consistent with the results 
of our micrographic analysis, less GFP was cleaved from Fet5 and more was cleaved from Fth1 
as compared to Vph1 after the fusion reaction progressed for 120 minutes. This approach also 
allowed us to more accurately measure rates of protein turnover as it eliminates the impact of 
new protein delivery to the isolated lysosomal vacuoles during study, since polysomes and 
components of the secretory system are absent from the preparation (Cabrera and Ungermann, 
2008). Deleting the PEP4 and PRB1 genes encoding critical lumenal proteases prevented GFP 
cleavage, further validating our model of the ILF pathway and highlighting the ability to 
selectively control polytopic protein lifetimes on lysosomal membranes. Furthermore, it suggests 
that lysosomes, and possibly other organelles, have the capability to remodel the protein 
landscape within their membranes with every fusion event. Two questions immediately arose 
upon making this exciting discovery: What is the function of the ILF pathway? What 
mechanisms underlie this process? 
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Figure 3. Polytopic proteins are sorted for degradation during lysosome fusion in vitro 
(A) Micrographs of isolated vacuoles expressing a different GFP-labeled membrane protein 
stained with FM4-64 under standard fusion conditions. Boundaries containing (closed) or lacking 
(open arrowheads) GFP fluorescence are indicated. (B) Membrane distribution of Vph1-GFP, 
Fet5-GFP or Fth1-GFP on isolated vacuoles at 60 minutes into the fusion reaction highlighting 
GFP localization in the boundary with line-scan analysis highlighting GFP fluorescence in the 
boundary. (C) Percent of GFP fluorescence in the boundary observed over the course of the in 
vitro fusion reaction calculated from micrographic data (n ≥ 168). (D) Cumulative probability 
curves of GFP fluorescence intensity within the boundary membrane (relative to outside) for all 
proteins tested in vitro. (E) Membrane distribution of Vph1-GFP, Fet5-GFP or Fth1-GFP on 
isolated vacuoles at 0, 30 and 120 minutes into the fusion reaction with line-scan analysis 
indicating GFP fluorescence in the lumen Associated GFP lumenal fluorescence intensity 
measurements are shown in (F) (n ≥ 168). (G) Western blots comparing Vph1-GFP, Fet5-GFP 
and Fth1-GFP degradation kinetics in wild type (WT) or pep4Δprb1Δ (pep4Δ) strains in vitro. 
Scale bars, 2 μm (in vitro). 
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2.4.2 The ILF pathway mediates quality control of lysosomal polytopic proteins 
A primary function of cellular protein degradation pathways is to clear misfolded or 
damaged proteins, a vital quality control mechanism within all eukaryotic cells (Chen et al., 
2011; Babst, 2014; Fang et al., 2014). Thus, we hypothesized that one function of the ILF 
pathway may be to clear damaged polytopic proteins from vacuolar lysosome membranes. To test 
this hypothesis, we first treated live yeast cells with heat stress, a known trigger of protein 
misfolding or damage (e.g. Keener and Babst, 2013), and studied its effect on the distribution of 
GFP-labeled polytopic proteins during vacuole fusion (Figure 4A, movies S4 and S5). As 
predicted, Fet5-GFP (an excluded protein) was shunted to the boundary and internalized within 
the lumen when cells were heat stressed, whereas Fth1-GFP (an enriched protein) continued to be 
cleared from the lysosome membrane. Indeed, all polytopic proteins tested were sorted into the 
boundary and internalized regardless of their sorting phenotypes (Figure 4B), suggesting that the 
ILF pathway functions to clear misfolded lysosomal proteins within cells. 
We next repeated these experiments using isolated vacuolar lysosomes and made similar 
findings (Figure 4C), confirming the molecular machinery required to sense and sort misfolded 
polytopic proteins co-purifies with the organelles. Because heat stress could also cause 
misfolding of fusogenic proteins, we measured homotypic vacuole fusion using a lumenal 
content mixing assay (Jun and Wickner, 2007) and confirmed that heat stress does not completely 
block the fusion reaction in vitro suggesting the machinery is intact (Figure 4D). To better assess 
protein sorting in response to heat stress, we next used micrographs shown in Figures 3A and 4C 
to calculate the proportion of docked vacuoles that contained Fet5-GFP or Fth1-GFP within their 
boundary membranes (Figure 4E). As expected, more Fet5-GFP was sorted into the boundary 
upon heat stress, whereas Fth1-GFP was enriched in the boundary under both conditions. 
Together, these results demonstrate that misfolded polytopic proteins are sorted into the ILF 
pathway for clearance. 
To demonstrate that damaged proteins within the boundary are indeed internalized upon 
fusion, we used micrographs shown in Figures 3A and 4C to calculate the proportion of total 
Fet5-GFP or Fth1-GFP fluorescence found within the lumen of vacuoles after fusion occurred 
(Figure 4F). As predicted, protein damage induced by heat stress increased lumenal levels of 
both proteins, suggesting their internalization by the ILF pathway. We next replaced cytoplasmic 
GFP tags with pHluorin, a pH-sensitive variant, and monitored fluorescence (an indicator of  
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Figure 4. The ILF pathway degrades misfolded lysosomal proteins 
(A) Images from time-lapse videos of vacuole fusion events within cells expressing Fet5-GFP or 
Fth1-GFP after heat stress (HS). Micrographs of docked vacuoles expressing eight different 
polytopic proteins tagged with GFP after HS imaged in vivo (B) or in vitro (C). (D) In vitro 
homotypic vacuole fusion measured using a lumenal enzyme complementation assay after 
isolated organelles were pretreated at 37 °C for indicated times. Grey circle indicates time of HS 
used in all other in vitro experiments shown. (E) Percent of boundaries observed containing Fet5-
GFP or Fth1-GFP and (F) GFP fluorescence intensity within the lumen of docked vacuoles 60 
minutes into the fusion reaction based on micrographic analysis (n ≥ 360). (G) Relative pHluorin 
fluorescence of isolated vacuoles expressing Fet5-pHluroin or Fth1-pHluorin under standard 
conditions (CTL) or after heat stress (HS). (H) Western blot analysis of Fet5-GFP or Fth1-GFP 
degradation after vacuole isolated from WT or pep4Δprb1Δ cells were permitted to fuse for 120 
minutes under control conditions (CTL) or after HS. Scale bars, 1 μm (in vivo) or 2 μm (in vitro); 
*, P < 0.05. See also Figure S1 and movies S4 and S5. 
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internalization) during the course of the vacuole fusion reaction in vitro. Our reasoning was that 
because the lumenal pH is lower (pH 5; Brett et al., 2005) than the reaction buffer (pH 6.8), a 
drop in fluorescence intensity occurs upon internalization of pHluorin-tagged proteins (Figure 
S1). As predicted, Fth1-pHluorin but not Fet5-pHluorin fluorescence was quenched over time 
under control conditions (Figure 4G), consistent with Fet5 being spared and Fth1 internalized 
during fusion. However, the fluorescence of both pHluorin-tagged proteins was quenched under 
heat stress, confirming that damaged polytopic proteins are internalized within the vacuole lumen 
during fusion.  
Finally, to confirm that these internalized proteins are degraded, we conducted western blot 
analysis after fusion reactions progressed for 120 minutes (Figure 4H). We observed that 
pretreating the vacuoles with heat stress increased the cleavage of Fet5-GFP, consistent with it 
being shunted to the boundary and internalized under these conditions. Whereas, heat stress had a 
minimal effect on Fth1-GFP cleavage as it is internalized under both conditions. GFP cleavage 
was abolished when PEP4 and PRB1 were deleted, confirming that observed proteolysis is 
conducted by lumenal acid hydrolases. Taken together, these findings demonstrate that the ILF 
pathway is responsible for clearing misfolded lysosomal polytopic proteins from membranes and 
thus contributes to cellular protein quality control. 
 
2.4.3 TOR activation by cycloheximide triggers protein degradation by the ILF pathway 
Because some lysosomal polytopic proteins studied were readily internalized and others were 
spared during organelle fusion under control conditions, we reasoned that they had different 
lifetimes. To better assess their rates of turnover, we employed a classic pulse-chase approach 
that involves treating live cells with the protein translation inhibitor cycloheximide and then 
monitored protein degradation by fluorescence microscopy (Watanabe-Asano et al., 2014). We 
predicted that when translation is blocked, levels of proteins that are enriched within the 
boundary would be depleted (as proteins degraded during lysosome fusion events would not be 
replenished) whereas levels of excluded proteins would persist over time. However, when we 
treated live yeast cells with low concentrations of cycloheximide (100 µM for 90 minutes), we 
observed sorting of all GFP-tagged polytopic proteins studied into the ILF pathway (Figures 5A 
and 5B, movies S6 and S7), including Fet5-GFP and other proteins that are normally spared. To 
better understand the basis of this preliminary observation, we repeated this experiment with 
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isolated organelles that do not co-purify with polysomes, ER or ribosomal components that are 
known targets of cycloheximide (Schneider-Poetsch et al., 2010, Cabrera and Ungermann, 2008). 
Again, to our surprise, cycloheximide caused the immediate sorting (Figures 5C and S2), 
internalization (Figures 5D and S2) and degradation (Figures 5E and S2) of all lysosomal 
polytopic proteins studied during organelle fusion in vitro. Although perplexing, these results 
suggest that cycloheximide has secondary targets on lysosomes that trigger polytopic protein 
degradation by the ILF pathway. 
Cycloheximide (CHX) is similar to many other bioactive compounds that do not target 
ribosomes, and it has been reported to have off-target effects for decades (e.g. MacDonald and 
Ellis, 1969; McMahon, 1975). In fact, surface polytopic protein degradation is also triggered by 
cycloheximide, supposedly through the TOR (Target Of Rapamycin) signaling pathway 
(MacGurn et al., 2011), which releases amino acids from lysosomal stores to accommodate 
protein translation by ribosomes (Loewith and Hall, 2011). Although somewhat controversial, 
this finding may explain our observations, especially since the TOR signaling machinery 
functions on lysosome membranes, co-purifies with vacuolar lysosomes, and is known to mediate 
major changes in lysosome physiology that could involve restructuring the protein content of 
lysosomal membranes (Settembre et al., 2013). Thus, to test whether the effects of CHX on the 
ILF pathway were mediated by TOR-signaling, we pretreated isolated vacuolar lysosomes with 
rapamycin, a TOR kinase inhibitor (7 µM for 15 minutes; Michaillat et al., 2012), with the 
expectation of abolishing CHX-mediated degradation of polytopic proteins by the ILF pathway. 
As expected, rapamycin blocked CHX-mediated sorting (Figure 5F), internalization (Figure S2) 
and degradation (Figure 5G) of Fet5-GFP, a polytopic protein that is degraded by the ILF 
pathway upon cycloheximide treatment but otherwise spared. Rapamycin alone or DMSO had no 
effect on Fet5-GFP sorting or degradation (Figure S2) and has no measurable effect on the 
membrane fusion reaction (Michaillat et al., 2012). Furthermore, rapamycin did not affect sorting 
of Fth1-GFP which does not require cycloheximide for degradation as it is constitutively sorted 
into the ILF pathway (Figure S2). Together these findings suggest that TOR-signaling mediates 
polytopic protein degradation by the ILF pathway in response to cycloheximide. 
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Figure 5. The ILF pathway degrades proteins in response to TOR signaling triggered by 
cycloheximide  
 (A) Images from time-lapse videos of vacuole fusion events within yeast cells expressing Fet5-
GFP or Fth1-GFP after incubation with cycloheximide (CHX). Micrographs of docked vacuoles 
expressing different polytopic proteins tagged with GFP after CHX treatment imaged within cells 
(B) or in vitro (C). (D) Relative fluorescence of isolated vacuoles expressing Fet5-pHluroin or 
Fth1-pHluorin during the in vitro fusion reaction under control conditions (CTL) or after CHX 
treatment. (E) Western blot analysis of Fet5-GFP or Fth1-GFP degradation after vacuole isolated 
from WT or pep4Δprb1Δ cells were permitted to fuse for 120 minutes under CTL or CHX 
treatment. (F) Micrographs of docked vacuoles expressing Fet5-GFP or Fet5-GFP:fpr1Δ in the 
absence or presence of rapamycin (RAP), CHX or puromycin (PUR). (G) Western blot analysis 
of Fet5-GFP degradation under RAP, CHX or (H) PUR treatment. Scale bars, 1 μm (in vivo) or 2 
μm (in vitro). See also Figure S1, S2 and movies S6 and S7. 
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2.4.4 pH regulates V-ATPase degradation by the ILF pathway 
Surface levels of transporters and receptors must be tightly regulated for cellular 
physiological processes, from regulating nutrient uptake for metabolic homeostasis to properly 
detecting external hormonal or environmental cues (Van Belle and André, 2001). Often, substrate 
or ligand concentrations determine polytopic protein surface levels. For example, surface 
transporters Mup1, Fur4 and Can1 are downregulated and degraded by the MVB pathway upon 
substrate withdrawal (MacDonald et al., 2012; Keener and Babst, 2013; Ghaddar et al., 2014). 
Similarly, Ypq1 a lysosomal lysine transporter is downregulated and degraded through the MVB 
pathway upon lysine withdrawal (Li et al., 2015a). Thus, we reasoned that the ILF pathway may 
control the levels of lysosomal membrane proteins in a similar manner, possibly to mediate 
organellar contributions to cellular homeostasis, metabolism or signaling.  
To test this hypothesis, we studied the effects of changing [H+] on Vph1-GFP turnover by 
the ILF pathway (Figure 2B; Wang et al., 2002). Vph1 is the stalk domain of the V-type H+-
ATPase pump complex that shunts H+ from the cytoplasm to the lysosome lumen (Forgac, 2007). 
Besides providing the acid environment required for lysosomal hydrolase function, the V-ATPase 
is critical for cytoplasmic pH homeostasis (Diakov and Kane, 2010): The pump is inactivated 
when free cytoplasmic [H+] is low to prevent it from increasing pH to a level that is toxic to the 
cell. Conversely, it is activated to sequester H+ within the vacuolar lumen when cytoplasmic [H+] 
is dangerously high. Thus, to mimic cytoplasmic pH acid or alkaline stress, we shifted the pH of 
the fusion reaction buffer from 6.80 to pH 6.38 or pH 7.32, respectively, and examined the effects 
on Vph1-GFP sorting (Figures 6A and 6B), internalization (Figure 6C) and degradation (Figure 
6D) by the ILF pathway in vitro. Under acid stress, when substrate levels are high, we find less 
Vph1-GFP in boundary membranes, less lumenal GFP fluorescence and less GFP-cleavage, 
demonstrating that Vph1 is spared under conditions that require V-ATPase activation for cell 
survival. In contrast, under alkali stress, we find enrichment of Vph1-GFP in the boundary 
membrane, an increase in lumenal GFP fluorescence and more GFP-cleavage, demonstrating that 
Vph1 is downregulated under conditions that promote V-ATPase inactivation. 
But fusing GFP to Vph1 could change its lifetime or account for the observed changes in its 
turnover in response to acid or alkali stress. To eliminate these possibilities, we studied 
endogenous Vph1 degradation under pH stress by western blot analysis (Figure 6E) and found a 
similar pattern of degradation as observed for Vph1-GFP (Figure 6D) confirming that the  
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Figure 6. Changing pH affects degradation of Vph1-GFP by the ILF pathway 
(A) Micrographs of docked vacuoles expressing Vph1-GFP imaged 60 minutes into the in vitro 
fusion reaction titrated to different pH values. (B) Percent of boundaries containing Vph1-GFP 
and (C) relative lumenal GFP fluorescence (normalized to pH 6.80; standard conditions) were 
calculated from micrographic data (n ≥ 308). Western blots stained with antibodies against GFP 
(D) or Vph1 (E) indicating degradation kinetics of Vph1-GFP (a-Vph1 wasn’t against Vph1-
GFP) before and after fusion of isolated vacuoles at different pH values. (F) Homotypic vacuole 
fusion of isolated vacuoles was measured after reactions were titrated over a range of pH values. 
Arrows indicate experimental pH values used in other experiments shown (n = 3). (G) 
Micrographs of docked vacuoles expressing Fth1-GFP imaged at 60 minutes into the in vitro 
fusion reaction titrated to three pH values. (H) Percent of boundaries containing Fth1-GFP and 
(I) relative lumenal GFP fluorescence (normalized to pH 6.80) were calculated from 
micrographic data (n ≥ 91). (J) Western blot kinetics of Fth1-GFP degradation before and after 
fusion of isolated vacuoles at different pH values. Scale bars, 2 μm (in vitro); *, P < 0.05. See 
also Figure S3.  
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epitope tag had no effect on Vph1 turnover. It is also possible that our observations were a 
consequence of simply altering the rates of organelle fusion. For example, acid stress could 
inhibit fusion accounting for the observed decrease in internalization and degradation of Vph1-
GFP. To eliminate this possibility, we measured homotypic vacuole fusion using a content-
mixing assay (Figure 6F) and confirmed that acid and alkali stress had no impact on organelle 
fusion in vitro. pH could also indiscriminately affect the machinery responsible for sorting within 
the ILF pathway. If so, then we expect that sorting of other polytopic proteins cleared by the ILF 
pathway should also be affected by acid and alkali stress. However, when we studied GFP-
labeled Fth1 (Figures 6G-J), or Fet5 (Figure S3; neither translocate H+), we found that sorting, 
internalization and degradation of both proteins were not affected by these stresses. Together, 
these results demonstrate that the ILF pathway selectively regulates membrane expression of 
Vph1, and presumably the activity of the V-ATPase, in response to changes in [H+] implicating a 
role in cellular pH homeostasis and confirming that it can mediate substrate-dependent 
degradation protein degradation. 
 
2.4.5 Protein sorting in the ILF pathway does not require autophagy or ESCRT machinery 
Findings presented thus far answer the first question posed earlier by demonstrating that the 
ILF pathway functions to control lysosome polytopic protein quality and quantity for organelle 
homeostasis and for membrane protein remodeling to accommodate cellular metabolism or ion 
homeostasis. But what are the mechanisms that underlie this process? Given that lysosomes 
contribute to autophagic and the MVB pathways, we first examined whether the ILF pathway 
may share underlying molecular machinery with these two major cellular protein degradation 
pathways. Although there is no evidence of autophagosomes or MVBs contributing to lysosomal 
polytopic protein sorting or internalization (Figures 2-6), it remains possible that mechanisms 
responsible for protein sorting in these pathways may also function in the ILF pathway, as they 
have been implicated in degradation of lysosome transporters and can be found on lysosome 
membranes (Li et al., 2015a,b). To eliminate this possibility, we deleted genes encoding essential 
components for autophagy, ATG1 and ATG7, or for the MVB pathway, VPS27 (ESCRT-0), 
VPS23 (ESCRT-I) and VPS36 (ESCRT-II), and examined effects on GFP-tagged polytopic 
protein distribution during homotypic vacuole fusion events (Figures S4 and S5). Deleting any 
of these genes had no affect on protein sorting in vivo (Figures S4A and S4B) or in vitro 
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(Figures S5A and S5B) or degradation (Figure S4D) even under conditions that induced protein 
clearance by the ILF pathway (Figures S4C, S4D and S5C, S5D). Thus, we are confident that 
the ILF pathway uses separate machinery from the autophagic and MVB pathways, representing 
a novel mechanism for cellular protein degradation.   
 
2.4.6 The docking machinery sorts polytopic proteins for degradation 
From the micrographic evidence presented, it is apparent that protein sorting occurs during 
the docking stage of the homotypic vacuolar lysosome fusion reaction when the boundary 
membrane is formed (Wang et al., 2002; Wickner, 2010). During docking, fusogenic lipids and 
proteins accumulate at the initial site of contact between organelles where they arrange into an 
expanding ring at the vertex between apposing membranes. This vertex ring represents the border 
between outer and boundary areas of the lysosome membrane where polytopic proteins are sorted 
to be spared or degraded. Thus, we hypothesized that the machinery assembled at the vertex ring 
may contribute to polytopic protein sorting, as well as driving membrane fusion. To test this 
hypothesis, we took a biochemical approach by blocking stages of the in vitro fusion reaction 
with protein or chemical inhibitors (Mayer and Wickner, 1997; Wickner and Haas, 2000; Wang 
et al., 2002) and monitored affects on the membrane distribution of Fet5-GFP or Fth1-GFP 
(Figure 7). First we targeted the lysosomal Rab GTPase Ypt7 that, when activated, orchestrates 
recruitment and assembly of the fusion machinery at the vertex ring (Brett et al., 2008). We 
reasoned that inactivating Ypt7 by adding rGyp1-46 (purified recombinant active domain of the 
Rab-GAP protein Gyp1; Rak et al., 2000) and rGdi1 (the Rab chaperone protein that extracts 
Ypt7 from vacuole membrane; e.g. Brett et al., 2008) or rGdi1 alone to fusion reactions should 
disrupt protein sorting (Eitzen et al., 2000). We found that these Ypt7 inhibitors prevent sorting 
of Fet5-GFP or Fth1-GFP into the boundary membrane (Figures 7A and 7B), even when protein 
clearance was triggered with heat stress (Figures 7C and 7D) or cycloheximide (Figures S6A 
and S6B), suggesting that active Ypt7 is important for selective entry, but not exclusion, of 
polytopic proteins into the boundary membrane during organelle fusion. Likewise, internalization 
(Figures 7E and S6C) and degradation (Figure 7F) of both polytopic proteins were blocked by 
Ypt7 inhibitors, illustrating the importance of the fusion machinery for lipid bilayer merger 
required to internalize polytopic proteins for degradation by the ILF pathway.   
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Figure 7. Lysosomal polytopic protein sorting and internalization requires the membrane 
fusion machinery 
(A) Micrographs of docked vacuoles expressing Fet5-GFP or Fth1-GFP during the in vitro fusion 
reaction in the absence (CTL) or presence of 4 μM rGdi, 4 μM rGdi and 3.2 μM rGyp1-46, or 
100 nM rVam7. (B) Percent of boundaries containing Fet5-GFP or Fth1-GFP under these 
conditions calculated from micrographic data (n ≥ 103). (C) Micrographs of docked vacuoles 
expressing Fet5-GFP or Fth1-GFP in vitro after heat stress (HS). (D) Percent of boundaries 
containing Fet5-GFP or Fth1-GFP calculated from micrographic analysis (n ≥ 242.). (E) Relative 
fluorescence of isolated vacuoles expressing Fet5-pHluroin or Fth1-pHluorin during in vitro 
fusion reactions incubated with rGdi or rVam7 in CTL and HS treatment. (F) Western blot 
analysis of Fet5-GFP and Fth1-GFP degradation before and after fusion of isolated vacuoles 
under CTL, CHX or HS conditions. Scale bars, 2 μm (in vitro); *, P < 0.05. See also Figures S4, 
S5 and S6. 
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Although this result implies a role for the docking machinery in protein sorting, an 
alternative interpretation is that blocking the membrane fusion reaction indirectly impairs protein 
sorting into the ILF pathway. Thus, we sought an approach to disrupt Ypt7 function without 
blocking membrane fusion to better understand its role in protein sorting. This involved using the 
recombinant soluble Q-SNARE protein Vam7 (rVam7) to drive the lysosome fusion reaction, as 
it bypasses the need for Rab activity (Thorngren et al., 2004). In the presence of rVam7, both 
Fet5-GFP and Fth1-GFP are present in the boundary membrane (Figures 7A and 7B) and 
internalized (Figure 7E) in the absence or presence of heat stress (Figures 7C-E) or 
cycloheximide (Figure S6). Thus, bypassing Ypt7 activity blocks exclusion, but not inclusion, of 
polytopic proteins into the boundary membrane during fusion. Together, these results suggest that 
active Rab must be engaged to selectively sort polytopic proteins into the ILF pathway. 
 
2.4.7 Protein sorting occurs during vertex ring expansion 
All things considered, it seems that the docking machinery contributes to polytopic protein 
sorting at the vertex ring that surrounds the boundary membrane during lysosome fusion. If so, 
this machinery could function by employing a protein sieving mechanism that sorts polytopic 
proteins encountered within the lysosome membrane as the vertex ring expands. Alternatively, it 
could recognize and actively move polytopic proteins marked for degradation across the vertex 
ring into the boundary after it has assembled at the vertex ring (Figure 8A). To test these models, 
we first examined the membrane distribution of Fet5-GFP at early time points after membrane 
fusion was triggered in vitro when docking occurs (Jun et al., 2006). To accurately study early 
docking events, it is important to consider that some docked interfaces observed at early time 
points could be mature because organelle interactions can occur prior to triggering fusion – either 
within yeast cells (which contain 2-3 vacuoles), prior to isolation or during the organelle isolation 
process. Thus, to distinguish newly formed organelle interactions from existing, mature contact 
sites, we mixed vacuolar lysosomes isolated separately from two different yeast strains, one 
expressing Fet5-GFP and the other lacking a GFP tag, stained their membranes with FM4-64 to 
visualize contact sites, and analyzed only boundary membrane between Fet5-GFP-labeled and 
GFP-free organelles (Figure 8B). To assess vertex ring assembly at these early time points, we 
also monitored the membrane distribution of Vps33-GFP using the same approach (Figure 8C). 
We selected Vps33 because it is one of six subunits that comprise the HOPS tethering  
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Figure 8. Protein sorting occurs during vertex ring expansion 
(A) Working model demonstrating two hypotheses of polytopic protein sorting from the 
boundary membrane either through a molecular sieving mechanism or through active sorting. (B) 
Micrographs of docked vacuoles between Fet5-GFP and GFP-free organelles or between (C) 
Vps33-GFP and GFP-free organelles acquired at different times during the in vitro fusion 
reaction. (D) Percent of docked clusters that were mixed between Fet5-GFP and GFP-free 
organelles. 2179 docked vacuole clusters were observed. (E) Micrographic data were used to 
calculate the boundary membrane length between apposed vacuoles as a percentage of the 
circumference (F) and the percent of boundaries either without Fet5-GFP or with Vps33-GFP (n 
≥ 108). (G) Micrographs of fluorescence recovery after photobleaching (FRAP) analysis of the 
boundary membrane between docked vacuoles expressing Fth1-GFP 10 and 60 minutes after 
vacuoles were permitted to fuse. (H) GFP fluorescence intensity in the boundary was measured 
over the course of the experiment and the mobile fraction (Mf) was calculated for ROIs 
photobleached in the boundary or outside membranes of docked vacuoles (n ≥ 11). (I) FRAP 
analysis of the boundary membrane between docked vacuoles expressing Vph1-GFP 10 and 60 
minutes into the in vitro fusion reaction. (J) GFP fluorescence intensity in the boundary was 
measured and Mf values for ROIs photobleached in the boundary and outside membranes were 
calculated from micrographic analysis (n ≥ 13). The red dotted box outlines ROIs subjected to 
photobleaching. Scale bars, 2 μm (in vitro); *, P < 0.05. See also Figure S7.  
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holocomplex, a key component of the fusion machinery that is recruited to the vertex ring by 
active Ytp7 as part of the docking subreaction (Wang et al., 2002). Hence, enrichment of Vps33-
GFP at the edges of the boundary membrane between GFP-labeled and GFP-free vacuoles labels 
fusion machinery assemblies at the vertex ring triggered by ATP in vitro. By measuring lengths 
over time, we confirmed that boundary expansion occurred at the same rate and terminated at the 
same time (30 minutes) in both samples (Figure 8E), consistent with previous reports (e.g. Wang 
et al., 2002). Importantly, Fet5-GFP exclusion from boundaries occurred at the same rate as 
vertex ring assembly, assessed by monitoring Vps33-GFP enrichment at organelle vertices over 
time (Figure 8F). Notably, the half times of boundary expansion, Vps33-GFP enrichment and 
Fet5-GFP were similar, strongly suggesting that polytopic protein exclusion from the boundary 
membrane occurs during vertex ring expansion. 
But does the same model also describe sorting of proteins into the boundary membrane for 
degradation? To address this question, we studied the lateral mobility of Fth1-GFP (an enriched 
protein) within the vacuole membrane using a fluorescence recovery after photo-bleaching 
(FRAP) during early and late stages of the docking subreaction in vitro. We hypothesized that if 
sorting occurred during vertex ring expansion, then Fth1-GFP should be mobilized into the 
boundary early (10 minutes) but not late into the reaction (60 minutes) after the fusion machinery 
is stabilized and no further increase in the boundary length is observed (Figure 8E). As 
predicted, Fth1-GFP fluorescence recovered to significantly higher level after photo-bleaching 
within the boundary membrane at 10 minutes (42.9%) as compared to 60 minutes (17.9%; 
Figures 8G and 8H). Fth1-GFP mobility on the outer area of the vacuole membrane did not 
change over the course of the fusion reaction, and values were similar to those obtained when 
studying the boundary membrane at 60 minutes. These values were also similar to Vph1-GFP 
mobility on the outer and boundary membranes at early and late times (Figures 8I and 8J). 
Because Vph1-GFP is uniformly distributed on the vacuole membrane (Figures 2, 3, and 6; 
Wang et al., 2002), we speculate that these values (mobile fractions between 10.8 and 14%) 
represent a good measure of polytopic protein lateral mobility within the vacuolar lysosome 
membrane. We also assessed lipid mobility by recording FM4-64 fluorescence recovery (Figure 
S7). As expected, the mobile fraction of FM4-64 within the lipid bilayer was much higher (80%; 
as previously reported in Dhonukshe et al., 2006) than the polytopic proteins studied, lending 
confidence to our assessment of Fth1-GFP movement during vacuole fusion. All things 
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considered, the lateral mobility of Fth1-GFP is highest within the boundary membrane during the 
early stage of docking, lending support to a molecular sieving model of protein sorting into the 
ILF pathway that occurs during vertex expansion. 
 
2.5 Discussion 
2.5.1 The ILF pathway is a new mechanism responsible for organelle polytopic protein 
degradation within cells 
Lysosomal polytopic proteins are critical for cellular nutrient recycling, signaling and ion 
homeostasis. Thus, it is important that we understand how they are regulated or degraded. Herein, 
we describe a new pathway responsible for turnover of transporters and membrane proteins on 
lysosomes: Using fluorescence microscopy we show that GFP-tagged polytopic proteins are 
selectively sorted into the boundary area of apposing membranes that is internalized into the 
lumen upon lipid bilayer fusion within living cells (Figures 2, 4, 5 and S4). We confirmed our 
original observations by monitoring protein internalization using a pHluorin-based fluorescence 
assay and show that internalized proteins are degraded by lumenal hydrolases by western blot 
(Figures 3-7 and S6). Of the eight studied, four proteins were spared and four were internalized 
by this pathway under normal growth conditions, indicating that lysosomal polytopic proteins 
have different lifetimes and that the protein content of the lysosomal membrane can change with 
every homotypic fusion event. Although it is not clear why the cell would want to rapidly 
turnover some proteins (e.g. Fth1) and not others (Fet5), this observation is consistent with 
reports of surface membrane proteins that are also constitutively degraded, e.g. the G-protein 
coupled receptor Ste3 is constitutively internalized and degraded by the MVB pathway (Davis et 
al, 1993). Because some proteins were spared, it was possible that they utilized an alternative 
mechanism for degradation, such as the vReD pathway (Li et al., 2015a,b). However, we found 
that all proteins were shunted to the ILF pathway after misfolding was induced by heat stress 
(Figure 4), confirming that all proteins studied can be degraded by this new pathway. 
Furthermore, by piggybacking membrane fusion, the ILF pathway seems like a more efficient 
alternative for lysosomes to turnover their membrane proteins as compared to the vReD pathway, 
which requires additional trafficking steps to deliver lysosomal proteins to the MVB for 
packaging and back to the lysosome for degradation (Li et al., 2015a). Although lysosomes 
frequently undergo homotypic fusion (Wickner, 2002), they require heterotypic fusion events 
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between MVBs or autophagosomes for delivery of incoming biomaterials to be recycled (Davies 
et al., 2009; Carlsson and Simonsen, 2015). As similar fusion machinery mediates these events 
(Luzio et al., 2009; Jiang et al., 2014), it is possible that intralumenal membrane fragments also 
form. Current advances in light and electron microscopy will allow us to test this hypothesis in 
the near future. In the mean time, it is tempting to speculate that the ILF pathway could allow 
these dynamic organelles to remodel the protein content within their membranes while they 
receive biomaterials for recycling. 
But how are intralumenal fragments degraded? To prevent lysosome rupture, membrane 
lipids and proteins facing the lumen are resistant to attack by hydrolases (see Kolter and 
Sandhoff, 2005). However, when a portion of this membrane is internalized through the ILF 
pathway, the membrane conserves its orientation (i.e. the lumenal face remains lumenal) but 
becomes susceptible to degradation. Although many factors may be at play (e.g. perhaps selective 
lipid sorting into the boundary membrane promotes rupture or susceptibility to hydrolases; see 
Fratti et al., 2004), we speculate that this may be an outcome of lipid bilayer merger driven by 
asymmetrically aligned SNARE complexes (D’Agostino et al., 2016): SNARE-domains of trans-
complexes extend into the cytoplasm around the vertex ring, where they interact with the fusion 
machinery (e.g. HOPS; Wickner, 2010). Upon zippering, they form cis-complexes that 
exclusively reside in the limiting membrane of the fusion product, not within the intralumenal 
fragment. As transmembrane domains of SNARE-complexes seem to stabilize the lipid bilayer 
during merger, the absence of these complexes within the fragment may destabilize the bilayer 
exposing the inner leaflet to lumenal hydrolases to initiate degradation. We have begun to 
characterize intermediates of this lipid bilayer fusion reaction in context to intralumenal fragment 
formation (Mattie et al., 2017) and plan to test this hypothesis in the near future. 
 
2.5.2 A molecular sieving mechanism may be responsible for protein sorting in the ILF 
pathway 
Upon the discovery of this new protein degradation pathway, we immediately sought to 
better understand the molecular basis of how it works. We present many lines of evidence to 
support a molecular sieving model of protein sorting that occurs during the docking stage of the 
fusion reaction when the machinery assembles at an expanding vertex ring between apposing 
organelles prior to lipid bilayer merger: (1) We find that polytopic proteins are selectively sorted 
into or out of the boundary area of membrane formed between apposing organelles during 
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docking (Figures 3, 8 and S7). (2) When we block or bypass the activity of Ypt7, an important 
mediator of docking, protein sorting is disrupted (Figures 7 and S6). (3) Using FRAP and time-
lapse microscopy, we demonstrate that protein sorting occurs during expansion of the vertex ring 
that encircles the boundary between apposing lysosomes (Figure 8). Topologically, this 
mechanism is analogous to polytopic protein sorting into budding intralumenal vesicles on the 
outer membrane of immature MVBs, where the ESCRT machinery assembles into a ring at the 
neck of the budding vesicle (Nickerson et al., 2007). However, we demonstrate that the ESCRT 
machinery, as well as the autophagy machinery, does not contribute to the ILF pathway (Figures 
S4 and S5). Furthermore, other cytoplasmic factors (e.g. components of the proteasome 
machinery) likely do not play a role because similar results were obtained from experiments 
conducted in vivo and in vitro (Figure 3). So what is the molecular basis of protein sorting in the 
ILF pathway?  
Although we implicate molecular sieving in this process, we did not uncover the basis of 
protein selection. We are however confident that it is not simply protein size, for example, as it 
does not correlate with the observed sorting phenotypes. Rather, we speculate that the ILF 
pathway uses a ubiquitin-based mechanism similar to the other protein degradation pathways in 
the cell based on the following observations: Proteomic screens reveal that most of the lysosomal 
polytopic proteins studied can be ubiquitylated (Peng et al., 2003). Protein ubiquitylation 
machinery, such as adaptor proteins (e.g. Ssh4) and E3-ligases (Rsp5), are found on vacuole 
membranes (Pokrzywa et al., 2009; Li et al., 2015a). This includes a paralog of Sna3, an 
important adapter protein in the MVB pathway, called Sna4 that exclusively resides on vacuole 
lysosome membranes. At MVBs, Sna3 binds internalized surface polytopic proteins to 
accommodate ubiquitylation by Rsp5 and sorting into ILVs, and by doing so it too is internalized 
and degraded by the MVB pathway (MacDonald et al., 2012). Like Sna3, we show that Sna4 is 
sorted into the boundary of docked lysosomes and is internalized upon fusion (Figures 2 and 3), 
suggesting that perhaps Sna4 performs a similar function in the ILF pathway.   
If ubiquitylation mediates degradation, then labeled proteins must be recognized at the vertex 
ring for sorting into the ILF pathway. Of the proteins that concentrate at this site, three contain 
partial potential ubiquitin binding domains (UBDs): Vps11, Vps18 and Vps39 (Nickerson et al., 
2009). Together with 3 other subunits, these proteins form HOPS, the lysosomal multisubunit 
tethering complex important for MVB-lysosome and homotypic vacuolar lysosome fusion 
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(Balderhaar and Ungermann, 2013). Although speculative, these three partial domains may form 
a UBD when in complex that recognizes and sorts ubiquitinated lysosomal polytopic proteins 
into the boundary, similar to how the multiple UBDs of the ESCRT machinery sort surface 
proteins in the MVB pathway (Shields and Piper, 2012). Using the comprehensive set of 
approaches to study the ILF pathway presented herein, we have begun to test this model and it 
will be interesting to determine whether the ILF pathway shares protein labeling machinery but 
has unique sorting machinery as compared to other protein degradation pathways. 
 
2.5.3 Importance of the ILF pathway to cell physiology 
What is the purpose of the ILF pathway? Herein, we show that it performs at least three 
important functions: First, it mediates lysosomal polytopic protein degradation upon misfolding 
by heat stress (Figure 4).  The ERAD pathway performs this function to clear damaged or 
unfolded proteins at the endoplasmic reticulum (Vembar and Brodsky, 2008), the proteasome for 
cytoplasmic proteins (Fang et al., 2014) and the MVB for surface polytopic proteins (Keener and 
Babst, 2013). Thus, we propose that the ILF pathway is an equally important contributor to 
cellular protein quality control. Second, the ILF pathway responds to changes in substrate levels 
to selectively regulate cognate transporter levels, as increasing pH promotes degradation of Vph1 
by the ILF pathway (Figure 6) consistent with reports of how the V-ATPase regulates cellular 
pH homeostasis (Tarsio et al., 2011). Similar mechanisms are in place at the plasma membrane to 
regulate cellular nutrient uptake, receptor signaling and osmotic homeostasis (Keener and Babst, 
2013). We speculate that ILF pathway performs an analogous function on lysosomes to 
potentially regulate Ca2+ signaling or nutrient export, for example, which are important 
contributors to cellular physiology and metabolism.  
Lastly, the ILF pathway degrades proteins in response to TOR activation induced by the 
protein translation inhibitor cycloheximide (Figure 5). Lysosomes are an important source of 
cellular amino acids needed to feed the protein translation machinery. Thus, the activities of these 
two fundamental processes are tightly regulated through extensive metabolic signaling circuitry 
including the TOR pathway (Efeyan et al., 2012; Settembre et al., 2013). For example, when 
cellular amino acid pools are depleted, translation stops, TOR is activated and lysosome activity 
is enhanced to increase amino acid levels, closing a negative feedback loop. Blocking protein 
translation with puromycin or cycloheximide triggers protein degradation by the ILF pathway 
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within live cells (Figure 5A and B; Figure S2) lending support to this model. However, only 
cycloheximide elicits this response when added to purified organelle preparations devoid of 
ribosomal components, which is abolished by rapamycin, a TOR-signaling inhibitor, suggesting 
that it may also have a second target present on lysosome membranes that activates TOR 
signaling and triggers degradation of lysosomal polytopic proteins to increase cellular amino acid 
levels. In any case, our findings clearly demonstrate a role for the ILF pathway in cellular amino 
acid metabolism. Maintenance of amino acid levels through sustained or enhanced lysosome 
function is critical for survival as cells age (Aris et al., 2012). As such, impaired lysosome 
activity correlates with many age-related disorders such as Alzheimer’s disease (Settembre et al., 
2013). The transcriptional regulator TFEB plays a critical role in this process by increasing 
lysosome biogenesis (Settembre et al., 2013). By remodeling existing lysosomes to accommodate 
changes in cell physiology as they age, we argue that the ILF pathway may play a complementary 
and equally important role in cellular longevity.  
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Chapter 3. ESCRT-independent Surface Receptor and Transporter Protein 
Degradation by the ILF Pathway 
3.1 Abstract 
Surface receptor and transporter protein down-regulation drives cell signaling, quality 
control and metabolism underlying diverse physiology. After endocytosis, proteins are delivered 
to endosomes where ESCRTs package them into intralumenal vesicles, which are degraded by 
acid hydrolases upon fusion with lysosomes. However, reports of ESCRT-independent surface 
protein degradation are emerging suggesting that alternative, non-canonical pathways exist. 
Using Saccharomyces cerevisiae as a model, here we show that in response to substrates, protein 
misfolding or TOR signaling, some internalized surface transporters (Hxt3, Itr1, Aqr1) bypass 
ESCRTs en route to the lysosome membrane where they are sorted into an area that is 
internalized as an intralumenal fragment (ILF) and degraded upon organelle fusion. This ILF 
pathway also degrades typical ESCRT client proteins (Mup1, Can1, Ste3) when ESCRT function 
is impaired. As the underlying machinery is conserved, we speculate that the ILF pathway is an 
important contributor to receptor and transporter down-regulation in all eukaryotes. 
 
3.2 Introduction 
Surface polytopic proteins including receptors, transporters and channels are internalized and 
sent to the lysosome for degradation (Katzmann et al., 2002; Babst 2011; Henne et al., 2011). 
Precise control of their surface levels underlies diverse physiology, including endocrine function, 
wound healing, tissue development, nutrient absorption and synaptic plasticity (Katzmann et al., 
2002; Palacios et al., 2005; Rodahl et al., 2009; Lobert and Stenmark, 2011; Zhou et al., 2010; 
Hislop and von Zastrow, 2011; Koumanov et al., 2012; Chassefeyre et al., 2015). Damaged 
surface proteins are also cleared by this mechanism to prevent proteotoxicity (Wang et al., 2011; 
Keener and Babst, 2013; Zhao et al., 2013). To trigger this process, surface proteins are labeled 
with ubiquitin – in response to changing substrate levels, heat stress to induce protein misfolding 
or cellular signaling for example – and then selectively internalized by the process of endocytosis 
(Blondel et al., 2004; Lewis and Pelham, 2009; MacGurn et al., 2011; Jones et al., 2012; 
MacDonald et al., 2012; Keener and Babst, 2013; Babst, 2014). Within the cell, they are sent to 
endosomes where they encounter ESCRTs (Endosomal Sorting Complexes Required for 
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Transport). These five protein complexes (ESCRT-0, ESCRT-I, ESCRT-II, ESCRT-III and the 
Vps4 complex) sort and package these internalized surface proteins into IntraLumenal Vesicles 
(ILVs; Henne et al., 2011). After many rounds, ILVs accumulate creating a mature 
MultiVesicular Body (MVB; Nickerson et al., 2010; Hanson and Cashikar, 2012). The MVB then 
fuses with lysosomes to expose protein laden ILVs to lumenal hydrolases for catabolism 
(Katzmann et al., 2002). Although many examples of ESCRT-mediated protein degradation have 
been published (see Babst, 2014), reports of ESCRT-independent degradation of surface proteins 
are emerging (e.g. Bowers et al., 2006; Theos et al., 2006; Leung et al., 2008; Silverman et al., 
2013; Parkinson et al., 2015). Furthermore, ILVs can be formed independent of ESCRT function 
and proteins recognized by ESCRTs continue to be degraded when ESCRTs are impaired 
(Trajkovic et al., 2008; Blanc et al., 2009; Stuffers et al., 2009b; Edgar et al., 2014). These 
realizations have led to one of the most prominent open questions in our field: What accounts for 
ESCRT-independent ILV formation and surface polytopic protein degradation? 
Around the time when ESCRTs were discovered (Katzmann et al., 2001), Wickner, Merz 
and colleagues reported that an ILV-like structure called an IntraLumenal Fragment (ILF) is 
formed as a byproduct of homotypic lysosome fusion in the model organism Saccharomyces 
cerevisiae (Wang et al., 2002). Prior to lipid bilayer merger, fusogenic proteins and lipids 
concentrate within a ring at the vertex between apposing lysosomal membranes (Wang et al., 
2003b; Fratti et al., 2004). Upon SNARE-mediated membrane fusion at the vertex ring, the 
encircled area of membrane, called the boundary, is excised and internalized within the lumen of 
the fusion product where it encounters lysosomal hydrolases (Mattie et al., 2017). We recently 
discovered that lysosomal polytopic proteins, e.g. ion and nutrient transporters, are selectively 
sorted into the boundary membrane for degradation in response to substrate levels, misfolding by 
heat stress or TOR (Target Of Rapamycin) signaling (McNally et al., 2017). Named the ILF 
pathway, this process functions independently of ESCRTs and instead relies on the fusion protein 
machinery for transporter sorting and ILF formation. Thus, this process performs similar 
functions as ESCRTs, except the mechanisms underlying protein sorting and packaging and their 
cellular locations are distinct. The possibility exists that surface polytopic proteins may also be 
degraded by the ILF pathway if they can be delivered to the lysosome membrane after 
internalization. 
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Can internalized surface proteins be delivered to lysosome membranes? To our knowledge, 
this hypothesis has not been formally tested. However, this proposition seems reasonable when 
considering the consequence of bypassing ESCRT function in the canonical MVB pathway 
(Figure 9A): In theory, any internalized surface polytopic protein that is not packaged into ILVs 
by ESCRTs (or returned to the surface) remains embedded within the outer membrane of the 
mature MVB. When this membrane merges with the lysosome membrane upon heterotypic 
fusion, these proteins are then exposed to the ILF machinery, which may package them for 
degradation. Thus, by simply avoiding recognition by ESCRTs, internalized surface proteins are–
–by default––delivered to lysosome membranes and the ILF pathway. Upon reexamination of 
micrographs presented in earlier reports on receptor and transporter down-regulation, we found 
that some internalized surface polytopic proteins appear on lysosome membranes en route to the 
lumen for degradation, e.g. the high affinity tryptophan permease Tat2 (Beck et al., 1999), 
glucose transporters Hxt1 and Hxt3 (O’Donnell et al., 2015), peptide transporter Ptr2 (Kawai et 
al., 2014), and myo-inositol transporter Itr1 (Nikko and Pelham, 2009). We also noticed that most 
of these published studies do not directly assess whether ESCRTs are required for protein 
degradation. However, when the dependence on MVB formation was assessed, internalized 
surface proteins often accumulated on lysosome membranes when ESCRT function was 
disrupted, e.g. the general amino acid permease Gap1 (Nikko et al., 2003), ATP-binding cassette 
transporter Ste6 (Krsmanovic et al., 2005), and G-protein coupled receptor Ste3 (Yeo et al., 2003; 
Shields et al., 2009; Prosser et al. 2010). Thus, given that internalized surface transporters and 
receptors can appear on lysosome membranes, we decided to test the hypothesis that the ILF 
pathway represents an alternative, ESCRT-independent mechanism for degradation of surface 
polytopic proteins and may compensate for the loss of ESCRT function (Figure 9A). 
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Figure 9. Internalized surface proteins take two routes to the lysosomal lumen for 
degradation 
(A) Cartoon illustrating how surface membrane proteins can be sorted for degradation by the 
canonical ESCRT-dependent or ILF pathways. Fluorescence and DIC micrographs showing 
routes taken by Can1-GFP (B) or Hxt3-GFP (C) from the surface to the lysosome lumen in 
response to 37 µM canavanine or 200 µM 2-deoxyglucose over time in live wild type or vps36∆ 
cells treated with FM4-64 to label vacuole membranes. Scale bars, 1 µm (in vivo). Middle panels 
include 3-dimensional GFP fluorescence intensity plots (right) and line plots (left) of GFP (blue) 
or FM4-64 (red) fluorescence intensity for micrographs where lines are indicated. Bottom panels 
indicate the proportion of the cell population that show GFP fluorescence on the plasma 
membrane (PM), intracellular puncta (Puncta), vacuolar lysosome membrane (VM) or lysosomal 
lumen (Lumen) over time after treatment with a toxic substrate. 
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3.3 Methods and Materials 
3.3.1 Yeast strains and materials 
All Saccharomyces cerevisiae strains used in this study are listed in Table 3. Biochemical 
and yeast growth reagents were purchased from either Sigma-Aldrich, Invitrogen or BioShop 
Canada Inc. Proteins used include recombinant Gdi1 purified from bacterial cells using a 
calmodulin-binding peptide intein fusion system (Brett and Merz, 2008) and recombinant Gyp1-
46 (the catalytic domain of the Rab-GTPase activating protein Gyp1) purified as previously 
described (Eitzen et al. 2000). Reagents used in fusion reactions were prepared in 20 mM Pipes-
KOH, pH 6.8, and 200 mM sorbitol (Pipes Sorbitol buffer, PS). 
 
3.3.2 Fluorescence Microscopy 
Images were acquired with a Nikon Eclipse TiE inverted microscope equipped with a 
motorized laser TIRF illumination unit, Photometrics Evolve 512 EM-CCD camera, CFI 
ApoTIRF 1.49 NA 100x objective lens, and 488 nm or 561 nm (50 mW) solid-state lasers 
operated with Nikon Elements software. Cross sectional images were recorded 1 μm into the 
sample and resulting micrographs and processed using ImageJ software (National Institutes of 
Health) and Adobe Photoshop CC. Images shown were adjusted for brightness and contrast, 
inverted and sharpened with an unsharp masking filter. Fluorescence intensity profiles of GFP 
fluorescence were generated using ImageJ software. 
 
3.3.3 Live cell microscopy 
Live yeast cells were stained with FM4-64 to label vacuole membranes and prepared for 
imaging using a pulse-chase method as previously described (Brett et al., 2008). For examining 
vacuolar localization of plasma membrane proteins, cells were incubated at 37 °C for 15 minutes 
for heat stress (Figure 10A) after FM4-64 staining. For other stress treatments yeast cells were 
incubated at 37°C for 30 minutes (Figure 11A) and incubated with 100 μM cycloheximide for 90 
minutes at 30 °C (Figure 12A). Time-lapse videos were acquired at 30°C using a Chamlide TC-
N incubator (Live Cell Instruments) with cells plated on coverslips coated with concavalin-A (1 
mg/ml in 50 mM HEPES, pH 7.5, 20 mM calcium acetate, 1 mM MnSO4). Yeast cells expressing 
Mup1-GFP were back diluted in Synthetic Complete (SC) media lacking methionine (Takara Bio 
USA, Inc.) for live cell microscopy. To assess surface protein degradation in response to 
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substrate addition, yeast cells expressing Can1-GFP or Hxt3-GFP wild type and when VPS36 is 
deleted were stained with FM4-64 for one hour at 30 °C in SC media. After two washes, cells 
were resuspended in fresh SC media with addition of either 37 μM canavinine (Sigma-Aldrich) 
for 2, 4, 6 or 8 hours (Can1) or with 500 μM 2-Deoxy-D-glucose (Sigma-Aldrich) for 5, 30, 60 or 
120 minutes (Hxt3 and Fet5). After incubation, cells were washed and resuspended in SC media 
prior to imaging. 
 
3.3.4 Vacuole isolation and homotypic vacuole fusion 
Vacuoles were isolated from GFP derivative yeast cells as previously described (Haas, 1995) 
and fusion reactions were prepared using 6 μg of isolated vacuoles in standard fusion reaction 
buffer with 0.125 M KCl, 5 mM MgCl2, 1 mM ATP and 10 μM CoA. Vacuolar membranes were 
stained with FM4-64 by treating vacuoles with 3 μM FM4-64 for 10 minutes at 27 °C. Reactions 
were incubated at 27 °C for 60 minutes, unless otherwise noted, and placed on ice prior to 
visualization by microscopy. Where indicated, vacuoles were incubated in the absence or 
presence of 3.2 μM Gyp1-46 and 4 μM rGdi. For heat stress treatment, vacuoles were pretreated 
for 5 minutes at 37 °C before addition to the fusion reaction and incubation for 30 minutes at 
27°C. Where indicated, vacuoles were pretreated with 100 μM cycloheximide for 15 minutes at 
27°C and incubated for an additional 15 minutes with the fusion reaction. 
 
3.3.5 pHluorin-based assay to detect transporter internalization 
Ecleptic pHluorin was cytoplasmically tagged to lysosomal membrane proteins (see Prosser 
et al., 2010). Fusion reactions (15 μl) were prepared using 6 μg of isolated vacuoles in standard 
reaction buffer, pH 6.80. Reactions were then transferred to black 96-well conical-bottom 
microtiter plates with 15 μl of titrated reaction buffer for a final buffer pH of 7.40. pHluorin 
fluorescence (λex = 480 nm; λem = 515 nm) was recorded every two minutes for 90 minutes using 
a BioTek Synergy H1 plate reading flourometer. Data shown are representative traces with values 
normalized to time zero, n≥4. 
 
3.3.6 Western blot analysis  
Fusion reactions (60 μl) were prepared using 6 μg of isolated vacuoles in standard fusion 
reaction buffer with 0.125 M KCl, 5 mM MgCl2, 1 mM ATP and 10 μM CoA from yeast strains 
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expressing GFP-tagged Mup1 or Hxt3 in wild type or when VPS27 or VPS36 is deleted. Where 
indicated, reactions were pretreated for 5 minutes at 37 °C for heat stress or for 15 minutes with 
100 μM cycloheximide at 27 °C in the absence (CTL) or presence of 3.2 μM Gyp1-46 and 4 μM 
rGdi (GDI) prior to addition to the fusion reaction. Reactions were incubated at 27 °C followed 
by addition of protease inhibitors (6.7 μM leupeptin, 33 μM pepstatin, 1 mM PMSF and 10.7 mM 
AEBSF), 1% DDM and 5X laemmli sample buffer. Membrane proteins were solubilized by 
incubating reactions at 27 °C for 10 minutes prior to running on an SDS-Page gel and probing for 
α-GFP (Abcam, Cambridge, UK: ab290). Samples were repeated a minimum of three times. Gels 
were imaged using GE Amersham Imager 600 by chemiluminescence and edited and prepared 
using Adobe Photoshop and Illustrator CC software. 
 
3.3.7 Data analysis and preparation 
Cumulative probability measurements were calculated using isolated vacuole micrographs of 
docked vacuoles only. GFP fluorescence intensities were measured using ROI 4x4 pixels in 
diameter and acquiring a fluorescence value on the outer membrane, within the lumen and on the 
boundary membrane of docked vacuoles using ImageJ software. For assessing GFP fluorescence 
in the boundary membrane, micrographs taken 60 minutes into the fusion reaction were assessed. 
For lumenal GFP fluorescence, micrographs were assessed at 0 (ice), 30, 60, 90 and 120 minutes 
into the fusion reaction and correlated to individual vacuole size (boundary length, surface area 
and circumference). Data are reported as mean ± SEM. Acquired data was plotted using Synergy 
KaleidaGraph 4.0 software and figures were prepared using Adobe Illustrator CC software. 
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Table 3. Yeast strains used in Chapter 3 
Strain Genotype Source 
SEY6210 MATα, leu1-3, 112 ura3-52 his3-200, trp1-
901 lys2-801 suc2-D9 
Huh et al., 2003 
 
BY4741 MATα his3-Δ1 leu2-Δ0 met15-Δ0 ura3-Δ0 Huh et al., 2003 
Fet5-GFP BY4741, Fet5-GFP::HIS3MX Huh et al., 2003 
Mup1-GFP SEY6210, Mup1-GFP::KanMX Prosser et al., 2011 
Mup1-GFP:vps27Δ SEY6210, Mup1-GFP::KanMX, 
vps27Δ:HIS3MX 
This study 
Mup1-GFP:vps36Δ SEY6210, Mup1-GFP::KanMX, 
vps36Δ:HIS3MX 
This study 
Mup1-pHluorin SEY6210, Mup1-pHluorin::KanMX Prosser et al., 2011 
Mup1-pHluorin:vps27Δ SEY6210, Mup1-pHluorin::KanMX, 
vps27Δ:HIS3MX 
This study 
Mup1-pHluorin:vps36Δ SEY6210, Mup1-pHluorin::KanMX, 
vps36Δ:HIS3MX 
This study 
Ste3-GFP SEY6210, Ste3-GFP::KanMX Prosser et al., 2011 
Ste3-GFP:vps27Δ SEY6210, Ste3-GFP::KanMX , 
vps27Δ:HIS3MX 
This study 
Can1-GFP BY4741, Can1-GFP::HIS3MX Huh et al., 2003 
Can1-GFP:vps36Δ BY4741, Can1-GFP::HIS3MX , 
vps36Δ:KanMX 
This study 
Hxt3-GFP BY4741, Hxt3-GFP::His3MX Huh et al., 2003 
Hxt3-GFP:vps36Δ BY4741, Hxt3-GFP::His3MX, 
vps36Δ:KanMX 
This study 
Hxt3-GFP:vps27∆ BY4741, Hxt3-GFP::His3MX, 
vps27Δ:KanMX 
This study 
Itr1-GFP BY4741, Itr1-GFP::His3MX Huh et al., 2003 
Itr1-GFP:vps27∆ BY4741, Itr1-GFP::His3MX, 
vps27Δ:KanMX 
This study 
Aqr1-GFP BY4741, Aqr1-GFP::His3MX Huh et al., 2003 
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3.4 Results 
3.4.1 Internalized surface proteins appear on lysosome membranes en route to the lumen 
for degradation 
To test this hypothesis, we first confirmed that conventional ESCRT client proteins 
accumulate on vacuolar lysosome membranes when internalized into live cells that are missing 
components of the ESCRT machinery. To do so, we monitored cellular distribution of GFP-
tagged transporters over time in populations of live S. cerevisiae cells using fluorescence 
microscopy and quantified their intracellular distribution (Figure 9B). GFP-tagged Can1, an 
arginine permease, is found on the plasma membrane prior to treatment with canavinine, a toxic 
arginine analog that triggers internalization and degradation of Can1 to prevent canavinine import 
and subsequent cell death (MacGurn et al., 2011). After treatment, Can1-GFP first appears on 
intracellular punctae and then later within the lysosomal lumen, but is never observed on the 
lysosome membrane. However when VPS36 (a subunit of ESCRT-II; Babst et al., 2002) is 
deleted, Can1-GFP continues to be internalized after canavanine treatment where it accumulates 
on large punctae (reminiscent of vps class E compartments; Raymond et al., 1992) as well as on 
lysosome membranes, and eventually some fluorescence is observed in the lumen. We also found 
GFP-tagged Hxt3, a low-affinity, high capacity glucose transporter, accumulated on lysosome 
membranes en route to the lysosomal lumen after being internalized in response to 2-
deoxyglucose, a toxic glucose analog (O’Donnell et al., 2015; Figure 9C). Importantly, this 
occurred in wild type cells and knocking out VPS36 did not prevent it from accumulating on 
lysosome membranes or within the lumen suggesting that Hxt3-GFP is processed for degradation 
by an ESCRT-independent mechanism. Because these surface polytopic proteins appear on the 
lysosome membrane after being internalized, we hypothesized that the ILF pathway may deliver 
them to the lysosome lumen for degradation. 
 
3.4.2 Surface transporters are sorted and packaged for degradation by the ILF pathway 
To test this hypothesis, we first studied the lysosome membrane distribution of Hxt3-GFP, 
which does not seem to require ESCRTs for lysosomal degradation and is present in boundary 
membranes of docked lysosomes within live cells after treatment with 2-deoxyglucose (Figures 
9C and S8). It is worth noting that the resident lysosomal polytopic protein Fet5-GFP was 
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excluded from boundaries when cells were treated with 2-deoxyglucose (Figure S8), confirming 
that Hxt3-GFP sorting into the boundary is selective. Treating cells with heat stress to induce 
protein misfolding also caused Hxt3-GFP to appear in boundary membranes, similar to proteins 
that are degraded by the ILF pathway (Figures 10A; McNally et al., 2017). This discovery was 
not limited to Hxt3-GFP: we found that GFP-tagged Itr1 (a myo-inositol transporter; Nikko and 
Pelham, 2009) as well as Aqr1 (a major facilitator superfamily-type transporter that excretes 
amino acids; Velasco et al., 2004) take a similar route from the surface to the lysosomal lumen 
when live wild type cells were treated with heat stress (Figure 10A). Importantly, knocking out 
VPS36 did not affect sorting of these proteins into the boundary of docked lysosomes, 
confirming that they are sorted by an ESCRT-independent mechanism. We also found that Hxt3-
GFP within the boundary was internalized during lysosome fusion events within live vps36∆ 
cells (Figure 10B; Movie S8), suggesting that ESCRT function is not necessary for protein 
delivery to the lumen for degradation. 
Because the ILF machinery co-purifies with vacuolar lysosomes, we were able to develop 
cell-free assays to assess protein sorting, internalization and degradation by the ILF pathway 
(McNally et al., 2017). Thus, to further study how surface proteins may use this mechanism for 
degradation, we next isolated lysosomes from Hxt3-GFP expressing cells and imaged them 60 
minutes after adding ATP to stimulate fusion in vitro (Figure 10C). Similar to findings made in 
vivo, Hxt3-GFP was sorted into the boundary during organelle fusion in vitro. Treating 
lysosomes with heat stress increased the amount of Hxt3-GFP sorted into the boundary (Figure 
10C and D), suggesting that the machinery necessary to enhance Hxt3 degradation is present on 
lysosomes. Because the Rab GTPase Ypt7 is important for protein sorting into the ILF pathway 
(McNally et al., 2017), we next added the Rab inhibitors rGdi1 (a Rab-GTPase chaperone 
protein) and rGyp1-46 (the catalytic domain of the Rab GTPase activating protein Gyp1; Brett et 
al., 2008) to fusion reactions and found that Hxt3-GFP was no longer included in boundary 
membranes (Figure 10C, 10D and S9). Hxt3-GFP membrane distribution was not affected by 
deletion of VPS36, suggesting that sorting of Hxt3-GFP into the boundary requires Ypt7 and the 
fusion protein machinery, not ESCRTs.  
To confirm that Hxt3 was internalized into the lumen upon lysosome fusion, we imaged 
lysosomes over the course of the fusion reaction in vitro (Figure 10E) and measured the GFP 
intensity within the lumen (Figure 10F, 10G and S9). As expected, Hxt3-GFP accumulated  
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Figure 10. Some surface proteins are sorted for degradation by the ILF pathway 
(A) Fluorescence and DIC micrographs of live wild type (left) or vps27∆ (right) cells expressing 
GFP-tagged Hxt3, Itr1 or Aqr1 before (control) and after heat stress for 15 minutes. (B) Images 
from time-lapse video showing homotypic lysosome fusion within live vps36∆ cells expressing 
Hxt3-GFP. See movie S8. (C) Fluorescence micrographs of lysosomes isolated from wild type 
(WT) or vps36∆ cells after 30 minutes of fusion in the absence or presence of heat stress (HS) or 
rGdi1 and rGyp1-46 (GDI). 3-dimensional fluorescence intensity (FI) plots of Hxt3-GFP are 
shown. Arrowheads indicate Hxt3-GFP enrichment (closed) or exclusion (open) within the 
boundary membrane. Also see Figure S9 A. (D) Cumulative probability plot of Hxt3-GFP 
fluorescence measured at boundaries between lysosomes isolated from wild type (WT) or vps36∆ 
cells after fusion in the presence or absence of heat stress (HS) or fusion inhibitors (rGdi1), as 
shown in C. Also see Figure S9 B. (E) Fluorescence micrographs of lysosomes isolated from 
wild type or vps36∆ cells expressing Hxt3-GFP acquired over the course of the fusion reaction in 
the absence or presence of heat stress (HS). (F) Cumulative probability plot of Hxt3-GFP 
fluorescence measured within the lumen of lysosomes isolated from vps36∆ cells after 0, 30, 60, 
90 or 120 minutes of fusion, as shown in E. Also see Figure S9 C. (G) Median values of lumenal 
GFP fluorescence observed over time for three conditions studied (n ≥ 105). (H and I) Western 
blot analysis of Hxt3-GFP degradation before or after lysosomes isolated from wild type (WT) or 
vps36∆ cells underwent fusion for 120 minutes in the absence (CTL) or presence of heat stress 
(HS; H), or after fusion in the presence or absence of the fusion inhibitors (F.I.) rGdi1 and 
rGyp1-46 (I). Cells or isolated organelles were stained with FM4-64 to label vacuolar 
membranes. Scale bars, 1 μm (in vivo) or 2 μm (in vitro). 
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within the lumen over time after lysosome fusion was stimulated with ATP. Heat stress increased 
the rate and amount of lumenal GFP accumulation over time. Importantly, Hxt3-GFP 
internalization did not require VPS36, confirming that delivery to the lumen did not require 
ESCRT function. Once delivered to the lumen of lysosomes, polytopic proteins embedded within 
ILFs are degraded by acid hydrolases (McNally et al., 2017). To assess proteolysis, we conducted 
western blot analysis to detect cleavage of GFP from Hxt3-GFP (Figure 10H) and found that 
more GFP was cleaved after lysosome fusion was stimulated in vitro. More Hxt3-GFP cleavage 
was further stimulated when lysosomes were treated with heat stress, consistent with sorting and 
internalization phenotypes observed. Furthermore, cleavage was unaffected by deleting VPS36 
(Figure 10H) but was blocked by the fusion inhibitors rGdi1 and rGyp1-46 (Figure 10I), 
confirming that the fusion machinery, not ESCRTs, was responsible for Hxt3-GFP degradation. 
Together, these findings indicate that in response to substrates or protein misfolding the surface 
transporter Hxt3-GFP is internalized and delivered to lysosome membranes where it utilizes the 
ILF pathway, and not ESCRTs, for degradation. 
 
3.4.3 The ILF pathway degrades ESCRT client proteins when MVB formation is impaired 
When ESCRT function is disrupted cells survive and surface proteins that are typically 
sorted and packaged by ESCRTs continue to be degraded although less efficiently (e.g. the 
manganese transporter Smf1; Jensen et al., 2009). In Figure 9B we show that Can1-GFP 
accumulates on lysosome membranes when VPS36 is deleted, suggesting that the ILF pathway 
may account for degradation. We confirmed that a similar distribution is observed for other 
ESCRT client proteins including GFP-tagged Ste3, a G-protein coupled receptor (Shields et al., 
2009), and Mup1, a methionine permease (MacDonald et al., 2012; Figure 11A). Importantly, all 
three are present on boundary membranes formed between docked lysosomes within cells 
missing either VPS36 or VPS27 (a subunit of ESCRT-0; Katzmann et al., 2003; Figure 11A and 
S10), suggesting that disrupting function of ESCRT–0 or –1 results in the same outcome. As 
expected, all three surface proteins also accumulate in boundaries upon treatment with heat stress 
to induce protein misfolding (Figure 11A) when components of ESCRTs are deleted. Using 
Mup1-GFP as an example, we next monitored live vps27∆ cells and found that it is present 
within ILFs that form during organelle fusion (Figure 11B; Movie S9), suggesting that Mup1-
GFP is sorted and packaged for degradation by the ILF pathway. 
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Figure 11. The ILF pathway compensates for ESCRTs when VPS27 is deleted 
(A) Fluorescence and DIC micrographs of live wild type (left) and vps27∆ or vps36∆ (right) cells 
expressing GFP-tagged Ste3, Can1 or Mup1 before (control) and after heat stress for 30 minutes. 
Also see Figure S10 A. (B) Images from time-lapse video showing homotypic lysosome fusion 
within live vps27∆ cells expressing Mup1-GFP. See movie S9. (C) Fluorescence micrographs of 
lysosomes isolated from wild type (WT) or vps27∆ cells after 30 minutes of fusion in the absence 
or presence of heat stress (HS) or rGdi1 and rGyp1-46 (GDI). 3-dimensional fluorescence 
intensity (FI) plots of Mup1-GFP are shown. Arrowheads indicate Mup1-GFP enrichment 
(closed) or exclusion (open) within the boundary membrane. (D) Cumulative probability plot of 
Mup1-GFP fluorescence measured at boundaries between lysosomes isolated from vps27∆ cells 
after 30 minutes of fusion in the absence (CTL) or presence of heat stress (HS) or fusion 
inhibitors (GDI), as shown in (C), Inset shows mean values (n ≥ 115). (E) Fluorescence of 
lysosomes isolated from vps27∆ cells expressing Mup1-pHluorin during the in vitro fusion 
reaction under control conditions (CTL) or after heat stress (HS) in presence or absence of rGdi1 
and rGyp1-46 (GDI). Also see Figure S10 B. (F) Fluorescence micrographs of lysosomes 
isolated from wild type or vps27∆ cells expressing Mup1-GFP acquired over the course of the 
fusion reaction in the absence or presence of heat stress (HS). (G) Cumulative probability plot of 
Mup1-GFP fluorescence measured within the lumen of lysosomes isolated from vps27∆ cells 
after 0, 30, 60, 90 or 120 minutes of fusion, as shown in (F). Inset shows median values at 30 
minutes for lysosomes from vps27∆ cells in the presence or absence of heat stress (n ≥ 118). Also 
see Figure S10 C. (H and I) Western blot analysis of Hxt3-GFP degradation before or after 
lysosomes isolated from wild type (WT) or vps36∆ cells underwent fusion for 120 minutes in the 
absence (CTL) or presence of heat stress (HS; H), or after fusion in the presence or absence of 
the fusion inhibitors (F.I.) rGdi1 and rGyp1-46 (I). Cells or isolated organelles were stained with 
FM4-64 to label vacuolar membranes. Scale bars, 1 μm (in vivo) or 2 μm (in vitro). 
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We confirmed this finding by isolating lysosomes from Mup1-GFP expressing cells and 
studying its membrane distribution during homotypic fusion in vitro (Figure 11C). Again, Mup1-
GFP only appears on lysosomal membranes when VPS27 is deleted, where it is present in 
boundary membranes of docked lysosomes. Inducing protein misfolding with heat stress 
promotes sorting of Mup1-GFP into the boundary (Figure 11C and D), confirming that isolated 
lysosomes possess the molecular machinery required to process Mup1-GFP for degradation. 
Furthermore, addition of the Ypt7 inhibitors rGdi1 and rGyp1-46 prevents Mup1-GFP entry into 
the boundary, confirming that this process is dependent on the fusion machinery and not ESCRT 
function.  
We next demonstrated that Mup1 was internalized into the lumen by tagging its cytoplasmic 
C-terminus with pHluorin, a pH-sensitive variant of GFP, and monitoring fluorescence over the 
course of the fusion reaction in vitro (Figure 11E). As expected, in the absence of VPS27, 
Mup1-pHluorin fluorescence decreases over the course of the fusion reaction, indicative of 
exposure to the acid lumen of the lysosome, in the presence or absence of heat stress. No change 
in Mup1-pHuorin was observed when lysosomes isolated from wild type cells were studied 
(Figure S10), as Mup1-GFP is exclusively found in the lumen (see Figure 11C). Addition of 
Ypt7 inhibitors prevented internalization (Figure 11E) confirming that the fusion machinery was 
required for Mup1-pHluorin internalization. To confirm this result, we imaged isolated 
lysosomes at different time points over the course of the fusion reaction in vitro (Figure 11F) and 
measured GFP intensity within the lumen (Figures 11G and S10). As Mup1-GFP is exclusively 
found within the lumen of lysosomes isolated from wild type cells, lumenal GFP intensity does 
not change over time. However, in the absence of VPS27, Mup1-GFP is initially present on 
lysosome membranes and accumulates within the lumen over time. Heat stress increases lumenal 
Mup1-GFP, consistent with an increase of Mup1-GFP observed in the boundary (Figure 11D) 
and increased Mup1-pHluorin internalization upon organelle fusion (Figure 11E) in the ESCRT 
deficient background.  
Once inside the lumen, Mup1-GFP should be degraded by acid hydrolases. To confirm, we 
conducted western blot analysis to detect cleavage of GFP from Mup1 before or 120 minutes 
after the homotypic lysosome fusion was stimulated with ATP in vitro (Figure 11H). Organelles 
isolated from wild type cells only contained cleaved GFP, confirming that Mup1-GFP was being 
sent to lysosomes for degradation prior to isolation. However, intact Mup1-GFP is detected on 
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lysosome preparations from vps27∆ cells and is cleaved after fusion is stimulated. As predicted, 
treating lysosomes isolated from vps27∆ cells with heat stress increases GFP cleavage (Figure 
11H) and the fusion inhibitors rGdi1 and rGyp1-46 blocks GFP cleavage (Figure 11I), consistent 
with effects on Mup1-GFP sorting and internalization (Figure 11C–G). Together these findings 
indicate that when ESCRT function is impaired, internalized surface polytopic proteins that are 
typically degraded by the ESCRT pathway are instead shunted to lysosome membranes where 
they are sorted and packaged for degradation by the ILF pathway. 
 
3.4.4 The ILF pathway degrades surface proteins in response to TOR signaling 
Thus far we have shown that the ILF pathway degrades internalized surface transporters and 
receptors in response to toxic substrates for cell survival, or in response to protein misfolding for 
cellular quality control. Another important stimulus of protein degradation is TOR signaling 
(Laplante and Sabatini, 2012): TOR kinase is thought to be activated by high cytoplasmic amino 
acid levels or ribosome inactivity to promote degradation of soluble cytosolic proteins by the 
proteasome (Rousseau and Bertolotti, 2016), surface polytopic proteins by ESCRTs (MacGurn et 
al., 2011) and lysosomal polytopic proteins by the ILF pathway (McNally et al., 2017), which in 
turn raises free amino acid levels and closes a negative feedback loop (Settembre et al., 2013). 
Given the newfound role of the ILF pathway in surface polytopic protein degradation, we next 
sought to determine if this process also responds to TOR using cycloheximide (CHX) to trigger 
TOR signaling (see MacGurn et al., 2011; McNally et al., 2017). As predicted, we found that 
surface Hxt3-GFP was internalized and appeared on membranes and in the lumen of lysosomes 
in live cells in response to CHX, in the presence or absence of VPS36 (Figure 12A), suggesting 
that CHX-mediated down-regulation of Hxt3-GFP does not require ESCRTs. Similar 
observations were made for Mup1-GFP in cells lacking VPS27 (Figure 12A) as well as other 
ESCRT client proteins (Figure S11), suggesting that CHX triggers degradation of these surface 
proteins by the ILF pathway when ESCRT function is impaired. To confirm these observations, 
we recorded lysosome fusion events within live vps27∆ or wild type cells and observed 
boundary-localized Mup1-GFP or Hxt3-GFP, respectively, being internalized into the lumen 
upon fusion (Figure 12B; movies S10 and S11). Together, these results suggest that TOR 
signaling also induces surface protein degradation by the ILF pathway. 
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We next confirmed these findings in vitro using cell-free assays to further validate our 
hypothesis (Figures 12C and S11). We find that in the absence of VPS27, Mup1-GFP is enriched 
in boundary membranes upon treatment with CHX in vitro (Figure 12D), confirming that the 
TOR machinery that responds to CHX co-purifies with isolated lysosomes (McNally et al., 
2017). We made similar findings for Hxt3-GFP in the absence or presence of VPS36 (Figure 
12D), confirming that ESCRT function was not important for Hxt3-GFP sorting in response to 
CHX. By measuring the lumenal GFP fluorescence intensity, we found that CHX caused more 
Hxt3-GFP and Mup1-GFP to accumulate inside lysosomes after membrane fusion was stimulated 
for 60 minutes in vitro (Figure 12E). We verified this finding by monitoring Mup1-pHluorin 
fluorescence over the course of the lysosome fusion reaction in vitro (Figure 12F), confirming 
that CHX stimulated protein internalization during fusion. We next confirmed that CHX also 
triggered more Hxt3-GFP and Mup1-GFP protein degradation by examining GFP cleavage by 
Western blot analysis (Figure 12G). Importantly, the lysosome membrane fusion inhibitors 
rGdi1 and rGyp1-46 blocked Hxt3-GFP and Mup1-GFP protein sorting (Figure 12C and D), 
internalization (Figure 12E and F) and degradation (Figure 12G). Furthermore, these events 
occurred in the absence of key components of the ESCRT machinery (VPS27 or VPS36; Figures 
12C–G and S11). Thus, we conclude that the ILF pathway is responsible for degradation of some 
surface proteins (e.g. Hxt3-GFP) and degrades others (Mup1-GFP) to compensate for ESCRT 
impairment in response to TOR activation by CHX. 
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Figure 12. The ILF pathway degrades surface proteins in response to TOR activation 
(A) Fluorescence and DIC micrographs of live wild type (left) or ESCRT impaired (vps27∆ or 
vps36∆; right) cells expressing GFP-tagged Hxt3 or Mup1 before (control) and after treatment 
with 100 µM cycloheximide (CHX) for 30 minutes. Also see Figure S11 A. (B) Images from 
time-lapse video showing homotypic lysosome fusion within live vps27∆ cells expressing Mup1-
GFP (see movie S10) or wild type cells expressing Hxt3-GFP (see movie S11) after CHX 
treatment. (C) Fluorescence micrographs of lysosomes isolated from cells expressing Mup1-GFP 
in wild type or vps27∆ background or from cells expressing Hxt3-GFP after 30 minutes of fusion 
in the absence or presence of CHX or rGdi1 and rGyp1-46 (GDI). 3-dimensional fluorescence 
intensity (FI) plots of Mup1-GFP or Hxt3-GFP are shown. Arrowheads indicate GFP enrichment 
(closed) or exclusion (open) within the boundary membrane. Also see Figure S11 B and C. (D) 
Cumulative probability plots of GFP fluorescence measured at boundaries between docked 
lysosomes isolated from yeast cells expressing Mup1-GFP or Hxt3-GFP in wild type or ESCRT 
deficient cells (vps27∆ or vps36∆) after fusion in the presence or absence of CHX or fusion 
inhibitors (GDI), as shown in (C; n ≥ 110). (E) Mean lumenal GFP fluorescence from 
micrographs as shown in C. Mean ± SEM. (F) Fluorescence of lysosomes isolated from vps27∆ 
cells expressing Mup1-pHluorin during the in vitro fusion reaction under control conditions 
(CTL) or after cycloheximide treatment (CHX) in presence or absence of rGdi1 and rGyp1-46 
(GDI). Also see Figure S11 D. (G) Western blot analysis of Mup1-GFP or Hxt3-GFP 
degradation before or after lysosomes isolated from wild type (WT) or ESCRT impaired (vps27∆ 
or vps36∆) cells underwent fusion for 120 minutes in the absence (CTL) or presence of CHX, or 
after fusion in the presence or absence of the fusion inhibitors (F.I.) rGdi1 and rGyp1-46. Cells or 
isolated organelles were stained with FM4-64 to label vacuolar membranes. Scale bars, 1 μm (in 
vivo) or 2 μm (in vitro). 
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3.5 Discussion 
3.5.1 The ILF pathway degrades surface proteins without ESCRTs 
Here we demonstrate that some internalized surface polytopic proteins are delivered to the 
vacuolar lysosome membrane where they are sorted into ILFs for degradation upon organelle 
fusion independent of ESCRT function (Figures 9C, 10 and 12). Previous reports of surface 
protein degradation often only include micrographs indicating the surface distribution of a protein 
before internalization, and its presence in the lumen of lysosomes afterwards (e.g. Berkower et 
al., 1994; Egner et al., 1995; Shields et al., 2009; Keener and Babst, 2013; Zhao et al., 2013; 
Ghaddar et al., 2014; O’Donnell et al., 2015); and many important papers originally describing 
degradation of surface receptors or transporters do not include any micrographs (e.g. Hicke and 
Reizman, 1996). Because the outcomes of both ESCRT and ILF pathways are equal, evidence 
showing the intracellular route of luminal delivery now seems important. For the ESCRT 
pathway, this requires imaging fixed and stained samples by electron microscopy to visualize 
proteins on small ILVs within endosomes (Haigler et al., 1979; Futter et al., 1996; Klumperman 
and Raposo, 2014) as current methods of light microscopy cannot distinguish whether proteins 
are present on ILVs or limiting membranes of endosomes. However for the ILF pathway, here we 
show surface transporters being delivered to the lumen during homotypic lysosome fusion in real 
time within live cells using HILO microscopy (e.g. Figures 10B and 12B, movies S9 and S11). 
These include sugar transporter Hxt3, as well as the peptide transporter Aqr1 and myo-inositol 
transporter Itr1, but re-examination of micrographs in previous reports reveal the presence of 
other internalized surface transporters on lysosome membranes as well (e.g. Tat2; Beck et al., 
1999), suggesting that ILF-dependent degradation of surface proteins may be widespread in S. 
cerevisiae. These transporters and the underlying fusion machinery responsible for the ILF 
pathway (Nickerson et al., 2009; Spang, 2016) are evolutionarily conserved, suggesting that a 
similar process may regulate surface glucose (Hxt/GLUT gene family) or myo-inositol 
(Itr/HMIT) transporters levels important for cellular metabolism or nutrient (re-) absorption in 
human epithelial cells within the ileum or kidney for example (Smith et al., 2013; Chen et al., 
2015; Schneider, 2015). Given that the mechanism of degradation has been elucidated for only a 
handful of an estimated ~5,500 polytopic proteins encoded by the human genome (Fagerberg et 
al., 2010), we speculate that the ILF pathway could be equally important as the ESCRT pathway 
for determining surface protein lifetimes and thus may underlie diverse physiology. 
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We also show that the ILF pathway sorts and packages internalized surface proteins that are 
typically processed for degradation by ESCRTs when MVB formation is impaired (Figures 9B, 
11 and 12). Unlike protein sorting into the ESCRT pathway, we were able to visualize their 
internalization by the ILF pathway in real time within live cells (Figures 11B and 12B; movies 
S9 and S10). These include the ESCRT client proteins Mup1, Ste3 and Can1 that have been 
extensively used to characterize this pathway in S. cerevisiae (e.g. Lin et al., 2008). This may not 
be limited to internalized surface proteins, as biosynthetic cargo such as lysosomal acid 
hydrolases (e.g. the carboxypeptidase Cps1 and polyphosphatase Phm5) also utilize the MVB 
pathway for delivery to the lysosomal lumen, and deleting components of ESCRTs redistributes 
it on the lysosome membrane (a classic phenotype used to discover and characterize the ESCRT 
pathway; e.g. McNatt et al., 2007). We speculate that compensation by the ILF pathway may 
mediate residual surface protein degradation previously observed when ESCRTs are impaired 
(Jensen et al., 2009), thus permitting cell survival when the primary process for sorting and 
packaging membrane proteins for degradation is dysfunctional. Loss-of-function mutations in 
human orthologs of ESCRT components are linked to cancers and neurodegenerative disorders 
for example and etiology is thought to involve improper cargo degradation (Saksena and Emr, 
2009; Stuffers et al., 2009a; Alfred and Viccari, 2016). Thus, assuming the ILF pathway also 
functions in human cells, it is tempting to speculate that up-regulating the ILF pathway by 
increasing lysosome numbers and activity through TFEB (Transcription Factor EB) signaling for 
example (Ferguson, 2015; Napolitano and Ballabio, 2016), may offer a therapeutic strategy to 
treat ESCRT-related diseases. 
 
3.5.2 Coordination of cellular protein degradation pathways for survival and physiology 
What determines whether a surface protein uses the ESCRT or ILF pathways for 
degradation? Here we show that protein sorting into the ILF pathway is triggered by the same 
stimuli that mediate entry into the ESCRT pathway: changes in substrate levels (e.g. Nikko and 
Pelham, 2009; Figure 9), protein misfolding by heat stress (Keener and Babst, 2013; Figures 10 
and 11), or TOR signaling (MacGurn et al., 2011; Jones et al., 2012; Figure 12). In the ESCRT 
pathway, this is mediated by cargo protein recognition by adapter proteins (e.g. arrestins; Lin et 
al., 2008; Nikko and Pelham, 2009) and ubiquitylation by E3-ligases (e.g. Rsp5; MacDonald et 
al., 2012) at surface or endosomal membranes. Although the mechanism responsible for protein 
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sorting by the ILF pathway has not been elucidated, we have preliminary evidence suggesting 
that adapter proteins and E3-ligases are required for protein sorting into the ILF pathway (data 
not shown), suggesting that both pathways recognize ubiquitylated proteins, which my explain 
why the ILF pathway can degrade proteins that are typically substrates for the ESCRT pathway. 
Furthermore, the same labeling machinery is present at the plasma membrane, endosomes and 
lysosomal membranes (e.g. Li et al., 2015a; Li et al., 2015b), suggesting that proteins are 
ubiquitylated in a similar manner at these sites and thus different patterns of protein 
ubiquitylation are unlikely. The presence of similar labeling machinery on the plasma and 
lysosome membranes may also explain why more Mup1-GFP is sorted into the ILF pathway and 
degraded when isolated lysosomes are treated with CHX or heat stress in vitro (Figures 11 and 
12).  
The underlying mechanism may also be ubiquitin-independent. This is because 
ubiquitylation is not required for sorting of all protein cargoes into the ESCRT pathway: some 
proteins bind to chaperones such as Sna3 to mediate degradation (Reggiori and Pelham, 2001; 
McNatt et al., 2007; MacDonald et al., 2012). Sna3 has a paralog called Sna4 that is exclusively 
found on lysosome membranes (Pokyrzwa et al., 2009) and is sorted into the ILF pathway 
(McNally et al., 2017). Thus, we hypothesize that perhaps chaperone binding specificity may 
determine which pathway is used by surface polytopic proteins for degradation. For example, 
Hxt3 may preferentially interact with Sna4 instead of Sna3. If so, internalized Hxt3 avoids Sna3-
mediated incorporation into ILVs by ESCRTs at the endosome and remains on the limiting 
membrane. Upon MVB-lysosome fusion, Hxt3 is delivered to lysosome membranes where it can 
encounter Sna4 and be degraded by the ILF pathway. We are currently testing this hypothesis and 
anticipated results will help reveal unique and shared mechanisms that underlie these different 
cellular protein degradation pathways, giving us a better understanding of how they orchestrate 
global changes in protein turn over that occur during cell differentiation, the cell cycle or cellular 
aging for example.  
 
3.5.3 The ILF pathway as an alternative for other ESCRT-related cellular physiology 
Could the ILF pathway also be responsible for ESCRT-independent ILV formation? Like 
ESCRTs, the ILF machinery selectively sorts and packages proteins into what are essentially 
large intralumenal vesicles. Thus, we speculate that homotypic fusion likely contributes to 
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generating intralumenal vesicles observed within lysosomes that are needed for proper lipid 
catabolism (Kallunki et al., 2013). However, the underlying machinery is also responsible for 
heterotypic lysosome membrane fusion events between autophagosomes (Jiang et al., 2014) and 
MVBs (Luzio et al., 2009; Epp et al., 2011). Moreover, paralogous machinery underlies 
endosome membrane fusion required for earlier trafficking events during endocytosis (Balderhaar 
and Ungermann, 2013; Spang, 2016; Chou et al., 2016). Thus we speculate that ILF formation 
during organelle fusion may occur at other sites in the cell, including during homo- or hetero-
typic endosome fusion, which may account for ILVs within endosomes observed when ESCRTs 
are depleted (Trajkovic et al., 2008; Blanc et al., 2009; Stuffers et al., 2009b; Edgar et al., 2014) 
or for observed ILVs that are much larger than those derived by ESCRTs (e.g. Fairn et al., 2011). 
Although incredibly speculative, this ESCRT-independent mechanism may also account for 
exosome formation when lysosomes or lysosome-related organelles containing ILVs fuse with 
the plasma membrane (Reddy et al., 2001; Jaiswal et al., 2002; Blott and Griffiths, 2002). New 
methods of super-resolution fluorescence microscopy or electron microscopy are necessary to test 
this hypothesis as these organelles, ILVs and exosomes are expected to be smaller (e.g. 25-50 nm 
in diameter; see Palay and Palade, 1955; Hanson and Cashikar, 2012; Edgar et al., 2014) than 
those observed during homotypic vacuolar lysosome fusion (up to 1 µm in diameter based on 
boundary membrane lengths observed; Mattie et al., 2017; McNally et al., 2017). If true, these 
findings will confirm that the ILF pathway is as important as the ESCRT pathway for cellular 
physiology.  
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Chapter 4. ILF and vReD pathways both control individual lysosomal 
transporter protein lifetimes 
4.1 Abstract 
Lysosomal nutrient transporter proteins move lumenal products of biomaterial catabolism to 
the cytoplasm for reuse by the cell. Two mechanisms control their lifetimes: the ILF 
(IntraLumenal Fragment) and vReD (Vacuole REcycling and Degradation) pathways. But it is 
not clear if they function independently. Using S. cerevisiae as a model, here we show that the 
ILF pathway mediates constitutive turnover of the lysine transporter Ypq1 and zinc transporter 
Cot1 – known vReD client proteins – in vivo and in vitro. In contrast, the vReD pathway 
mediates constitutive degradation of the amino acid transporter Vba4. Activation of TOR with 
cycloheximide enhances their degradation by these pathways. However, misfolding by heat stress 
shunts all three into the ILF pathway. Thus, both pathways control individual transporter 
lifetimes, although only the ILF pathway mediates protein quality control. The pathway chosen 
depends on protein fate: degradation is imminent by the ILF pathway, whereas the vReD 
pathway permits reuse. 
 
4.2 Introduction 
Lysosomes are tasked with recycling biomaterials within all eukaryotic cells (Perera and 
Zoncu, 2016). In addition to being an important source of cellular nutrients, their activity is 
required to clear toxic aggregates or damaged proteins and organelles to prevent cell death. To 
function, lysosomes must perform three fundamental functions (de Duve and Wattiaux, 1966; 
Luzio et al., 2007): first they must fuse with membrane-encapsulated compartments containing 
biomaterials, which exposes them to lumenal acid hydrolases for catabolism–the second essential 
function of lysosomes. Finally, the products of degradation (lipids, sugars, amino acids, and other 
nutrients) are translocated across the lysosomal membrane by nutrient transporter proteins to the 
cytoplasm where they are re-used by the cell. In addition to acting as important stores for 
nutrients, lysosomes also store metals and other ions, and controlled release (or uptake) by 
lysosomal transporter proteins is critical for metabolism, signaling and programmed cell death 
(Kroemer and Jäättelä, 2005; Xu and Ren, 2015; Lim and Zoncu, 2016). Thus, lysosomal 
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transporter proteins expression and activity is critical for lysosome function, yet we know little 
about their lifetimes or how they are regulated. 
Recently two mechanisms have been discovered that control polytopic protein lifetimes on 
the vacuolar lysosome (or vacuole) in the model organism Saccharomyces cerevisiae: The first, 
termed the vReD (Vacuole membrane REcycling and Degradation) pathway, is essentially a 
mechanism to feed vacuolar polytopic proteins to the canonical MultiVesicular Body (MVB) 
pathway, which is responsible for surface transporter and receptor protein down-regulation 
(Davies et al., 2009; Figure 13A): In response to changes in substrate levels, the vacuolar amino 
acid transporter Ypq1 (Li et al., 2015a) or zinc transporter Cot1 (Li et al., 2015a) are 
ubiquitylated and sorted into areas of the vacuole membrane that form vesicles, which then 
supposedly fuse with endosomal compartments. Here they are thought to encounter ESCRTs 
(Endosomal Sorting Complexes Required for Transport) that sort and package them into 
intralumenal vesicle (ILVs) forming a MVB, which when mature fuses with the vacuole to 
expose protein-laden ILVs to lumenal acid hydrolases for catabolism. Although the evidence 
presented confirms the existence of the vReD pathway, widespread use by vacuolar polytopic 
proteins has not been confirmed and its contributions to vacuole membrane homeostasis or 
remodeling remain elusive. 
The second, termed the IntraLumenal Fragment (ILF) pathway, is an ESCRT-independent 
mechanism that relies on vacuole membrane fusion machinery for protein sorting and 
internalization (McNally et al., 2017; Figure 13A): In response to substrates, protein misfolding 
or TOR-signaling, vacuolar polytopic proteins such as the V-ATPase (Vph1), metal transporters 
(Fth1, Fet5), ABC transporters (Ybt1, Ycf1) and the lipid transporter Ncr1 are selectively sorted 
into an area of membrane, called the boundary, encircled by the fusion machinery that assembles 
into a ring at contact sites between apposing organelles prior to homotypic fusion. Upon lipid 
bilayer scission at the ring, the boundary membranes merge and are internalized within the lumen 
of single organelle as a protein-laden ILF that is catabolized by hydrolases. The ILF pathway is 
thus intrinsic to organelle membrane fusion, utilizing the fusion protein machinery – including 
the Rab GTPase Ypt7, the HOmotypic fusion and Protein Sorting (HOPS) tethering complex and 
soluble NSF attachment protein receptor (SNARE) proteins – for efficient cargo protein 
degradation. While this pathway has been shown to be crucial for remodeling the vacuolar 
membrane proteome, protein sorting and degradation by this pathway remains relatively elusive. 
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Although these pathways seem mutually exclusive, the outcome is equal: To topologically 
accommodate degradation by lumenal hydrolases, vacuolar membrane proteins are either sorted 
and packaged into ILVs by ESCRTs at endosomes for the vReD pathway, or into ILFs – which 
are essentially large ILVs – by the fusion machinery on vacuoles for the ILF pathway (Figure 
13A). But it is unclear why lysosomal membrane proteins take different routes. Furthermore, Emr 
and colleagues reported that they were unable to visualize entry of some ILF client proteins into 
the vReD pathway (e.g. Vph1, Fth1; Li et al., 2015a), suggesting that protein degradation by 
these pathways is mutually exclusive and possibly dependent on protein identity. However, we 
found that the ZnT family zinc transporter and vReD client protein Cot1 is also degraded by the 
ILF pathway (Li et al., 2015b; McNally et al. 2017). This preliminary work raises many 
important questions that must be answered to comprehensively understand vacuole transporter 
regulation and its contribution to cell biology: Can both pathways degrade the same client 
proteins? What determines which degradation pathway is selected? Does each contribute to 
vacuole membrane homeostasis or protein quality control? Does each mediate vacuolar lysosome 
membrane remodeling in response to signaling responsible for cellular metabolism or aging? 
 
4.3 Methods and Materials 
4.3.1 Yeast strains and reagents 
All Saccharomyces cerevisiae strains used in this study are listed in Table 4. Biochemical 
and yeast growth reagents were purchased from either Sigma-Aldrich, Invitrogen or BioShop 
Canada Inc. Proteins used include recombinant Gdi1 purified from bacterial cells using a 
calmodulin-binding peptide intein fusion system (Brett and Merz, 2008) and recombinant Gyp1-
46 (the catalytic domain of the Rab-GTPase activating protein Gyp1) purified as previously 
described (Eitzen et al., 2000). Reagents used in fusion reactions were prepared in 20 mM Pipes-
KOH, pH 6.8, and 200 mM sorbitol (Pipes Sorbitol buffer, PS).   
 
4.3.2 Fluorescence microscopy 
Images were acquired with a Nikon Eclipse TiE inverted microscope equipped with a 
motorized laser TIRF illumination unit, Photometrics Evolve 512 EM-CCD camera, CFI 
ApoTIRF 1.49 NA 100x objective lens, and 488 nm or 561 nm (50 mW) solid-state lasers 
operated with Nikon Elements software. Cross sectional images were recorded 1 μm into the 
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sample and resulting micrographs were processed using ImageJ software (National Institutes of 
Health) and Adobe Photoshop CC. Images shown were adjusted for brightness and contrast, 
inverted and sharpened with an unsharp masking filter. Fluorescence intensity profiles of GFP 
fluorescence were generated using ImageJ software. 
 
4.3.3 Live cell microscopy 
Live yeast cells were stained with FM4-64 to label vacuole membranes and prepared for 
imaging using a pulse-chase method as previously described (Brett et al., 2008). Where indicated, 
cells were incubated at 37 °C for 30 minutes for heat stress, with 100 μM cycloheximide for 90 
minutes at 30 °C, or with 7 μM rapamycin for 90 minutes at 30 °C after FM4-64 staining. Time-
lapse videos were acquired at 30°C using a Chamlide TC-N incubator (Live Cell Instruments) 
with cells plated on coverslips coated with concavalin-A (1 mg/ml in 50 mM HEPES, pH 7.5, 20 
mM calcium acetate, 1 mM MnSO4). 
To assess how changing substrate levels affect polytopic protein sorting, yeast cells 
expressing Ypq1-GFP were incubated over night at 30 °C in YPD media supplemented with 125 
μM lysine. Cells were back diluted in fresh YPD media supplemented with lysine and stained 
with FM4-64 for one hour at 30 °C. After two washes, cells were resuspended in SC media 
lacking lysine for 6 hours before collection and imaging. 
Yeast cells expressing Cot1-GFP were incubated over night at 30 °C in SC media. Cells were 
back diluted in fresh SC media for FM4-64 staining, one hour at 30 °C. After two washes, cells 
were resuspended in SC media supplemented with 2 mM ZnCl2 and grown for two hours at 30 °C 
(Li et al., 2015b). Cells were washed twice prior to imaging. 
   
4.3.4 Vacuole isolation and homotypic vacuole fusion 
Vacuoles were isolated from yeast cells as previously described (Haas, 1995). Fusion 
reactions were prepared using 6 μg of vacuoles isolated from GFP derivative strains in standard 
fusion reaction buffer with 0.125 M KCl, 5 mM MgCl2, 1 mM ATP and 10 μM CoA. Vacuolar 
membranes were stained with FM4-64 by treating vacuoles with 3 μM FM4-64 for 10 minutes at 
27 °C. Reactions were incubated at 27 °C for 60 minutes, unless otherwise noted, and placed on 
ice prior to visualization by HILO microscopy.  
For examining the contribution of the fusion machinery, vacuoles were incubated in the 
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absence (CTL) or presence of 3.2 μM rGyp1-46 or 4 μM rGdi1 (F.I.). For heat stress treatment, 
vacuoles were pretreated for 5 minutes at 37 °C before addition to the fusion reaction and 
incubation for 30 minutes at 27 °C. Where indicated, vacuoles were pretreated with 100 μM 
cycloheximide for 15 minutes at 27 °C and incubated for an additional 15 minutes with the fusion 
reaction. Vacuoles were pretreated for 15 minutes at 27 °C with 7 μM Rapamycin, followed by 
addition of cycloheximide (where indicated) and fusion reaction constituents for an additional 30 
minute incubation. Vacuoles were pretreated for 5 minutes at 27 °C with 25 μM ZnCl2 before 
addition to the fusion reaction and incubation for additional time points. 
Vacuole content mixing was assessed using a complementary, split β-lactamase based assay 
as previously described (Jun and Wickner, 2007) with increasing concentrations of ZnCl2. For all 
concentrations tested, isolated vacuoles were pretreated for 5 minutes at 27 °C prior to addition of 
the fusion reaction constituents and further incubation for 90 minutes at 27 °C. Data shown was 
normalized to values obtained at 90 minutes under standard fusion conditions (n = 2). 
 
4.3.5 Western blot analysis 
Samples were prepared from isolated vacuoles from yeast strains expressing a GFP-tagged 
vacuolar membrane protein. Fusion reactions were prepared as previously described. Where 
indicated, samples were pretreated with heat stress, cycloheximide, or rapamycin and with fusion 
inhibitors rGyp1-46 and rGdi1, as previously described. Samples were incubated for 0 (ice), 30, 
60, 90, or 120 minutes at 27 °C. After incubation, protease inhibitors (6.7 μM leupeptin, 33 μM 
pepstatin, 1 mM PMSF and 10.7 mM AEBSF), 1% DDM and 5X laemmli sample buffer were 
added. To solubilize membrane proteins but avoid aggregation due to boiling, reactions were 
incubated at 27 °C for 10 minutes prior to running on an SDS-Page gel. Samples were probed for 
α-GFP (Abcam, Cambridge, UK). All samples were repeated at least three times. Gels were 
imaged using GE Amersham Imager 600 by chemiluminescence and edited and prepared using 
Adobe Photoshop and Illustrator CC software. 
 
4.3.6 Data analysis and presentation 
For quantitative analysis of isolated vacuole micrographs we calculated the relative boundary 
membrane or lumenal GFP fluorescence using only docked vacuoles by measuring the surface 
area, the length of the boundary. GFP fluorescence intensities were measured using a ROI 4x4 
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pixels in diameter and acquiring a fluorescence value on the outer vacuole membrane, within the 
lumen and on the boundary membrane using ImageJ software. Data are reported as mean ± SEM. 
Comparisons were calculated using Student two-tailed t-test, P values < 0.05 indicate significant 
differences (*). Quantitative data was acquired using ImageJ software and plotted using Prism 
GraphPad version 7.0 software. Figures were prepared using Adobe Illustrator CC software. 
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Table 4. Yeast strains used in Chapter 4 
Strain Genotype Source 
BY4741 MATα his3-Δ1 leu2-Δ0 met15-Δ0 ura3-Δ0 Huh et al., 2003 
Ypq1-GFP BY4741, Ypq1-GFP::KanMX This study 
Ypq1-GFP:vps36Δ BY4741, Ypq1-GFP::KanMX, vps36∆:HIS3MX This study 
Cot1-GFP BY4741, Cot1-GFP::HIS3MX Huh et al., 2003 
Cot1-GFP:vps27∆ BY4741, Cot1-GFP::HIS3MX, vps27∆:KanMX This study 
Vph1-GFP BY4741, Vph1-GFP::HIS3MX Huh et al., 2003 
Vba4-GFP BY4741, Vba4-GFP::HIS3MX Huh et al., 2003 
Vba4-GPF:vps27∆ BY4741, Vba4-GFP::HIS3MX, vps27∆:HIS3MX This study 
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4.4 Results 
4.4.1 vReD client proteins Cot1 and Ypq1 are constitutively degraded by the ILF pathway 
To better resolve how vReD and ILF pathways contribute to vacuole membrane protein 
turnover, we first determined if Ypq1, the only other known vReD client protein besides Cot1 (Li 
et al., 2015a), is also degraded by the ILF pathway. Recently, Emr and colleagues suggested that 
Ypq1 is exclusively degraded by the vReD pathway (Zhu et al., 2017). But they mostly present 
images of yeast cells containing a single vacuole, eliminating the possibility of detecting sorting 
and degradation of Ypq1 by the ILF pathway, as it requires two organelles. However, most cells 
within an actively growing yeast culture contain two or more vacuoles (Li and Kane, 2009). To 
resolve this issue, we simply studied cells with multiple vacuoles. Similar to Cot1, we find that 
GFP-tagged Ypq1 is present in the boundary membranes of docked organelles within live cells 
under standard growth conditions (Figure 13B). Using HILO microscopy, we then recorded 
homotypic vacuole fusion events in live cells and found that Ypq1-GFP embedded in the 
boundary membrane is internalized within the lumen upon the completion of fusion (Figure 
13C; Movie S12). Closer examination of micrographs presented in the three publications 
describing the vReD pathways reveal that fluorescent protein-tagged Ypq1 and Cot1 also 
accumulate within the boundary membrane between docked vacuoles when images of untreated 
yeast cells containing two or more vacuolar lysosomes are shown (Li et al., 2015a Figures 2A, 
2C and 4I; Li et al., 2015b Figures 5D, 6C and 7C; Zhu et al., 2017 Figures 1A). Thus, our results 
are consistent with these previous reports, and suggest that, like Cot1-GFP, Ypq1-GFP is 
constitutively sorted for degradation by the ILF pathway. 
When degraded by the vReD pathway, Ypq1-GFP is recognized, sorted and packaged for 
degradation by the ESCRT machinery (Li et al., 2015a). Thus, it is possible that ESCRTs may 
sort Ypq1-GFP into the boundary as well. To test this hypothesis, we deleted VPS36, a gene 
encoding a subunit of ESCRT-I (Henne et al., 2011), to disable the ESCRT machinery and found 
that it had no effect on Ypq1-GFP sorting into the ILF pathway (Figure 13B and C; Movie S13). 
We made similar observations for Cot1-GFP when VPS27, a gene encoding a component of 
ESCRT-0 (Katzmann et al., 2003), was deleted (Figure 13C; Movies S14-15). This confirms our 
previous work suggesting that protein degradation by the ILF pathway is ESCRT-independent 
(McNally et al., 2017) and eliminating the possibility that the vReD pathway was responsible for 
the observed sorting phenotypes.  
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Figure 13.  vReD client proteins, Ypq1 and Cot1, are constitutively degraded by the ILF 
pathway 
(A) Working model describing how lysosomal membrane proteins can be selectively sorted for 
degradation by either the ILF or vReD pathways. (B) vReD client proteins, Ypq1 and Cot1, are 
constitutively degraded by the ILF pathway within wild type cells or when components of the 
ESCRT machinery are deleted. Line-scan analysis of Ypq1-GFP or Cot1-GFP in wild type and 
ESCRT deficient cells illustrating GFP (blue) or FM4-64 (red) fluorescence distribution along the 
dotted line. (C) Images from time-lapse videos of live yeast cells undergoing vacuole fusion 
expressing Ypq1-GFP or Cot1-GFP in wild type and ESCRT deficient cells. Cells were stained 
with FM4-64 to label with vacuolar membrane. Dotted lines outline each cell as observed in DIC. 
Scale bars, 1 μm (in vivo). (D) Micrographs of vacuoles isolated from cells expressing Ypq1-GFP 
or Cot1-GFP in wild type or ESCRT deficient backgrounds labeled with FM4-64 under standard 
fusion conditions. Isolated vacuoles from cells expressing Vph1-GFP demonstrating that Vph1-
GFP is uniformly distributed around the vacuolar membrane. A closed arrowhead indicates 
boundary membranes containing GFP fluorescence. GFP fluorescence intensity profile plots (left 
panel). Scale bar, 2 μm (in vitro). Cumulative probability curves of GFP fluorescence intensity 
within the boundary (E) or vacuolar lumen (F) of micrographs presented in D (n ≥ 102). Western 
blot analysis of Ypq1-GFP (G) and Cot1-GFP (H) degradation before and after fusion of isolated 
vacuoles in wild type (WT) and ESCRT deficient backgrounds. See also Movies S12-15.  
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The machinery necessary for protein degradation by the ILF pathway co-purifies with 
isolated organelles permitting study in vitro (McNally et al., 2017). Thus, we next confirmed that 
Ypq1-GFP sorting into the ILF pathway observed in vivo also persists in vitro (Figure 13D). We 
measured the GFP fluorescence at these boundary membranes and found that, like Cot1-GFP, 
Ypq1-GFP was enriched at these sites (Figure 13E), as compared to GFP-tagged Vph1, the stalk 
domain of the vacuolar V-type H+-ATPase, that is uniformly distributed on vacuole membranes 
during fusion (Wang et al., 2002; McNally et al., 2017). Furthermore, protein sorting was 
unaffected by deleting components of the ESCRT machinery, confirming that entry of Ypq1 and 
Cot1 into the ILF pathway is independent of ESCRTs and as such, the vReD pathway. To 
confirm that Ypq1-GFP was internalized during the fusion reaction in vitro, we sought to 
determine if Ypq1-GFP appeared within the lumen over time (Figure 13F). As expected, we 
found that more Ypq1-GFP and Cot1-GFP accumulated within the lumen as compared to Vph1-
GFP under fusogenic conditions. Here they should be exposed to acid hydrolases for degradation 
(Luzio et al., 2007). Thus, we next conducted western blot analysis to assess protein degradation 
and found that more GFP was cleaved from Ypq1 and Cot1 (Figure 13G) after lysosome fusion 
was stimulated in vitro. Importantly, observed protein degradation continued to occur in the 
absence of ESCRT activity. In all, these results reveal that both known vReD client proteins, 
Ypq1 and Cot1, are constitutively turned over by the ILF pathway. 
 
4.4.2 Vba4, a vacuolar amino acid transporter, is constitutively degraded by the vReD 
pathway 
At this point, it would seem that all vacuolar polytopic proteins rely on the ILF pathway for 
constitutive turnover. However, when conducting studies to identify additional ILF client 
proteins, we discovered that GFP-tagged Vba4, a vacuole amino acid transporter (Kawano-
Kawada et al., 2015), was excluded from boundary membranes between docked vacuoles in 
living cells (Figures 14A and B; Movie S16). We quantified this phenotype using still images 
(Figure 14C) and confirmed that it is prevalent within the population of cells analyzed (Figure 
14D). This sorting phenotype (boundary exclusion) is similar to other resident transporter 
proteins that were reported to avoid the ILF pathway and are spared during homotypic vacuole 
fusion (e.g. GFP-tagged Fet5, Ybt1, Ycf1 and Ncr1; McNally et al., 2017). However, unlike these 
other transporter proteins, Vba4-GFP also appeared on puncta adjacent to the vacuole membranes  
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Figure 14. The vacuolar amino acid transporter, Vba4, is a new and constitutive vReD 
cargo within live cells 
(A) Micrographs of docked vacuoles within cells expressing Vba4-GFP, Cot1-GFP, or Ypq1-
GFP demonstrating their sorting by vReD and ILF pathways. Vba4-GFP is a constitutive vReD 
client protein, whereas Cot1-GFP and Ypq1-GFP are sorted by the vReD pathway when cognate 
substrate levels are manipulated: addition of 2 mM ZnCl2 or lysine withdrawal, respectively. 
Arrows highlight puncta adjacent to the vacuolar membrane. (B) Images from time-lapse videos 
of live yeast cells undergoing vacuole fusion expressing Vba4-GFP in a wild type strain or when 
VPS36 is deleted. Cells were stained with FM4-64 to label the vacuolar membrane. Dotted lines 
outline each cell as observed in DIC. Scale bar, 1 μm (in vivo). (C) Line-scan analysis of images 
shown in A illustrating GFP (blue) or FM4-64 (red) fluorescence distribution along the dotted 
line. (D) Quantification of in vivo micrographs demonstrating the percent of cells with GFP 
fluorescence present within the boundary membrane and the percent of cells with dots (puncta) 
adjacent to the vacuolar membrane (n ≥ 155). See also Movies S16-17. 
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(Figure 14A) within most cells analyzed (Figure 14D). Importantly, these puncta resembled 
Cot1-GFP or Ypq1-GFP -positive structures that form to mediate their degradation by the vReD 
pathway in response to changes in substrate levels (Figures 14A and D; Li et al., 2015a; Li et al., 
2015b). Consistent with this interpretation, in the presence of ZnCl2 Cot1-GFP was also excluded 
from boundary membranes and appeared on puncta adjacent to the vacuole membrane (Figure 
14A), suggesting that it is redirected from the ILF pathway to the vReD pathway. However, 
despite the appearance of Ypq1-GFP on puncta, the GFP-tagged protein continued to be present 
in boundary membranes after lysine withdrawal (Figures 14A and D), suggesting that Ypq1-GFP 
substrate-induced degradation is not dependent on the vReD pathway exclusively. In any case, 
together these results show that Vba4 avoids the ILF pathway and rather is a bone fide vReD 
client protein, the first shown to be constitutively degraded by this pathway. 
To further study protein degradation by these two pathways, we purified vacuoles from these 
strains and found that puncta form adjacent to isolated vacuoles when we monitored Vba4-GFP 
or Cot1-GFP (with ZnCl2) under fusogenic conditions over time (Figures 15A and B). This 
suggests that the vReD machinery responsible for protein sorting and packaging also co-purifies 
with organelles permitting further study in vitro. Notably, Ypq1-GFP did not appear on puncta in 
vitro (Figure 13D) despite the absence of lysine from the reaction buffer, suggesting that the 
machinery responsible for sensing extracellular lysine withdrawal to signal Ypq1-GFP 
degradation by the vReD pathway may not co-purify with lysosomes. Thus, we focused on 
studying only Vba4-GFP and Cot1-GFP and found that both proteins continued to be excluded 
from boundaries between docked organelles (Figure 15C) and appeared on puncta (Figure 15B) 
over time, confirming that their sorting phenotypes were recapitulated in vitro. Importantly, the 
conditions used to stimulate Cot1-GFP sorting into the vReD pathway do not completely block 
the in vitro fusion reaction, suggesting the membrane fusion machinery is intact (Figure S12). 
When counting GFP-positive puncta that formed over time in vitro, we noticed that this 
variably increased until a peak at 30 minutes for Vba4-GFP or 60 minutes for Cot1-GFP and then 
decreased afterwards, suggesting that these compartments were generated and then consumed 
during the reaction (Figure 15B). This result is consistent with Cot1-GFP and Vba4-GFP being 
first sent to endosomal compartments (represented as puncta in our micrographs) where they are 
packaged by the ESCRT machinery in to ILVs within MVBs which later fuse with vacuoles 
(consumption of puncta) to deliver these proteins to the lumen for degradation (Li et al., 2015a). 
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To test this hypothesis, we measured the fluorescence intensity of Vba4-GFP and Cot1-GFP 
(with ZnCl2) within the lumen over time (Figure 15D). As expected, both GFP-tagged proteins 
accumulated within the lumen, signifying that they were exposed to acid hydrolases for 
degradation. To confirm this, we assessed GFP-cleavage from Vba4 or Cot1 (with ZnCl2) by 
western blot (Figures 15E and F) and found that both proteins were indeed degraded over time 
in vitro. As Vba4-GFP is excluded from boundary membranes, but rather appears on vesicles that 
are consumed over time under standard fusion conditions, we conclude that Vba4-GFP is 
constitutively delivered to the vacuole for degradation by the vReD pathway, whereas Cot1-GFP 
degradation by the vReD pathway requires manipulating cognate substrate levels.  
 
4.4.3 The ILF pathway compensates for loss of vReD function 
The vReD pathway requires ESCRTs to recognize, sort and package proteins for 
degradation. To confirm that the vReD pathway is responsible for constitutive Vba4-GFP 
degradation, we deleted VPS36 to block ESCRT function and expected Vba4-GFP to accumulate 
in puncta (as this stage of the vReD pathway is supposedly ESCRT-independent) but it should 
not be delivered to the vacuole lumen, as ILV formation is ESCRT-dependent (Li et al., 2015a). 
However, we found that knocking out VPS36 caused Vba4-GFP to accumulate within the 
boundary membrane at the interface between docked vacuoles (Figures 14A–C) in nearly all 
cells examined (Figure 14D), and Vba4-GFP was internalized within an ILF upon homotypic 
vacuole fusion within living cells (Figure 14B; Movie S17). We made similar observations in 
vitro (Figures 15A) whereby the intensity of Vba4-GFP fluorescence within the boundary 
membrane increased over time (Figure 15C), suggesting that it was now sorted into the ILF 
pathway.  
Moreover, Vba4-GFP–positive puncta did not efficiently form in vivo (Figure 14D) or in 
vitro (Figure 15B), although Vba4-GFP continued to accumulate in the lumen over time (Figure 
15D). Consistent with this finding, Vba4-GFP continued to be degraded in the absence of VPS36 
(Figure 15E). We made similar observations in vitro for Cot1-GFP, whereby ZnCl2 normally 
triggers Cot1-GFP degradation by the vReD pathway, but when ESCRT function is disrupted, it 
resorts to the ILF pathway (Figures 14 and 15). All things considered, we conclude that vReD-
mediated protein degradation is rerouted to the ILF pathway when ESCRT function is impaired. 
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Figure 15. Vba4-GFP and Cot1-GFP are sorted by the vReD pathways on isolated vacuoles 
(A) Fluorescence micrographs of docked vacuoles isolated from cells expressing either Vba4-
GFP or Vba4-GFP:vps36∆ under standard fusion conditions, or from cells expressing Cot1-GFP 
or Cot1-GFP:vps27∆ after pre-treatment with 25 μM ZnCl2 for 5 minutes over time. Arrows 
highlight puncta adjacent to the vacuolar membrane. Boundaries containing (closed) or lacking 
(open arrowheads) GFP fluorescence are indicated. GFP fluorescence intensity profile plots (left 
panel). Scale bar, 2 μm (in vitro). (B) Quantification of the number of dots (puncta) compared to 
the number of vacuoles (normalized to the wild type (WT) strain at time zero) from micrographs 
as shown in A. Average boundary membrane (C) or lumenal (D) GFP fluorescence intensity over 
time for micrographs as shown in A. Data presented are means ± SEM (n ≥ 123). Western blot 
analysis of (E) Vba4-GFP and Vba4-GFP:vps36∆ degradation kinetics before and after fusion of 
isolated vacuoles under standard reaction conditions or (F) Cot1-GFP before and after fusion of 
isolated vacuoles in the absence or presence of ZnCl2 treatment. See also Figure S12. 
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4.4.4 Protein degradation by the vReD pathway can be stimulated by TOR 
TOR (target of rapamycin) is a critical signaling serine/threonine kinase important for a 
variety of cellular processes including cellular metabolism, regulating organismal growth and 
homeostasis, and for supplying the cell with nutrients under metabolic stress conditions (Dunlop 
and Tee, 2009; Laplante and Sabatini, 2012; Perera and Zoncu, 2016). To presumably increase 
cellular amino acid levels, both the ILF and MVB pathways degrade vacuolar or surface 
polytopic proteins, respectively, in response to activation of TOR signaling by the translation 
inhibitor cycloheximide (CHX; MacGurn et al., 2011; McNally et al., 2017). However, it is not 
known if vReD also mediates vacuolar transporter protein degradation in response to TOR 
signaling. Thus to test this, we treated cells with cycloheximide and examined the membrane 
distribution of Vba4-GFP, the only client protein that is constitutively degraded by the vReD 
pathway. We find that Vba4-GFP continues to be excluded from boundary membranes (Figures 
16A and B) within the cell population (Figure 16C) but more puncta appear adjacent to vacuoles 
(Figure 16C) in the presence of CHX, indicating that sorting of Vba4-GFP into the vReD 
pathway is enhanced. In addition, Vba4-GFP is spared from internalization into the vacuolar 
lumen upon fusion, despite the presence of a lumenal membrane fragment, and instead 
accumulates on puncta (Movie S18). Importantly, treatment with rapamycin, a TOR signaling 
inhibitor, blocked this effect (Figures 16A, 16B and 16D), confirming that TOR activation was 
required. We made similar observations in vitro (Figures 16E–H) and found that more Vba4-
GFP accumulated in the vacuole lumen in the presence of CHX (Figure 16G). Consistent with 
this observation, GFP cleavage from Vba4 was enhanced in the presence of CHX (Figure 16H). 
Importantly, the observed increase in lumenal delivery (Figure 16G) and degradation (Figure 
16H) of Vba4-GFP was blocked by pretreating isolated organelles with rapamycin. Thus, we 
conclude that Vba4-GFP degradation by the vReD pathway can be regulated by TOR signaling. 
Can other proteins get shunted into the vReD pathway in response to TOR signaling? 
Although Ypq1-GFP and Cot1-GFP are constitutively degraded by the ILF pathway (see Figure 
13), they are rerouted into the vReD pathway in response to changing substrate levels (Figure 
14). Thus, it is possible that TOR activation by CHX may also drive Ypq1-GFP or Cot1-GFP into 
the vReD pathway for degradation. To answer this question, we treated cells expressing either 
protein with CHX and examined the effects on their cellular membrane distribution (Figures 
16A–C). Both proteins continued to be present in boundary membranes in all cells, and neither  
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Figure 16. Protein degradation by the vReD pathway is stimulated in response to TOR 
signaling 
(A) Fluorescence micrographs of docked vacuoles within cells expressing Vba4-GFP, Cot1-GFP 
or Ypq1-GFP under standard conditions (CTL) or after incubation with cycloheximide (CHX), 
rapamycin (RAP), or both. Arrows highlight puncta adjacent to the vacuolar membrane. (B) 
Images from a time-lapse video of a vacuole fusion event within a yeast cell expressing Vba4-
GFP after CHX treatment, stained with FM4-64 to label the vacuolar membrane. Dotted line 
outlines the yeast cell as observed in DIC. Scale bars, 1 μm (in vivo). (C) Quantification of in 
vivo micrographs demonstrating the percent of cells with GFP fluorescence present within the 
boundary membrane and the percent of cells with dots (puncta) adjacent to the vacuolar 
membrane (n ≥ 204). (D) Micrographs of vacuoles isolated from cells expressing Vba4-GFP 
under standard fusion conditions (CTL) or after treatment with CHX, RAP or both. Boundary 
membranes lacking GFP fluorescence are indicated by open arrowheads and GFP fluorescence 
profile are plotted (left panel). Arrows highlight puncta adjacent to the vacuolar membrane. Scale 
bar, 2 μm (in vitro). Cumulative probability curves of GFP fluorescence intensity within the 
boundary membrane (E) or vacuolar lumen (G) of micrographs presented in D. (n ≥ 104). (F) 
Quantification of the number of dots (puncta) compared to the number of vacuoles (normalized to 
Vba4-GFP CTL at time zero) from micrographs as shown in D. (n ≥ 359 vacuoles). (H) Western 
blot analysis of Vba4-GFP degradation before or after fusion has progressed for 30 minutes under 
standard fusion conditions or after treatment with CHX, RAP or both. See also Figure S13 and 
Movie S18.  
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really appeared on puncta, suggesting that CHX did not reroute Ypq1-GFP or Cot1-GFP from the 
ILF pathway to the vReD pathway. These results were confirmed in vitro (Figure S13A), 
whereby CHX enhanced sorting into the boundary membrane (Figure S13B), increased lumenal 
delivery (Figure S13C) and increased degradation (Figure S13D) of Ypq1-GFP and Cot1-GFP. 
Furthermore, protein degradation was blocked by fusion inhibitors (Figure S13E), confirming 
that enhanced degradation of Ypq1-GFP and Cot1-GFP by TOR activation was mediated by the 
ILF pathway instead of the vReD pathway. 
 
4.4.5 The ILF pathway exclusively mediates vacuolar polytopic protein quality control 
To prevent cellular proteotoxicity and maintain proteostasis, misfolded or damaged proteins 
are selectively cleared by multiple degradation pathways, such as the proteasome or chaperone-
mediate autophagy for cytoplasmic proteins (Cuervo and Dice, 2000b; Kaushik et al., 2011), the 
ESCRT pathway for some surface polytopic proteins (Babst, 2014), and the ILF pathway for 
vacuolar polytopic proteins including Cot1 (McNally et al., 2017). Although its contribution to 
protein quality control has not been assessed, the vReD pathway relies on similar ESCRT 
machinery that clears misfolded surface proteins (Raiborg and Stenmark, 2009; Li et al., 2015a). 
Thus, it is possible that, like the ILF pathway, the vReD pathway may clear some misfolded 
vacuolar transporter proteins. To test this hypothesis, we subjected cells to heat stress to induce 
protein misfolding (Keener and Babst, 2013; McNally et al., 2017) and monitored changes in the 
membrane distributions of Vba4-GFP, Ypq1-GFP and Cot1-GFP within living cells (Figures 
17A and B). We found that Ypq1-GFP and Vba4-GFP are both sorted into the boundary 
membrane between docked organelles in response to heat stress in nearly all cells analyzed 
(Figure 17C), similar to Cot1-GFP as previously reported (McNally et al., 2017). As Vba4-GFP 
is normally excluded from boundary membranes, we also used HILO microscopy to confirm that 
it was indeed internalized within an ILF upon homotypic lysosome fusion after heat stress within 
living cells (Figure 17D; Movie S19). We made similar observations when VPS36 or VPS27 
were deleted, confirming that sorting of misfolded proteins into the boundary in response to heat 
stress was ESCRT-independent (Figures 17A–C).  
To better characterize this process, we replicated these results in vitro (Figure 18A), 
whereby heat stress caused enrichment of all three proteins within the boundary membrane 
(Figure 18B) and enhanced accumulation within the vacuole lumen (Figure 18C). To confirm 
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that these misfolded proteins were degraded, we assessed GFP-cleavage by western blot and 
found that degradation of Vba4-GFP, Cot1-GFP and Ypq1-GFP was enhanced by heat stress 
(Figure 18D). Since the ILF pathway relies on the vacuole fusion machinery for protein sorting 
and internalization (McNally et al., 2017), we reasoned that blocking the membrane fusion 
reaction would also inhibit protein sorting into the boundary membrane. To test this, we added 
the vacuole fusion inhibitors rGdi1 and rGyp1-46 (to block Rab-GTPase activation; Brett et al., 
2008). As expected, blocking Rab activity prevented protein sorting (Figures 18A and B), 
internalization (Figure 18C), and proteolysis (Figure 18D), confirming that membrane fusion 
machinery, not ESCRTs, are required for observed polytopic protein degradation. In sum, we 
conclude that the ILF pathway, not vReD, is responsible for clearing misfolded vacuolar 
polytopic proteins, and thus is an important contributor to cellular protein quality control. 
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Figure 17. The ILF pathway degrades misfolded lysosomal polytopic proteins within live 
cells 
(A) Fluorescence and DIC micrographs of docked vacuoles from cells expressing Vba4-GFP, 
Cot1-GFP or Ypq1-GFP in wild type or ESCRT deficient (vps27∆ or vps36∆) strains after heat 
stress treatment. Arrow highlights puncta adjacent to the vacuolar membrane. (B) Line-scan 
analysis of in vivo images shown in A illustrating GFP (blue) or FM4-64 (red) fluorescence 
distribution along the dotted line. (C) Quantification of in vivo micrographs demonstrating the 
percent of cells with GFP fluorescence present within the boundary membrane and the percent of 
cells with dots (puncta) adjacent to the vacuolar membrane under standard fusion conditions 
(CTL) or when cells were treated with heat stress (HS). CTL bars are quantifications from Figure 
14 D and E. (n ≥ 148). (D) Images from a time-lapse video demonstrating a vacuole fusion event 
within a yeast cell expressing Vba4-GFP after heat stress (HS) treatment, stained with FM4-64 to 
label the vacuolar membrane. Dotted line outlines the yeast cell as observed in DIC. Scale bars, 1 
μm (in vivo). See also Movie S19.  
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Figure 18. The ILF pathway degrades polytopic proteins when misfolded by heat stress on 
isolated vacuoles 
(A) Fluorescence micrographs of vacuoles isolated from cells expressing Vba4-GFP, Cot1-GFP 
or Ypq1-GFP from wild type or ESCRT deficient strains after treatment with heat stress (HS) in 
the absence or presence of the fusion inhibitors rGdi1 and rGyp1-46 (F.I.). Boundary membranes 
containing (closed arrowhead) or lacking (open arrowhead) GFP fluorescence are indicated and 
GFP fluorescence profile are plotted (left panel). Scale bar, 2 μm (in vitro). Cumulative 
probability curves of GFP fluorescence intensity within the boundary (B) or vacuolar lumen (C) 
of micrographs presented in A. (n ≥ 102). (D) Western blots comparing Vba4-GFP, Cot1-GFP 
and Ypq1-GFP degradation kinetics before and after fusion under standard conditions (CTL) or 
when isolated vacuoles were subjected to heat stress (HS) in the absence or presence of fusion 
inhibitors rGdi1 and rGyp1-46 (F.I.). 
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4.5 Discussion 
4.5.1 vReD and ILF pathways cooperate for lysosomal proteostasis 
Despite being critical for lysosome physiology, it was unclear how lysosomal nutrient 
transporter proteins lifetimes were regulated until recently, when two processes were 
independently discovered: the ESCRT-dependent vReD pathway (Li et al., 2015a) and ESCRT-
independent ILF pathway (McNally et al., 2017). However, if the two pathways function 
independently or cooperate to maintain or remodel the protein landscape on vacuolar lysosome 
membranes remained elusive. Herein, we find that they work together to control lysosomal 
proteostasis and begin to decipher their distinct contributions to this process: (1) Client proteins 
are shared by both pathways, as vReD client proteins Ypq1 and Cot1 are constitutively degraded 
by the ILF pathway (Figure 13). (2) Both pathways are responsible for constitutive turnover of 
vacuolar nutrient transporters, as we identified a new vReD client protein, Vba4, which is the 
first shown to be constitutively degraded by this pathway (Figures 14 and 15). (3) Similar to the 
ILF pathway, the vReD pathway responds to TOR activation suggesting that both may play a role 
in cellular metabolic homeostasis (Figure 16). (4) Only the ILF pathway appears to mediate 
quality control of lysosomal polytopic proteins, as all proteins studied are shunted into this 
pathway when misfolded upon heat stress (Figures 17 and 18). (5) The ILF pathway 
compensates for the loss of the vReD pathways when ESCRT function is impaired (Figures 14 
and 15). Two questions immediately arise from these discoveries: What allows one pathway to 
compensate for the other? Why two pathways? 
 
4.5.2 What allows one pathway to compensate for the other?  
Here we show that when components of the ESCRT machinery are deleted, the vReD 
pathway is blocked and the ILF pathway compensates for this loss by degrading Vba4 for 
example (Figure 14). We have also shown that the ILF pathway degrades internalized surface 
proteins that are normally packaged into intralumenal vesicles at the endosome by ESCRTs when 
MVB formation is impaired (McNally and Brett, submitted). These results provide important 
insight into the underlying mechanisms that maybe shared. Fundamentally, both pathways 
require a mechanism to recognize and label client polytopic proteins, and selectively sort them 
into an area of membrane that is internalized into the organelle lumen for exposure to and 
degradation by acid hydrolases. These two pathways diverge at the sorting stage, as the sorting 
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machinery is different (i.e. ESCRT-dependent versus ESCRT-independent), as are the membrane 
locations where sorting occurs and the mechanisms used for membrane severing required for 
internalization. Thus, we argue that they share the same labeling machinery. Selective client 
protein sorting by the vReD pathway requires protein ubiquitylation by E3-ubiquitin ligases and 
E4-adapter proteins (Li et al., 2015a; Li et al., 2015b). It is not surprising that the E3-ligase Rsp5 
implicated in the vReD pathway also ubiquitylates surface proteins sorted into the canonical 
MVB pathway, as both are ESCRT-dependent (Horák, 2003; MacDonald et al., 2012). This 
ligase is also important for mediating soluble protein labeling for degradation by the proteasome 
(Glickman and Ciechanover, 2002), highlighting that most degradation pathways share protein 
labeling machinery. 
However, the basis of client protein labeling in the ILF pathway remains unknown. But 
given that it can degrade vReD client proteins in the absence of ESCRT function and all cellular 
degradation pathway seem to share protein labeling machinery, we speculate that the ILF 
pathway also recognizes and sorts client proteins ubiquitylated by E3-ligases and E4-adapter 
proteins. We have initiated studies to test this hypothesis and preliminary work indicates that the 
E4-adapter protein Ssh4, responsible for Ypq1 ubiquitylation for degradation by the vReD 
pathway (Li et al., 2015a), also mediates degradation of the copper-oxidase Fet5 by the ILF 
pathway (data not shown). Thus, because they share the same protein labeling machinery, it 
seems that the ILF and vReD pathways coordinate functions with other cellular protein 
degradation pathways to restructure the cellular proteome, e.g. for metabolic reprogramming 
which requires remodeling the proteomes of lysosomes, mitochondria, peroxisomes, lipid 
droplets, ER, and cytoplasm (Lemus and Goder, 2014; Tasset and Cuervo, 2016). 
 
4.5.3 Why two pathways? 
There are two important distinctions between these two pathway that may explain why they 
co-exist: First, the vReD pathway permits vacuole polytopic protein recycling, whereby after 
sorting and delivery to the endosomes client proteins could avoid being packaged into ILVs by 
the ESCRT machinery. If so, they would remain on the MVB perimeter membrane, and upon 
MVB-vacuole fusion, be returned to the vacuole membrane. This is akin to surface receptor 
protein recycling, whereby after internalization, receptors can be packaged into ILVs for 
degradation or returned to the surface (Maxfield and McGraw, 2004). Thus, we propose that the 
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vReD pathway acts in a similar manner, to regulate levels of nutrient transporter proteins on 
vacuolar lysosome membranes. On the other hand, sorting into the ILF pathway ensures client 
protein degradation, as they are immediately exposed to lumenal proteases. This is based on the 
assumption that ILF-vacuole membrane “back” fusion does not occur, as GFP accumulates 
within the lumen in a diffuse pattern, not on puncta, over the course of the fusion reaction 
(Figures 13 - 18), and ILFs fragment and seem to dissolve quickly after being formed within the 
lumen (Movies S13 and S17; also see McNally et al., 2017). This explains why all misfolded 
proteins – which cannot be reused – are shunted into the ILF pathway for degradation (Figures 
17 and 18). 
It should be noted however, that the same group that published the first papers describing the 
vReD pathway now claim that an endosomal intermediate is not required (Zhu et al., 2017). 
Rather, the ESCRT machinery is recruited to the vacuole membrane where it drives ILV 
formation directly into the vacuole lumen. Why the authors would contradict their original claims 
and why this mechanism exists as an alternative to microautophagy, which produces similar 
products, is unclear. However, we find that GFP-positive puncta continue to form, albeit less 
efficiently, when components of the ESCRT machinery are deleted (Figures 15A and B). We 
argue that this phenotype supports the original hypothesis, whereby client proteins accumulate at 
an endosomal intermediate adjacent to the vacuole membrane, because they cannot be packaged 
into ILVs by ESCRTs. This result cannot explain the alternative, where we would expect sorting 
on the vacuole membrane to be entirely abolished, resulting in no observable puncta.  
This alternative model also suggests that the vReD pathway does not require membrane 
fusion. This is based on two observations: (1) Applying heat shock to inhibit temperature-
sensitive alleles of genes necessary for endosome and vacuole membrane fusion (Vps18 and 
Vam7) does not impair Ypq1-GFP degradation by the vReD pathway (Zhu et al., 2017). 
However, prolonged heat shock induces many cellular stress pathways, and here we show that it 
also stimulates protein misfolding and degradation by the ILF pathway. Using an alternative 
approach that does not require heat shock, we find that protein degradation by the vReD pathway 
is blocked in vitro by protein inhibitors that target both endosome and vacuole membrane fusion 
(e.g. Vba4-GFP; Figure 18D). Thus, we argue that perhaps other cellular mechanisms stimulated 
by heat stress could account for their observations. (2) ILVs are observed within vacuoles after 
triggering degradation of Ypq1-GFP using a “RapiDeg” method, whereby addition of rapamycin 
 101  
induces binding of a Ypq1 fusion protein (Ypq1-GFP-2xFKBP) to FBR domain of human mTOR 
fused to ubiquitin (FRB-Ubx3), which mimics K63 ubiquitin linkage (Zhu et al., 2017). Only in 
the presence of rapamycin, these two inserted motifs rapidly heterodimerize to ubiquitinate Ypq1, 
without requiring its previously characterized E3 Ub-ligase (Rsp5) and E4-adaptor protein (Ssh4; 
Li et al., 2015a; Zhu et al., 2017). Once ubiquitinated, Ypq1 is sorted off of the vacuolar 
membrane and into the lumen where it is degraded. But the origin of these ILVs is unclear, as 
they do not show how they are formed – noting that herein we show formation of ILFs to 
demonstrate that they are a product of vacuole fusion (Figures 13C, 14B, 16B and 17D; Movies 
S12 – S19). Also, herein we show that addition of rapamycin affects protein degradation by the 
vReD pathway, suggesting that this method has off-target effects that interfere with the 
interpretation of the data. Importantly, these vesicles are only observed in an unusual mutant 
background (Zhu et al., 2017). Thus, given that the method of ubiquitylation to trigger 
degradation and the genetic background are not found in nature, it is not clear whether this 
process is physiologically relevant. Whereas, herein we show how these two pathways contribute 
to protein turnover in wild type cells under normal growth conditions. Thus, in all, our data 
support the original model describing the vReD pathway that requires an endosomal 
intermediate, possibly permitting lysosomal polytopic protein recycling, as it does for surface 
proteins.  
The second distinction between the ILF and vReD pathways is organelle copy number: The 
vReD pathway can function when cells contain only a single vacuolar lysosome. However, 
because it requires merger of two organelle membranes, the ILF pathway functions only in cells 
with two or more vacuoles. Although this distinction seems trivial, it is worth noting that most 
micrographs presented in the reports by Emr and colleagues exclusively show cells containing 
single vacuoles (Li et al., 2015a; Li et al., 2015b; Zhu et al., 2017), which only permits analysis 
of the vReD pathway. Here we use an unbiased approach to study both pathways, by studying all 
cells in the population, i.e. those with single or multiple vacuoles. When conducting experiments, 
we did notice that GFP-positive puncta were more likely to be found in cells containing single 
vacuoles, suggesting that the vRed pathway may prevail in these cells, whereas the ILF pathway 
would only contribute to vacuolar lysosome protein turnover in cells with multiple organelles. 
When considering this idea, it is important to note that metazoan cells contain hundreds to 
thousands of lysosomes (Luzio et al., 2014). These organelles are particularly mobile and 
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frequently make contact often resulting in fusion (Wang et al., 2002; Luzio et al., 2007; Wickner, 
2010). Each of these fusion events could accommodate protein turnover by the ILF pathway, 
which seems like a logical and efficient mechanism for maintaining organelle homeostasis or 
accommodating proteome remodeling. Whereas, the vReD pathway requires multiple membrane 
trafficking steps and seems to be most relevant when only a single vacuolar lysosome is present – 
something that never occurs in metazoan cells – questioning its relevance to human cell 
physiology. 
 
4.5.4 Physiological relevance 
What roles do these pathways potentially play in lysosome and cell physiology? All proteins 
have finite lifetimes. Lysosomal transporter proteins are proposed to have shorter than average 
lifetimes because their lumenal faces are exposed to acid hydrolases making them particularly 
susceptible to damage. In support of this idea, here we find that both the ILF and vReD pathways 
constitutively turnover (presumably defective) nutrient transporters from the vacuolar lysosome 
membrane. Without such mechanisms in place, these damaged proteins would accumulate, which 
is thought to permeabilize the lysosome membrane. This in turn facilitates release of lumenal 
hydrolases into the cytoplasm, which is catastrophic for the cell and implicated in cell death 
programs (Aits and Jäättelä, 2013; Donida et al., 2017). Here we find the ILF pathway clears and 
degrades misfolded lysosomal polytopic proteins and thus we speculate that its function is critical 
for preserving lysosome integrity necessary for cell survival or it may be inhibited during 
programmed cell death.  
Beyond potential roles in organelle homeostasis, the protein landscape on the lysosome 
membrane defines organellar signaling properties (by possibly regulating levels of Ca2+ 
transporter or channels) and metabolic output (by changing the repertoire of nutrient 
transporters). This is akin to altering the expression profile of transporters or receptors on the 
plasma membrane in response to changes in nutrient levels or cellular signaling to mediate a 
myriad of physiological events. Here we show that the ILF and vReD pathways respond to 
similar stimuli to selectively down regulate some nutrient transporters and speculate that this 
alters organelle function for diverse cell physiology, including the cellular aging program that 
depends on changes in lysosome function (Carmona-Gutierrez et al., 2016). The machinery 
underlying both pathways and most client proteins are evolutionarily conserved, suggesting that 
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they contribute to lysosome physiology in all eukaryotic cells. However, currently neither 
pathway has been shown to function in metazoan cells. But we hypothesize that they also 
determine lysosomal polytopic protein lifetimes and contribute to lysosome physiology in a 
similar manner, whereby they may also contribute to human lysosomal disorders linked to 
mutations in lysosomal transporters, e.g. the cholesterol transporter Ncr1 and Niemann-Pick type 
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Chapter 5. Discussion 
5.1 Overview 
We sought to investigate how eukaryotic cells control the expression levels of lysosomal 
polytopic proteins and combat ESCRT-impairment using Saccharomyces cerevisiae and its 
vacuolar lysosome as models. All proteins tested and their primary cellular functions are listed in 
Table 5. This work is represented as three publications, each an individual chapter with 
conclusions as follows: 
In Chapter 2, we discovered a new cellular protein degradation pathway, that we named the 
IntraLumenal Fragment (ILF) pathway, which intrinsically accommodates the internalization and 
degradation of resident vacuolar lysosome polytopic proteins. Prior to this work, these proteins 
lacked a described mechanism of regulated turnover, despite their obvious importance to 
eukaryotic cell physiology. We found that resident nutrient transporters are selectively sorted, 
internalized, and degraded within the lysosomal (vacuolar) lumen upon homotypic organelle 
membrane fusion (Figures 2 and 3). Importantly, we show that this process is independent of the 
autophagy or ESCRT machinery (Figure S4 and S5) and instead relies on the membrane fusion 
machinery, specifically the Rab GTPase Ypt7 for protein sorting and internalization (Figures 7 
and S6). These proteins have diverse lifetimes (Figures 2 and 3) that are regulated in response to 
protein quality control (Figure 4), changes in cognate substrate levels (Figure 6), and TOR 
activation induced by cycloheximide treatment (Figures 5 and S2). We propose that the ILF 
pathway plays a critical role in lysosome remodeling and homeostasis by changing the lysosomal 
membrane protein landscape to accommodate changes in cell physiology, such as clearing 
misfolded proteins to retain organelle function or as cells age. 
In Chapter 3, we demonstrate that plasma membrane polytopic proteins, such as surface 
receptors and transporter, can also be sorted for degradation by the ILF pathway when localized 
to the vacuolar membrane. This work illustrates how the ILF pathway can accommodate the 
degradation of known ESCRT client proteins by compensating for the MultiVesicular Body 
pathway when MVB formation is impaired (Figures 9, 11, 12 S10 and S12), thus permitting cell 
survival. In addition, we show that some surface proteins can bypass ESCRT machinery for 
degradation by the ILF pathway, identifying the ILF pathway as an ESCRT-independent pathway 
for surface protein turnover (Figures 10 and S9). In both cases, surface proteins that are 
internalized by endocytosis avoid packaging into intralumenal vesicles and upon fusion between 
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the endosome and the lysosome, proteins are redistributed to the lysosomal membrane where they 
can interact with and be sorted by the membrane fusion machinery for degradation (Figures 10, 
11, 12, S9 and S11). Surface protein sorting and degradation by the ILF pathway is in response to 
changes in substrate levels (Figures 9 and S8), upon protein misfolding (Figures 10, 11, S9 and 
S10) and in response to TOR activation (Figures 12 and S11). Our data suggests that the ILF 
pathway is an important contributor to the overall regulation of not only lysosomal membrane 
proteins, but also of surface polytopic proteins. Thus, we propose that the ILF pathway can likely 
degrade other proteins within eukaryotic cells if they can localize to lysosomal membranes, such 
as soluble proteins known to function at lysosomal membranes.  
In Chapter 4, we addressed the contributions of the ILF and vReD (Vacuole membrane 
REcycling and Degradation) pathways in remodeling the lysosomal polytopic protein landscape 
and found that the two pathways complement each other. Since the vReD pathway has only been 
shown to function in response to changes in substrate levels, we first concluded that the ILF 
pathway constitutively degrades both previously reported vReD cargoes, Ypq1 and Cot1, in the 
presence or absence of ESCRT proteins (Figure 13). We identified a new, constitutive vReD 
cargo, the amino acid permease Vba4, and confirmed that sorting by vReD requires the ESCRT-
machinery (Figures 14 and 15). Similar to surface protein degradation, the ILF pathway 
compensates for ESCRT impairment (Figures 14 and 15). Lastly, we show that all lysosomal 
membrane proteins tested, including Vba4, are shunted into the boundary membrane for 
degradation upon heat stress (Figures 17 and 18). This key finding highlights the ILF pathway as 
a universal quality control mechanism for lysosomal polytopic protein turnover, contributing to 
preserving organelle integrity and cellular homeostasis.  
 
Taken together, we have identified several vital physiological roles the ILF pathway 
performs within cells. First, we demonstrated that the ILF pathway controls the quantity and 
quality of polytopic proteins, acting as a critical quality control mechanism (Figures 4, 10, 11, 
17, 18, S9 and S10). Proteins are constantly at risk of misfolding. In order to properly fulfill its 
cellular function, a protein must achieve the appropriate conformation and localize to the correct 
cellular compartment. Due to the high diversity of proteins and the types of damage that can 
induce misfolding, eukaryotic cells have evolved elaborate quality control networks to remove 
misfolded proteins in various cellular compartments, such as the cytoplasm, nucleus, 
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endoplasmic reticulum, and mitochondria (Ciechanover and Kwon, 2015) to avoid proteotoxicity 
and preserve cellular viability. These quality control mechanisms are capable of monitoring and 
maintaining the cellular proteome whereby misfolded proteins can be refolded, degraded, or 
sequestered into specialized quality control compartments to maintain protein homeostasis, or 
“proteostasis” (Balch et al., 2008). Appropriate clearance of these misfolded proteins is essential 
as their accumulation will ultimately compromise cellular homeostasis and many human diseases, 
including lysosomal storage disorders (Valastyan and Lindquist, 2014), cancer (Xu et al., 2011), 
cystic fibrosis (Koulov et al., 2010), and numerous neurodegenerative disorders (Voisine et al., 
2010) are linked to protein misfolding or aggregation. Additionally, one function of the MVB 
pathway is to clear misfolded surface proteins from the plasma membrane. Since the ILF pathway 
is analogous to the MVB pathway but functioning at lysosomal membranes, it is not surprising 
that the ILF pathway is also implicated in the clearance of misfolded polytopic proteins, to 
preserve organelle function and avoid proteotoxicity. Understanding how the ILF pathway 
functions as a protein quality control mechanism in recognizing and targeting misfolded proteins 
for degradation could unveil new therapeutic strategies or targets in various neurodegenerative 
diseases linked with toxic accumulation of protein aggregates including Alzheimer’s, 
Parkinson’s, and Huntington’s disease. 
Equally important to proteostasis is the regulation of ions and nutrients, which requires 
transporter function. Numerous studies have shown that the MVB pathway functions to 
downregulate surface transporters in response to changes in cognate substrate levels. Under 
normal growth conditions, surface transporters such as Gap1 (a general amino acid permease), 
Can1 (an arginine permease), and Mup1 (a methionine permease) are stable and active at the 
plasma membrane. However, in response to excess substrates, these transporters undergo 
ubiquitin-dependent endocytosis and delivery to the lysosomal lumen for degradation 
(MacDonald et al., 2012; Ghaddar et al., 2014). This represents an important mechanism for 
regulating nutrient transporter levels at the surface to balance between nutrient uptake from the 
extracellular environment and metabolism. Since the lysosome is crucial for nutrient sensing and 
for the storage of biomaterials, a similar mechanism is necessary to balance transporter levels and 
intracellular nutrient levels. Here we demonstrate that the ILF pathway performs a related 
function acting at the vacuolar lysosome by regulating the degradation of Vph1-GFP, a 
component of the V-ATPase, in response to changes in cytoplasmic pH (Figure 6). Importantly, 
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we confirm that this substrate-induced degradation is selective, whereby degradation of only the 
transporter recognizing the substrate is either stimulated or suppressed (Figures 6 and S3). 
Lastly, we demonstrate that the ILF pathway can regulate protein lifetimes in response to 
TOR activation induced by cycloheximide treatment (Figures 5, 12, 16, S2, S11 and S12). The 
mechanistic Target of Rapamycin (mTOR) is a critical signaling serine/threonine kinase 
important for a variety of cellular processes including cellular metabolism, regulating organismal 
growth and homeostasis, and for supplying the cell with nutrients under metabolic stress 
conditions (Laplante and Sabatini, 2012; Perera and Zoncu, 2016). mTOR (TOR in yeast) is 
essential for lysosomal (or vacuolar) nutrient sensing and metabolic regulation through their 
physical and functional association. mTOR interacts with several different proteins to form two 
distinct complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Of the two 
complexes, mTORC1 is better characterized and often referred to as the master regulator of cell 
growth and proliferation. mTORC1 is responsible for modulating cellular metabolism by 
incorporating environmental and cellular cues, such as growth factors, energy levels, cellular 
stress or amino acids (Dunlop and Tee, 2009). By integrating these cues, mTORC1 can promote 
growth through phosphorylating substrates that promote biosynthetic processes, such as mRNA 
translation and lipid synthesis, or substrates that inhibit catabolic pathways like autophagy.  
It has been previously shown that some surface transporters undergo ubiquitin-dependent 
endocytic downregulation in response to TOR activation triggered by cycloheximide (MacGurn 
et al., 2011). In this case, addition of cycloheximide mimics nutrient replete conditions, thus 
boosting intracellular amino acid levels and activating TOR. Once activated, TOR functions to 
control elevated nutrient levels by regulating the abundance of transporter proteins on the surface. 
The same logic holds true in reference to the lysosome and its membrane proteins. The addition 
of cycloheximide triggers a cellular response to combat the changes in nutrient availability and 
uptake by stimulating lysosomal transporter degradation by the ILF pathway. Furthermore, TOR 
is directly associated with the lysosome allowing for continuous communication and the ability 
for quick adaptation in response to stress conditions. Since the lysosome is a critical source of 
nutrients for the cell and TOR is important for integrating lysosomal and cytoplasmic nutrient 
information, the ILF pathway could represent one way to remodel the lysosomal membrane in 
response to metabolic stress.  
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Our studies describe another mechanism for selective cellular protein degradation that is intrinsic 
to homotypic organelle membrane fusion. Just as the discovery of endocytosis was paramount to 
our understanding of how surface transporters and receptors contribute to cell physiology, the 
IntraLumenal Fragment pathway will likely have similar impact on our understanding of 
lysosome physiology and function. We propose that the ILF pathway plays a critical role in 
lysosome remodeling and homeostasis by changing the membrane protein landscape to 
accommodate changes in cell physiology, such as clearing misfolded proteins to retain organelle 
function or as cells age. The ILF pathway may also reveal new contributions to overall cellular 
physiology, thus contributing to our fundamental understanding of metabolic regulation and may 
point to new therapeutic avenues in several human diseases including storage disorders, 
neurological diseases, and cancers. 
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Table 5. List of polytopic proteins studied and their primary cellular function 
 Mammalian homolog Cellular function 
Lysosomal polytopic   
Fth1 NRAMP1 Iron efflux transporter 
Fet5 Hephaestin Multicopper oxidase,  
Vph1 ATP6V0A1 V0 subunit of H+-ATPase 
Cot1 ZnT2 Zinc transporter 
Ncr1 NPC1 Sterol transporter 
Ybt1 ABCC/MRP Bile acid and phosphatidylcholine 
transporter 
Ycf1 CFTR Glutathione transporter 
Sna4 ? Potential Rsp5 adaptor protein 
Vba4 Major facilitator 
superfamily 
Basic amino acid transporter 
Ypq1 PQLC2 Cationic amino acid transporter 
   
Surface polytopic   
Mup1 LAT1 Methionine permease 
Can1 CAT/SLC7 Arginine permease 
Hxt3 GLUT/SLC2 Glucose transporter 
Aqr1 Major facilitator 
superfamily 
Major facilitator superfamily-type 
transporter that excretes amino acids 
Ste3 GPCRs a-factor pheromone receptor 
Itr1 HMIT Myo-inositol transporter  
  
 110  
5.2 Future Directions 
The discovery of the IntraLumenal Fragment pathway has opened new avenues to assess 
protein degradation and its contributions to eukaryotic cell physiology; however several central 
questions persist: 
 
Herein, we demonstrate that the ILF pathway can sort and degrade non-lysosomal membrane 
proteins (Chapter 3), but can it degrade soluble proteins, lysosomal membrane-associated 
proteins or lipids? For example, the EGO (Exit from G0) GTPase complex (homologous to the 
mammalian Rag-GTPase complex Ragulator) is a vacuolar-membrane-associated protein 
complex that interacts with and activates TORC1 to mediate amino acid signaling (Binda et al., 
2009; Zoncu et al., 2011; Kingsbury et al., 2014). Thus, it is likely that the ILF pathway can 
selectively degrade components of the EGO complex as well as TORC1 – which in yeast is 
constitutively located on the vacuolar membrane while mammalian (m)TORC1 is recruited to 
lysosomal membranes upon amino acid signaling (Zoncu et al., 2011). Just as the protein 
machinery (HOPS, Ypt7 and SNAREs) concentrates at the vertex domain to promote organelle 
membrane fusion (Wang et al., 2002) fusogenic, regulatory lipids also play a critical role in 
fusion events. Regulatory lipids, including phosphatidylinositol 3-phosphate (PI(3)P), 
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), ergosterol (a yeast sterol), and diacylglycerol 
(DAG), are recruited to and concentrate at the vertex domain and work together with fusion 
proteins to assemble the vertex ring and facilitate bilayer merger (Fratti et al., 2004). While it has 
yet to be formally tested, DAG appears to concentrate within the boundary membrane (Fratti et 
al., 2004), thus perhaps the ILF pathway can accommodate the selective turnover of DAG or 
other lipids if they remain present within the boundary upon organelle membrane fusion. 
 
While we demonstrated that the ILF pathway is a critical component of the protein quality 
control network, how else does this pathway contribute to organelle and cell physiology? One 
possibility is that the ILF pathways may function to maintain lysosomal membrane integrity. The 
lysosomal lumen is occupied with a wide variety of hydrolases for the catabolism of various 
biomaterials. In order to retain these hydrolases in the lumen, the lysosomal limiting membrane 
must remain stable. If the lysosomal membrane destabilizes and becomes permeable, the lumenal 
contents including hydrolases, such as cathepsins, translocate to the cytosol. This leakage 
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eventually leads to cell death through a pathway called lysosomal cell death (LCD), partially due 
to the acidification of the cytoplasm and to the degradative activity of the released cathepsins, as 
cathepsins B and D are still active at neutral pH (Aits and Jäättelä, 2013; Gómez-Sintes et al., 
2016).   
One cause of lysosomal membrane permeabilization and LCD is oxidative stress caused by 
reactive oxygen species (ROS). At low levels, ROS are necessary for many biochemical 
pathways; however when in excess they lead to the oxidation of a variety of biomaterials leading 
to membrane protein inactivation, DNA mutation induction, alteration of lysosomal enzymatic 
activities, or lipid membrane instability (Aits and Jäättelä, 2013; Donida et al., 2017). In all cases, 
consequences of oxidative stress eventually cause lysosomal membrane destabilization and cell 
death. In addition, a relationship between lysosomal storage disorders (LSDs) and oxidative 
stress has recently emerged. LSDs are characterized by the abnormal accumulation of substances 
within the lysosomal lumen due to a genetic defect in a gene encoding a lysosomal hydrolytic 
enzyme, transporter protein or other gene products critical for lysosome function (Ballabio and 
Gieselmann, 2009). The increase in biomaterials present within the lysosomal lumen is coupled 
with an increase in the number and size of lysosomes, ultimately leading to lysosome dysfunction 
and multisystemic manifestations. Together, this may induce the excessive production of reactive 
species or the depletion of antioxidant capacity resulting in biomolecule oxidative stress (Donida 
et al., 2017). Thus, cellular damage due to oxidative stress likely contributes to the 
pathophysiology of numerous LSDs. The ILF pathway could potentially contribute to membrane 
remodeling and maintain organelle stability by removing proteins inactivated due to ROS or by 
changing the lipid composition to prevent the lysosome from permeabilization and consequent 
cathepsin leakage. 
The lysosome is also largely linked with aging, whereby both physical and chemical 
properties of the lysosome are altered over time. In general, protein degradation declines with 
age, leading to an increase in the overall cellular protein content, many of which possess 
inappropriate posttranslational modifications (Cuervo and Dice, 2000a). While there are likely 
many causes for the age-related decrease in lysosomal activity and proteolysis, one contributing 
factor is an increase in lysosomal membrane fragility. As mentioned, lysosomal membrane 
proteins and lipids are sensitive to oxidative stress causing membrane instability and fragility. 
With age, lysosomal membranes become more fragile and sensitive to oxidative stress, ultimately 
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leading to an increased susceptibility for membrane permeabilization and LCD. In addition, the 
membrane lipid composition influences a variety of lysosomal functions, thus any change in the 
levels of important lipids can affect not only lysosome integrity, but also membrane fusion events 
and the stability of polytopic proteins (Fraldi et al., 2010; Gómez-Sintes et al., 2016). Further 
research is needed to identify if there are any specific age-related changes in lysosomal lipid 
composition, however given their central role in organelle physiology it would not be 
unexpected. If the ILF pathway is capable of selectively degrading lipids, stimulating their 
degradation might be able to overcome some of the physical alterations to the lysosome caused 
by aging.  
A number of age-related diseases are also associated with lysosome membrane 
permeabilization and damage including Alzheimer’s disease, Parkinson’s disease, and 
Amyotrophic lateral sclerosis, among others. These diseases exhibit neurological pathology, as 
with age neurons are particularly vulnerable to lysosomal defects. The exact reasons for this 
sensitivity remain elusive; however it may be due in part to their limited regenerative capacity or 
their lack of compensatory cellular metabolic pathways. In these diseases, aggregate-prone 
proteins, mainly delivered through autophagy, accumulate within the lysosome representing a 
pathological hallmark of each disease (Bellettato and Scarpa et al., 2010; Appelqvist et al., 2013; 
Settembre et al., 2013). Akin to lysosomal storage disorders, abnormal substance build up in the 
lysosome leads to progressive loss of normal cellular function coupled with neurodegeneration. 
Furthermore, an imbalance in the activity of cathepsins in neurons has been detected during 
aging, further contributing to neurodegeneration (Gómez-Sintes et al., 2016). Perhaps stimulating 
the ILF pathway to selectively eliminate associated aggregate-prone proteins may facilitate new 
therapeutic approaches to treatment these diseases. 
 
Is the ILF pathway evolutionarily conserved? Here, we demonstrate that the ILF pathway 
functions within yeast cells and well as on purified vacuoles, but does the same hold true in 
higher eukaryotic organisms? We speculate that the ILF pathway does exist in all eukaryotic cells 
as the underlying molecular machinery is evolutionarily conserved and all of the proteins studied, 
have mammalian orthologues. In addition, the fundamental research uncovering other cellular 
degradation pathways including autophagy and the MVB pathway, were first discovered in yeast 
and later confirmed in higher eukaryotes. Since lysosomal compartments are found to exist in all 
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eukaryotic organisms, using other model organisms such as Caenorhabditis elegans, Arabidopsis 
thaliana, or Drosophila could aid in confirming that the ILF pathway is evolutionarily conserved. 
Additionally, lumenal fragments have been observed within the lysosomes of C. elegans 
(Treusch et al., 2004; Holmes et al., 2007), A. thaliana (Scheuring et al., 2015) and Drosophila 
(Corrigan et al., 2014), but the events resulting in these fragments remains to be elucidated. 
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Figure S1. pHluorin-based assay to monitor polytopic protein internalization during fusion 
(A) Model of the pHluroin assay with the pHluorin tag cytoplasmically tagged and after 
internalization, pHluroin fluorescence is quenched. (B) Micrographs of isolated vacuoles 
expressing Fth1-pHluorin or Fet5-pHuolin in reaction buffer titrated to increasing pH values 
(from 6.08 to 7.92) to visually demonstrate the pHluorin tag is responsive to changes in pH. The 
same acquisition and editing settings were used for all micrographs. (C) pHluorin fluorescence 
intensity was measured in isolated vacuole samples titrated to different reaction buffer pH and 
plotted as a calibration curve demonstrating that the pHluorin tag is cytoplasmic facing and pH 
sensitive. Values shown are relative to the fluorescence intensity measured at pH 7.4. (D) 
Relative pHluroin fluorescence of isolated vacuoles expressing Fet5-pHluorin or Fth1-pHluorin 
over the course of the fusion reaction treated in the absence or presence of 100 μM 
cycloheximide (CHX). After vacuoles were permitted to fuse for 90 minutes, 50 μM nigericin 
was added to demonstrate this is an assay of transporter internalization. Data shown are 
representative traces with values normalized to time zero (n = 2). Scale bar, 2 μm (in vitro). 
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Figure S2. Rapamycin blocks cycloheximide-induced protein degradation by the ILF 
pathway 
(A) Micrographs of docked vacuoles expressing Fet5-GFP pretreated with DMSO in the absence 
or presence of cycloheximide (CHX). (B) Percent of boundaries observed that contain Fet5-GFP 
and (C) GFP fluorescence intensity within the lumen of docked vacuoles under control (CTL), 
rapacmycin (RAP), or DMSO conditions in the absence or presence of cycloheximide (CHX) 
based on micrographic analysis (n ≥ 205). (D) In vitro homotypic vacuole fusion of isolated 
vacuoles was measured after reactions were pretreated increasing concentrations of 
cycloheximide. Grey circle indicates CHX concentration (100 μM) used in all other experiments 
shown. (E) Micrographs of docked vacuoles expressing Fth1-GFP in the presence or absence of 
RAP, CHX or both. (F) Percent of boundaries containing Fth1-GFP and (G) lumenal GFP 
fluorescence were calculated from micrographic analysis (n ≥ 189). (H) Western blot analysis of 
Fth1-GFP degradation in the absence (CTL) or presence of CHX, RAP or DMSO. (I) 
Micrographs of isolated vacuoles expressing Fth1-GFP in wildtype or fpr1Δ strain in the absence 
(CTL) or presence of CHX or RAP. (J) Western blot analysis of Fet5-GFP degradation in 
wildtype or fpr1Δ strain under CTL, CHX, and RAP conditions. (K) Western blot analysis of 
Fth1-GFP degradation in wildtype or fpr1Δ strain under CTL, CHX, and RAP conditions. (L) 
Images from time-lapse videos of vacuole fusion events within live yeast cells expressing either 
Fet5-GFP or Fth1-GFP in the presence of 100 μM puromycin. (M) Micrographs of docked 
vacuoles expressing Fth1-GFP in the absence or presence of PUR and RAP. (N) Western blot 
analysis of Fth1-GFP degradation under CTL, CHX, PUR and RAP conditions. Dotted lines 
outline each cell as observed by DIC. Scale bars, 1 μm. GFP fluorescence intensity profile plots 
(left panel). Scale bars, 1 μm (in vivo) or 2 μm (in vitro); *, P < 0.05. 
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Figure S3. Fet5-GFP sorting and degradation are not affected by changes in pH 
 (A) Micrographs of docked vacuoles expressing Fet5-GFP imaged 60 minutes into the in vitro 
fusion reaction titrated to different pH values. (B) Percent of boundaries containing Fet5-GFP 
and (C) relative lumenal GFP fluorescence (normalized to pH 6.80; standard conditions) were 
calculated from micrographic data (n ≥ 83). (D) Western blot comparing degradation kinetics of 
Fet5-GFP before and after fusion of isolated vacuoles at different pH values. Scale bars, 2 μm (in 
vitro). 
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Figure S4. Autophagy and ESCRT machinery are not required for lysosomal polytopic 
protein sorting by the ILF pathway within cells 
Micrographs of docked vacuoles within cells expressing Fet5-GFP or Fth1-GFP in (A) autophagy 
or (B) ESCRT machinery mutants. Micrographs of yeast cells treated (C) with cycloheximide or 
(D) after heat stress in atg7Δ and vps23Δ mutants. Dotted lines outline each cell as observed by 
DIC. Scale bars, 1 μm (in vivo). 
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Figure S5. The ILF pathway does not require autophagy and MVB machinery for protein 
sorting in vitro  
Micrographs of docked vacuoles expressing Fet5-GFP or Fth1-GFP imaged 60 minutes into the 
in vitro fusion reaction with mutations in the (A) autophagy or (B) ESCRT machinery. (C) 
Micrographs of docked vacuoles expressing Fet5-GFP or Fth1-GFP and (D) western blot analysis 
of degradation in atg7Δ and vps23Δ mutants in the absence (CTL) or presence of cycloheximide 
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Figure S6. The docking machinery is responsible for cycloheximide-induced polytopic 
protein degradation by the ILF pathway 
(A) Micrographs of docked vacuoles expressing Fet5-GFP or Fth1-GFP during the in vitro fusion 
reaction pretreated with cycloheximide (CHX) in the absence (CTL) or presence of 4 μM rGdi, 4 
μM rGdi and 3.2 μM Gyp1-46, or 100 nM rVam7. (B) Percent of boundaries containing Fet5-
GFP or Fth1-GFP under these conditions was calculated from micrographic analysis (n ≥ 203). 
(C) Relative pHluorin fluorescence of isolated vacuoles expressing Fet5-pHluorin or Fth1-
pHluorin during in vitro the fusion reaction incubated with rGdi or rVam7 in CTL or CHX 
treatment. Scale bars, 2 μm (in vitro); *, P < 0.05. 
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Figure S7. FRAP analysis of FM4-64 stained lysosomal vacuole membranes 
(A) FRAP analysis of the boundary membrane between docked GFP-free vacuoles stained with 
FM4-64 10 and 60 minutes after vacuoles were permitted to fuse. (B) FM4-64 fluorescence 
intensity plots demonstrating fluorescence recovery in photobleached boundary membrane ROIs 
and Mf quantifications for boundary and outside membrane ROIs were calculated from 
micrographic data (n ≥ 12). The red dotted box outlines ROIs subjected to photobleaching. Scale 
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Figure S8. Fet5-GFP sorting is not affected by 2-deoxyglucose 
Fluorescence and DIC micrographs of live wild type cells expressing GFP-tagged Hxt3 or Fet5 
before (control) and after addition of 2-deoxyglucose for 30 minutes. Scale bars, 1 µm (in vivo). 
See also Figure 10. 
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Figure S9. Hxt3-GFP is sorted and packaged for degradation by the ILF pathway 
independently of ESCRT machinery in vitro 
(A) Fluorescence micrographs of lysosomes isolated from wild type yeast cells expressing Hxt3-
GFP in the presence of fusion inhibitors (GDI) alone or in the presence of heat stress (HS) 
treatment. (B) Cumulative probability plots (top) of Hxt3-GFP fluorescence measured at 
boundaries between lysosomes isolated from wild type (WT) or vps36∆ cells after fusion in the 
presence or absence of heat stress (HS) alone or with fusion inhibitors (GDI) and respective mean 
(bottom) values as shown in Figure 10C. (C) Fluorescence micrographs of lysosomes isolated 
from wild type cells expressing Hxt3-GFP after 30 minutes of fusion in the presence of rGdi1 and 
rGyp1-46 (GDI) alone or with heat stress (HS) treatment. (D) Cumulative probability plots of 
Hxt3-GFP fluorescence measured within the lumen of lysosomes isolated from WT or vps36∆ 
cells after 0, 30, 60, 90 or 120 minutes of fusion in the presence of heat stress, as shown in 
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Figure S10. The ILF pathway sorts and internalizes the ESCRT client protein Mup1-GFP 
when MVB formation is impaired 
(A) Fluorescence and DIC micrographs of live vps36∆ cells expressing GFP-tagged Mup1 before 
(CTL) and after heat stress (HS) for 30 minutes. 3-dimensional fluorescence intensity (FI) plots 
of Mup1-GFP are shown. (B) Fluorescence of lysosomes isolated from wild type cells expressing 
Mup1-pHluorin during the in vitro fusion reaction under control conditions (CTL) or after heat 
stress (HS) treatment in presence or absence of rGdi1 and rGyp1-46 (GDI). (C) Cumulative 
probability plots of Mup1-GFP fluorescence measured within the lumen of lysosomes isolated 
from WT (top) or vps27∆ (bottom) cells with heat stress treatment after 0, 30, 60, 90 or 120 
minutes of fusion, as shown in Figure 11F. Scale bars, 1 μm (in vivo). 
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Figure S11. The ILF pathway sorts and internalizes surface polytopic proteins in response 
to TOR signaling 
(A) Fluorescence and DIC micrographs of live wild type (left) and vps27∆ or vps36∆ (right) cells 
expressing GFP-tagged Ste3, Can1 or Mup1 after incubation with 100 μM cycloheximide for 70 
minutes. (B) Fluorescence micrographs of lysosomes isolated from wild type Mup1-GFP cells in 
the absence (WT) or presence of pretreatment with cycloheximide (CHX). (C) Fluorescence 
micrographs of lysosomes isolated from vps36∆ cells expressing Hxt3-GFP in the absence or 
presence of cycloheximide (CHX) or rGdi1 and rGyp1-46 (GDI). 3-dimensional fluorescence 
intensity (FI) plots of Mup1-GFP or Hxt3-GFP are shown. Arrowheads indicate GFP-tagged 
protein enrichment (closed) or exclusion (open) within the boundary membrane. (D) 
Fluorescence of lysosomes isolated from wild type cells expressing Mup1-pHluorin during the in 
vitro fusion reaction under control conditions (CTL) or after cycloheximide (CHX) treatment in 
the presence or absence of rGdi1 and rGyp1-46 (GDI). Scale bars, 1 μm (in vivo) or 2 μm (in 











Figure S12. Conditions used to trigger Cot1-GFP degradation by the vReD pathway do not 
impair the membrane fusion reaction 
(A) Fluorescence micrographs of isolated vacuoles from cells expressing Cot1-GFP pretreated for 
5 minutes with different concentrations of ZnCl2 prior to addition to the fusion reaction and 
further incubation for 30 minutes. (B) In vitro homotypic vacuole fusion of isolated vacuoles was 
measured after reactions were pretreated for 5 minutes at 27 °C with increasing concentrations of 
ZnCl2. Grey circle indicates ZnCl2 concentration (25 μM) used in all other experiments shown. 
Scale bar, 2 μm (in vitro). See also Figure 15. 
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Figure S13. The ILF pathway degrades Cot1 and Ypq1 in response to TOR signaling on 
isolated vacuoles 
(A) Fluorescence micrographs of vacuoles isolated from cells expressing Cot1-GFP or Ypq1-
GFP under standard fusion conditions (CTL) or when vacuoles were pretreated with 
cycloheximide (CHX). Boundary membranes containing GFP fluorescence are indicated by 
closed arrowheads and GFP fluorescence profile are plotted (left panel). Scale bar, 2 μm (in 
vitro). Cumulative probability curves of GFP fluorescence intensity within the boundary 
membrane (B) or vacuolar lumen (C) of micrographs presented in A. (n ≥ 142). (D) Western 
blots comparing Cot1-GFP and Ypq1-GFP degradation kinetics before and after fusion under 
standard conditions (CTL) or when isolated vacuoles were pretreated with cycloheximide (CHX) 
(E) in the absence or presence of fusion inhibitors rGdi1 and rGyp1-46 (F.I.). See also Figure 16. 
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Supplemental Movie Legends 
Movie S1, related to Figure 2 
Movie of a vacuole fusion event demonstrating the sorting and internalization of Vph1-GFP into 
the vacuolar lumen. GFP and FM4-64 fluorescence, and the two channels merged are shown. 
 
Movie S2, related to Figure 2 
Movie of a vacuole fusion event demonstrating the exclusion of Fet5-GFP from the boundary 
membrane although a membrane fragment was formed. GFP and FM4-64 fluorescence, and the 
two channels merged are shown. 
 
Movie S3, related to Figure 2 
Movie of a vacuole fusion event demonstrating the sorting and internalization of Fth1-GFP into 
the vacuolar lumen. GFP and FM4-64 fluorescence, and the two channels merged are shown. 
 
Movie S4, related to Figure 3 
Movie of a vacuole fusion event demonstrating the sorting and internalization of Fet5-GFP into 
the vacuolar lumen after heat stress. GFP and FM4-64 fluorescence, and the two channels merged 
are shown. 
 
Movie S5, related to Figure 3 
Movie of a vacuole fusion event demonstrating the sorting and internalization of Fth1-GFP into 
the vacuolar lumen after heat stress. GFP and FM4-64 fluorescence, and the two channels merged 
are shown. 
 
Movie S6, related to Figure 4 
Movie of a vacuole fusion event demonstrating the sorting and internalization of Fet5-GFP into 
the vacuolar lumen after cycloheximide treatment. GFP and FM4-64 fluorescence, and the two 
channels merged are shown. 
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Movie S7, related to Figure 4 
Movie of a vacuole fusion event demonstrating the sorting and internalization of Fth1-GFP into 
the vacuolar lumen after cycloheximide treatment. GFP and FM4-64 fluorescence, and the two 
channels merged are shown. 
 
Movie S8, related to Figure 10 
Movie of a vacuole fusion event demonstrating the internalization of vps36∆ cells expressing 
Hxt3-GFP into the vacuolar lumen. GFP and FM4-64 fluorescence, and the two channels merged 
are shown. 
 
Movie S9, related to Figure 11 
Movie of a vacuole fusion event demonstrating the internalization of vps27∆ cells expressing 
Mup1-GFP into the vacuolar lumen. GFP and FM4-64 fluorescence, and the two channels 
merged are shown. 
 
Movie S10, related to Figure 12 
Movie of a vacuole fusion event demonstrating the internalization of vps27∆ cells expressing 
Mup1-GFP into the vacuolar lumen after cycloheximide treatment. GFP and FM4-64 
fluorescence, and the two channels merged are shown. 
 
Movie S11, related to Figure 12 
Movie of a vacuole fusion event demonstrating the internalization of Hxt3-GFP into the vacuolar 
lumen after cycloheximide treatment. GFP and FM4-64 fluorescence, and the two channels 
merged are shown. 
 
Movie S12, related to Figure 13 
Movie of a vacuole fusion event demonstrating the sorting and internalization of Ypq1-GFP into 
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Movie S13, related to Figure 13 
Movie of a vacuole fusion event demonstrating the internalization of vps36∆ cells expressing 
Ypq1-GFP into the vacuolar lumen. GFP and FM4-64 fluorescence, and the two channels merged 
are shown. 
 
Movie S14, related to Figure 13 
Movie of a vacuole fusion event demonstrating the sorting and internalization of Cot1-GFP into 
the vacuolar lumen. GFP and FM4-64 fluorescence, and the two channels merged are shown. 
Scale bar, 1 μm. 
 
Movie S15, related to Figure 13 
Movie of a vacuole fusion event demonstrating the internalization of vps27∆ cells expressing 
Cot1-GFP into the vacuolar lumen. GFP and FM4-64 fluorescence, and the two channels merged 
are shown. 
 
Movie S16, related to Figure 14 
Movie of a vacuole fusion event demonstrating the exclusion of Vba4-GFP from the boundary 
membrane although a membrane fragment was formed. GFP and FM4-64 fluorescence, and the 
two channels merged are shown. 
 
Movie S17, related to Figure 14 
Movie of a vacuole fusion event demonstrating the internalization of vps36∆ cells expressing 
Vba4-GFP into the vacuolar lumen. GFP and FM4-64 fluorescence, and the two channels merged 
are shown. 
 
Movie S18, related to Figure 16 
Movie of a vacuole fusion event demonstrating the exclusion of Vba4-GFP from the boundary 
membrane although a membrane fragment was formed and the presence of puncta closely 
apposed to the vacuolar membrane after cycloheximide treatment. GFP and FM4-64 
fluorescence, and the two channels merged are shown. 
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Movie S19, related to Figure 17 
Movie of a vacuole fusion event demonstrating the internalization of Vba4-GFP into the vacuolar 
lumen after heat stress. GFP and FM4-64 fluorescence, and the two channels merged are shown. 
 
